Inactive Ingredient Search for Approved Drug Products
Search Names Beginning with S
Inactive Ingredient | Route | Dosage Form | CAS Number | UNII | Maximum Potency per unit dose | Maximum Daily Exposure (MDE) | Record Updated |
---|---|---|---|---|---|---|---|
SACCHARIN | DENTAL | PASTE, DENTIFRICE | 81072 | FST467XS7D | 0.23%w/w | ||
SACCHARIN | DENTAL | POWDER, DENTIFRICE | 81072 | FST467XS7D | NA | ||
SACCHARIN | ORAL | DROPS | 81072 | FST467XS7D | 20mg/1ml | ||
SACCHARIN | ORAL | ELIXIR | 81072 | FST467XS7D | 2mg/1ml | ||
SACCHARIN | ORAL | GRANULE, FOR SOLUTION | 81072 | FST467XS7D | 16mg | ||
SACCHARIN | ORAL | POWDER, FOR SOLUTION | 81072 | FST467XS7D | NA | ||
SACCHARIN | ORAL | SOLUTION | 81072 | FST467XS7D | 10mg/1ml | ||
SACCHARIN | ORAL | SUSPENSION | 81072 | FST467XS7D | 12.5mg/5ml | ||
SACCHARIN | ORAL | SYRUP | 81072 | FST467XS7D | 8mg | ||
SACCHARIN | ORAL | TABLET | 81072 | FST467XS7D | 1.6mg | ||
SACCHARIN | ORAL | TABLET, CHEWABLE | 81072 | FST467XS7D | 0.9mg | ||
SACCHARIN | ORAL | TABLET, EXTENDED RELEASE | 81072 | FST467XS7D | 8mg | ||
SACCHARIN | RESPIRATORY (INHALATION) | AEROSOL, METERED | 81072 | FST467XS7D | 0.05%w/w | ||
SACCHARIN | RESPIRATORY (INHALATION) | AEROSOL, SPRAY | 81072 | FST467XS7D | 0.05%w/w | ||
SACCHARIN | SUBLINGUAL | TABLET | 81072 | FST467XS7D | 0.2mg | ||
SACCHARIN | TOPICAL | OINTMENT | 81072 | FST467XS7D | 0.5%w/w | ||
SACCHARIN CALCIUM | ORAL | SOLUTION | 6381915 | 5101OP7P2I | 17.5mg/5ml | ||
SACCHARIN CALCIUM | ORAL | SYRUP | 6381915 | 5101OP7P2I | 0.5mg | ||
SACCHARIN SODIUM | BUCCAL | FILM | 6155573 | SB8ZUX40TY | 3mg | ||
SACCHARIN SODIUM | BUCCAL | FILM, SOLUBLE | 6155573 | SB8ZUX40TY | 2mg | ||
SACCHARIN SODIUM | BUCCAL | TABLET | 6155573 | SB8ZUX40TY | 0.4mg | ||
SACCHARIN SODIUM | DENTAL | GEL | 6155573 | SB8ZUX40TY | 0.3%w/w | ||
SACCHARIN SODIUM | DENTAL | OINTMENT | 6155573 | SB8ZUX40TY | NA | ||
SACCHARIN SODIUM | DENTAL | PASTE | 6155573 | SB8ZUX40TY | 0.3%w/w | ||
SACCHARIN SODIUM | DENTAL | PASTE, DENTIFRICE | 6155573 | SB8ZUX40TY | 0.2%w/w | ||
SACCHARIN SODIUM | DENTAL | SOLUTION | 6155573 | SB8ZUX40TY | 0.05%w/v | ||
SACCHARIN SODIUM | INTRAMUSCULAR | INJECTION | 6155573 | SB8ZUX40TY | 22mg | ||
SACCHARIN SODIUM | INTRAVENOUS | INJECTION | 6155573 | SB8ZUX40TY | 22mg | ||
SACCHARIN SODIUM | ORAL | CAPSULE | 6155573 | SB8ZUX40TY | 24mg | ||
SACCHARIN SODIUM | ORAL | CONCENTRATE | 6155573 | SB8ZUX40TY | 6mg | ||
SACCHARIN SODIUM | ORAL | ELIXIR | 6155573 | SB8ZUX40TY | 15mg/5ml | ||
SACCHARIN SODIUM | ORAL | GRANULE, FOR SOLUTION | 6155573 | SB8ZUX40TY | 5.5mg/120ml | ||
SACCHARIN SODIUM | ORAL | LIQUID | 6155573 | SB8ZUX40TY | 45mg | ||
SACCHARIN SODIUM | ORAL | PASTE | 6155573 | SB8ZUX40TY | 3mg | ||
SACCHARIN SODIUM | ORAL | POWDER, FOR SOLUTION | 6155573 | SB8ZUX40TY | 533.2mg/5ml | ||
SACCHARIN SODIUM | ORAL | POWDER, FOR SUSPENSION | 6155573 | SB8ZUX40TY | 85mg | ||
SACCHARIN SODIUM | ORAL | SOLUTION | 6155573 | SB8ZUX40TY | 665mg | ||
SACCHARIN SODIUM | ORAL | SUSPENSION | 6155573 | SB8ZUX40TY | 5000mg/5ml | ||
SACCHARIN SODIUM | ORAL | SYRUP | 6155573 | SB8ZUX40TY | 24mg | Y | |
SACCHARIN SODIUM | ORAL | TABLET | 6155573 | SB8ZUX40TY | 43mg | ||
SACCHARIN SODIUM | ORAL | TABLET, CHEWABLE | 6155573 | SB8ZUX40TY | 84mg | ||
SACCHARIN SODIUM | ORAL | TABLET, FILM COATED | 6155573 | SB8ZUX40TY | 2mg | ||
SACCHARIN SODIUM | ORAL | TABLET, FOR SUSPENSION | 6155573 | SB8ZUX40TY | 6mg | Y | |
SACCHARIN SODIUM | ORAL | TABLET, ORALLY DISINTEGRATING | 6155573 | SB8ZUX40TY | 10mg | ||
SACCHARIN SODIUM | ORAL | WAFER | 6155573 | SB8ZUX40TY | 8mg | ||
SACCHARIN SODIUM | RECTAL | SOLUTION | 6155573 | SB8ZUX40TY | 665mg | ||
SACCHARIN SODIUM | RECTAL | SUSPENSION | 6155573 | SB8ZUX40TY | 290mg | ||
SACCHARIN SODIUM | RECTAL | TABLET | 6155573 | SB8ZUX40TY | 0.6mg | ||
SACCHARIN SODIUM | RESPIRATORY (INHALATION) | AEROSOL, METERED | 6155573 | SB8ZUX40TY | 0.05%w/w | ||
SACCHARIN SODIUM | RESPIRATORY (INHALATION) | SOLUTION | 6155573 | SB8ZUX40TY | NA | ||
SACCHARIN SODIUM | SUBLINGUAL | TABLET | 6155573 | SB8ZUX40TY | 7mg | ||
SACCHARIN SODIUM | TOPICAL | OINTMENT | 6155573 | SB8ZUX40TY | NA | ||
SACCHARIN SODIUM ANHYDROUS | BUCCAL | MOUTHWASH | 128449 | I4807BK602 | 0.2mg/1ml | ||
SACCHARIN SODIUM ANHYDROUS | DENTAL | PASTE, DENTIFRICE | 128449 | I4807BK602 | 0.15%w/w | ||
SACCHARIN SODIUM ANHYDROUS | INTRAMUSCULAR | INJECTION | 128449 | I4807BK602 | 0.09%w/v | ||
SACCHARIN SODIUM ANHYDROUS | INTRAVENOUS | INJECTION | 128449 | I4807BK602 | 0.09%w/v | ||
SACCHARIN SODIUM ANHYDROUS | NASAL | DROPS | 128449 | I4807BK602 | 0.5mg/1ml | ||
SACCHARIN SODIUM ANHYDROUS | NASAL | SOLUTION | 128449 | I4807BK602 | 0.5mg/1ml | ||
SACCHARIN SODIUM ANHYDROUS | ORAL | EMULSION | 128449 | I4807BK602 | 0.4mg/1ml | ||
SACCHARIN SODIUM ANHYDROUS | ORAL | LIQUID | 128449 | I4807BK602 | 1.5mg/5ml | ||
SACCHARIN SODIUM ANHYDROUS | ORAL | POWDER, FOR SUSPENSION | 128449 | I4807BK602 | 18.75mg/5ml | ||
SACCHARIN SODIUM ANHYDROUS | ORAL | SOLUTION | 128449 | I4807BK602 | 20mg | ||
SACCHARIN SODIUM ANHYDROUS | ORAL | SUSPENSION | 128449 | I4807BK602 | 16.65mg/5ml | ||
SACCHARIN SODIUM ANHYDROUS | ORAL | SYRUP | 128449 | I4807BK602 | 3.96mg/5ml | ||
SACCHARIN SODIUM ANHYDROUS | ORAL | TABLET | 128449 | I4807BK602 | 97mg | ||
SACCHARIN SODIUM ANHYDROUS | ORAL | TABLET, CHEWABLE | 128449 | I4807BK602 | 7.5mg | ||
SACCHARIN SODIUM ANHYDROUS | ORAL | TABLET, FILM COATED | 128449 | I4807BK602 | 0.35mg | ||
SACCHARIN SODIUM ANHYDROUS | ORAL | WAFER | 128449 | I4807BK602 | 4.8mg | ||
SACCHARIN SODIUM ANHYDROUS | RECTAL | SOLUTION | 128449 | I4807BK602 | 0.67%w/v | ||
SACCHARIN SODIUM MONOHYDRATE | ORAL | SUSPENSION | 171734717 | A9CO00M9HV | 30mg | ||
SAFFLOWER OIL | TOPICAL | LOTION | 8001238 | 65UEH262IS | 3510mg | ||
SASSAFRAS OIL | DENTAL | PASTE, DENTIFRICE | 8006802 | 78ZX2PFG2Z | 3.5%w/w | ||
SCOTCHPAK 1022 | TRANSDERMAL | FILM, EXTENDED RELEASE | 156014812 | NA | 2335mg | ||
SCOTCHPAK 1022 | TRANSDERMAL | SYSTEM | 156014812 | NA | 381mg | ||
SD ALCOHOL 40 | TOPICAL | AEROSOL, FOAM | NA | 46%w/w | |||
SD ALCOHOL 40-2 | TOPICAL | AEROSOL | NA | 57.65%w/w | |||
SD ALCOHOL 40-2 | TOPICAL | GEL | NA | 97.5%w/w | |||
SD ALCOHOL 40B | TOPICAL | AEROSOL, FOAM | NA | 56.09%w/w | |||
SD ALCOHOL 40B | TOPICAL | SOLUTION | NA | 54.2%w/w | |||
SEPIFILM LP-761 BLANC | ORAL | TABLET | NA | 5mg | |||
SEPIFILM LP-761 BLANC | ORAL | TABLET, DELAYED RELEASE | NA | 10mg | |||
SEPINEO P 600 | TOPICAL | CREAM | NA | 64mg | |||
SEPINEO P 600 | TOPICAL | GEL | NA | 200mg | |||
SEPINEO P 600 | TOPICAL | OINTMENT | NA | 43mg | |||
SERINE | INTRAVENOUS | INJECTION | 56451 | 452VLY9402 | 0.5%w/v | ||
SERINE | INTRAVENOUS | INJECTION, SOLUTION | 56451 | 452VLY9402 | 0.18%w/v | ||
SESAME OIL | INTRAMUSCULAR | INJECTION | 8008740 | QX10HYY4QV | 70%v/v | ||
SESAME OIL | ORAL | CAPSULE | 8008740 | QX10HYY4QV | 2325mg | ||
SHEA BUTTER | TOPICAL | LOTION | 194043920 | K49155WL9Y | 2340mg | Y | |
SHELLAC | ORAL | CAPSULE | 9000593 | 46N107B71O | 34.48mg | ||
SHELLAC | ORAL | CAPSULE, COATED PELLETS | 9000593 | 46N107B71O | 29mg | ||
SHELLAC | ORAL | CAPSULE, COATED, EXTENDED RELEASE | 9000593 | 46N107B71O | NA | ||
SHELLAC | ORAL | CAPSULE, DELAYED RELEASE | 9000593 | 46N107B71O | 1mg | ||
SHELLAC | ORAL | CAPSULE, EXTENDED RELEASE | 9000593 | 46N107B71O | 75.01mg | ||
SHELLAC | ORAL | SUSPENSION | 9000593 | 46N107B71O | 3mg/1ml | ||
SHELLAC | ORAL | TABLET | 9000593 | 46N107B71O | 112mg | ||
SHELLAC | ORAL | TABLET, COATED | 9000593 | 46N107B71O | 30mg | ||
SHELLAC | ORAL | TABLET, DELAYED RELEASE | 9000593 | 46N107B71O | 21.44mg | ||
SHELLAC | ORAL | TABLET, EXTENDED RELEASE | 9000593 | 46N107B71O | 213.24mg | ||
SHELLAC | ORAL | TABLET, FILM COATED | 9000593 | 46N107B71O | 4.4mg | ||
SHELLAC | ORAL | TABLET, FILM COATED, EXTENDED RELEASE | 9000593 | 46N107B71O | NA | ||
SHELLAC | ORAL | TABLET, SUGAR COATED | 9000593 | 46N107B71O | NA | ||
SHELLAC | SUBLINGUAL | FILM | 9000593 | 46N107B71O | NA | ||
SHELLAC P.V.P. SOLUTION NO. 4 | ORAL | CAPSULE, EXTENDED RELEASE | NA | 87mg | |||
SHELLAC P.V.P. SOLUTION NO. 4 | ORAL | TABLET | NA | 5.62mg | |||
SILASTIC MEDICAL ADHESIVE,SILICONE TYPE A | SUBCUTANEOUS | IMPLANT | NA | 7.5mg | |||
SILICA DIMETHYL SILYLATE | ORAL | CAPSULE | 68611449 | EU2PSP0G0W | 0.5mg | ||
SILICA DIMETHYL SILYLATE | ORAL | SUSPENSION | 68611449 | EU2PSP0G0W | 120mg | ||
SILICA DIMETHYL SILYLATE | ORAL | TABLET | 68611449 | EU2PSP0G0W | 8mg | ||
SILICA DIMETHYL SILYLATE | ORAL | TABLET, EXTENDED RELEASE | 68611449 | EU2PSP0G0W | 10mg | ||
SILICA DIMETHYL SILYLATE | ORAL | TABLET, FILM COATED | 68611449 | EU2PSP0G0W | 2mg | ||
SILICA DIMETHYL SILYLATE | SUBLINGUAL | TABLET | 68611449 | EU2PSP0G0W | 2mg | ||
SILICA DIMETHYL SILYLATE | VAGINAL | CREAM | 68611449 | EU2PSP0G0W | 50mg | Y | |
SILICIFIED MICROCRYSTALLINE CELLULOSE (125 .MICRO.M) | ORAL | CAPSULE | 212693817 | 88X4A2YW6T | 283mg | ||
SILICIFIED MICROCRYSTALLINE CELLULOSE (125 .MICRO.M) | ORAL | CAPSULE, EXTENDED RELEASE | 212693817 | 88X4A2YW6T | 18mg | ||
SILICIFIED MICROCRYSTALLINE CELLULOSE (125 .MICRO.M) | ORAL | TABLET | 212693817 | 88X4A2YW6T | 1440mg | ||
SILICIFIED MICROCRYSTALLINE CELLULOSE (125 .MICRO.M) | ORAL | TABLET, CHEWABLE | 212693817 | 88X4A2YW6T | 28mg | ||
SILICIFIED MICROCRYSTALLINE CELLULOSE (125 .MICRO.M) | ORAL | TABLET, DELAYED RELEASE | 212693817 | 88X4A2YW6T | 159mg | ||
SILICIFIED MICROCRYSTALLINE CELLULOSE (125 .MICRO.M) | ORAL | TABLET, EXTENDED RELEASE | 212693817 | 88X4A2YW6T | 1063mg | ||
SILICIFIED MICROCRYSTALLINE CELLULOSE (125 .MICRO.M) | ORAL | TABLET, FILM COATED | 212693817 | 88X4A2YW6T | 213mg | Y | |
SILICIFIED MICROCRYSTALLINE CELLULOSE (125 .MICRO.M) | ORAL | TABLET, ORALLY DISINTEGRATING | 212693817 | 88X4A2YW6T | 70mg | ||
SILICIFIED MICROCRYSTALLINE CELLULOSE (125 .MICRO.M) | SUBLINGUAL | TABLET | 212693817 | 88X4A2YW6T | 75mg | ||
SILICIFIED MICROCRYSTALLINE CELLULOSE (125 .MICRO.M, HIGH-DENSITY) | ORAL | CAPSULE | 212693817 | GRV5BG8C5N | 1600mg | ||
SILICIFIED MICROCRYSTALLINE CELLULOSE (125 .MICRO.M, HIGH-DENSITY) | ORAL | CAPSULE, DELAYED RELEASE | 212693817 | GRV5BG8C5N | 304mg | ||
SILICIFIED MICROCRYSTALLINE CELLULOSE (125 .MICRO.M, HIGH-DENSITY) | ORAL | TABLET | 212693817 | GRV5BG8C5N | 1168mg | ||
SILICIFIED MICROCRYSTALLINE CELLULOSE (125 .MICRO.M, HIGH-DENSITY) | ORAL | TABLET, DELAYED RELEASE | 212693817 | GRV5BG8C5N | 764mg | ||
SILICIFIED MICROCRYSTALLINE CELLULOSE (125 .MICRO.M, HIGH-DENSITY) | ORAL | TABLET, EXTENDED RELEASE | 212693817 | GRV5BG8C5N | 1029mg | ||
SILICIFIED MICROCRYSTALLINE CELLULOSE (125 .MICRO.M, HIGH-DENSITY) | ORAL | TABLET, FILM COATED | 212693817 | GRV5BG8C5N | 240mg | ||
SILICIFIED MICROCRYSTALLINE CELLULOSE (125 .MICRO.M, HIGH-DENSITY) | ORAL | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE | 212693817 | GRV5BG8C5N | 226mg | ||
SILICIFIED MICROCRYSTALLINE CELLULOSE (50 .MICRO.M) | ORAL | TABLET | DVB3KG8URF | 189mg | Y | ||
SILICIFIED MICROCRYSTALLINE CELLULOSE (50 .MICRO.M) | ORAL | TABLET, EXTENDED RELEASE | DVB3KG8URF | 632mg | Y | ||
SILICIFIED MICROCRYSTALLINE CELLULOSE (65 .MICRO.M) | ORAL | CAPSULE | 212693817 | K2EZE348C4 | 355mg | ||
SILICIFIED MICROCRYSTALLINE CELLULOSE (65 .MICRO.M) | ORAL | CAPSULE, EXTENDED RELEASE | 212693817 | K2EZE348C4 | 440mg | ||
SILICIFIED MICROCRYSTALLINE CELLULOSE (65 .MICRO.M) | ORAL | TABLET | 212693817 | K2EZE348C4 | 1889mg | ||
SILICIFIED MICROCRYSTALLINE CELLULOSE (65 .MICRO.M) | ORAL | TABLET, EXTENDED RELEASE | 212693817 | K2EZE348C4 | 648mg | ||
SILICIFIED MICROCRYSTALLINE CELLULOSE (65 .MICRO.M) | ORAL | TABLET, FILM COATED | 212693817 | K2EZE348C4 | 70mg | ||
SILICON | ORAL | DROPS | 7440213 | Z4152N8IUI | NA | ||
SILICON | ORAL | POWDER, FOR SUSPENSION | 7440213 | Z4152N8IUI | NA | ||
SILICON | ORAL | SUSPENSION | 7440213 | Z4152N8IUI | NA | ||
SILICON | TOPICAL | CREAM | 7440213 | Z4152N8IUI | 0.4%w/w | ||
SILICON | TRANSDERMAL | FILM, EXTENDED RELEASE | 7440213 | Z4152N8IUI | NA | ||
SILICON DIOXIDE | BUCCAL | TABLET | 7631869 | ETJ7Z6XBU4 | 3mg | ||
SILICON DIOXIDE | DENTAL | GEL | 7631869 | ETJ7Z6XBU4 | 19%w/w | ||
SILICON DIOXIDE | DENTAL | PASTE | 7631869 | ETJ7Z6XBU4 | 34%w/w | ||
SILICON DIOXIDE | NASAL | GEL | 7631869 | ETJ7Z6XBU4 | 20mg | ||
SILICON DIOXIDE | ORAL | CAPSULE | 7631869 | ETJ7Z6XBU4 | 100mg | ||
SILICON DIOXIDE | ORAL | CAPSULE, COATED | 7631869 | ETJ7Z6XBU4 | 3mg | ||
SILICON DIOXIDE | ORAL | CAPSULE, COATED PELLETS | 7631869 | ETJ7Z6XBU4 | 69mg | ||
SILICON DIOXIDE | ORAL | CAPSULE, COATED, EXTENDED RELEASE | 7631869 | ETJ7Z6XBU4 | NA | ||
SILICON DIOXIDE | ORAL | CAPSULE, DELAYED RELEASE | 7631869 | ETJ7Z6XBU4 | 40mg | ||
SILICON DIOXIDE | ORAL | CAPSULE, EXTENDED RELEASE | 7631869 | ETJ7Z6XBU4 | 168mg | ||
SILICON DIOXIDE | ORAL | CAPSULE, LIQUID FILLED | 7631869 | ETJ7Z6XBU4 | 106mg | ||
SILICON DIOXIDE | ORAL | DROPS | 7631869 | ETJ7Z6XBU4 | NA | ||
SILICON DIOXIDE | ORAL | FILM, SOLUBLE | 7631869 | ETJ7Z6XBU4 | 2mg | ||
SILICON DIOXIDE | ORAL | GRANULE | 7631869 | ETJ7Z6XBU4 | 5000mg | ||
SILICON DIOXIDE | ORAL | GRANULE, DELAYED RELEASE | 7631869 | ETJ7Z6XBU4 | 3.2mg | ||
SILICON DIOXIDE | ORAL | GRANULE, FOR SOLUTION | 7631869 | ETJ7Z6XBU4 | 1.8mg/120ml | ||
SILICON DIOXIDE | ORAL | GRANULE, FOR SUSPENSION | 7631869 | ETJ7Z6XBU4 | 200mg | ||
SILICON DIOXIDE | ORAL | GRANULE, FOR SUSPENSION, EXTENDED RELEASE | 7631869 | ETJ7Z6XBU4 | NA | ||
SILICON DIOXIDE | ORAL | LOZENGE | 7631869 | ETJ7Z6XBU4 | 120mg | ||
SILICON DIOXIDE | ORAL | PELLET | 7631869 | ETJ7Z6XBU4 | 34mg | ||
SILICON DIOXIDE | ORAL | POWDER | 7631869 | ETJ7Z6XBU4 | 602mg | ||
SILICON DIOXIDE | ORAL | POWDER, FOR SOLUTION | 7631869 | ETJ7Z6XBU4 | 280mg | ||
SILICON DIOXIDE | ORAL | POWDER, FOR SUSPENSION | 7631869 | ETJ7Z6XBU4 | 2553mg | ||
SILICON DIOXIDE | ORAL | SOLUTION | 7631869 | ETJ7Z6XBU4 | 336mg | ||
SILICON DIOXIDE | ORAL | SUSPENSION | 7631869 | ETJ7Z6XBU4 | 400mg | ||
SILICON DIOXIDE | ORAL | SUSPENSION, EXTENDED RELEASE | 7631869 | ETJ7Z6XBU4 | 70mg | ||
SILICON DIOXIDE | ORAL | TABLET | 7631869 | ETJ7Z6XBU4 | 336mg | ||
SILICON DIOXIDE | ORAL | TABLET, CHEWABLE | 7631869 | ETJ7Z6XBU4 | 254mg | ||
SILICON DIOXIDE | ORAL | TABLET, CHEWABLE, EXTENDED RELEASE | 7631869 | ETJ7Z6XBU4 | 2mg | ||
SILICON DIOXIDE | ORAL | TABLET, COATED | 7631869 | ETJ7Z6XBU4 | 176mg | ||
SILICON DIOXIDE | ORAL | TABLET, DELAYED RELEASE | 7631869 | ETJ7Z6XBU4 | 910mg | Y | |
SILICON DIOXIDE | ORAL | TABLET, DELAYED RELEASE PARTICLES | 7631869 | ETJ7Z6XBU4 | 170mg | ||
SILICON DIOXIDE | ORAL | TABLET, EXTENDED RELEASE | 7631869 | ETJ7Z6XBU4 | 450mg | ||
SILICON DIOXIDE | ORAL | TABLET, FILM COATED | 7631869 | ETJ7Z6XBU4 | 166mg | ||
SILICON DIOXIDE | ORAL | TABLET, FILM COATED, EXTENDED RELEASE | 7631869 | ETJ7Z6XBU4 | 336mg | ||
SILICON DIOXIDE | ORAL | TABLET, FOR SUSPENSION | 7631869 | ETJ7Z6XBU4 | 220mg | ||
SILICON DIOXIDE | ORAL | TABLET, ORALLY DISINTEGRATING | 7631869 | ETJ7Z6XBU4 | 68mg | ||
SILICON DIOXIDE | ORAL | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE | 7631869 | ETJ7Z6XBU4 | 69mg | ||
SILICON DIOXIDE | RECTAL | SUPPOSITORY | 7631869 | ETJ7Z6XBU4 | 14mg | ||
SILICON DIOXIDE | RESPIRATORY (INHALATION) | CAPSULE | 7631869 | ETJ7Z6XBU4 | NA | ||
SILICON DIOXIDE | RESPIRATORY (INHALATION) | POWDER | 7631869 | ETJ7Z6XBU4 | NA | ||
SILICON DIOXIDE | SUBLINGUAL | TABLET | 7631869 | ETJ7Z6XBU4 | 10mg | ||
SILICON DIOXIDE | TOPICAL | GEL | 7631869 | ETJ7Z6XBU4 | 6mg | Y | |
SILICON DIOXIDE | TRANSDERMAL | FILM, EXTENDED RELEASE | 7631869 | ETJ7Z6XBU4 | 49mg | ||
SILICON DIOXIDE | TRANSDERMAL | SYSTEM | 7631869 | ETJ7Z6XBU4 | 35mg | ||
SILICON DIOXIDE | VAGINAL | CREAM | 7631869 | ETJ7Z6XBU4 | 38mg | Y | |
SILICON DIOXIDE | VAGINAL | GEL | 7631869 | ETJ7Z6XBU4 | 8%w/w | ||
SILICON DIOXIDE | VAGINAL | INSERT | 7631869 | ETJ7Z6XBU4 | 8mg | ||
SILICON DIOXIDE | VAGINAL | TAMPON | 7631869 | ETJ7Z6XBU4 | NA | ||
SILICONE | INTRAMUSCULAR | INJECTION | 63394025 | NA | NA | ||
SILICONE | INTRAUTERINE | SUPPOSITORY, EXTENDED RELEASE | 63394025 | NA | 60mg | ||
SILICONE | INTRAVENOUS | INJECTION | 63394025 | NA | NA | ||
SILICONE | ORAL | CAPSULE | 63394025 | NA | 15mg | ||
SILICONE | ORAL | CAPSULE, EXTENDED RELEASE | 63394025 | NA | 0.14mg | ||
SILICONE | ORAL | POWDER, FOR SUSPENSION | 63394025 | NA | 5mg/5ml | ||
SILICONE | ORAL | SUSPENSION | 63394025 | NA | NA | ||
SILICONE | ORAL | TABLET | 63394025 | NA | NA | ||
SILICONE | TOPICAL | LOTION | 63394025 | NA | 0.09%w/w | ||
SILICONE | TRANSDERMAL | FILM, EXTENDED RELEASE | 63394025 | NA | 114.7mg | ||
SILICONE | TRANSDERMAL | SYSTEM | 63394025 | NA | NA | ||
SILICONE ADHESIVE 4302 | TRANSDERMAL | SYSTEM | NA | 60mg | |||
SILICONE EMULSION | ORAL | CAPSULE | NA | NA | |||
SILICONE EMULSION | ORAL | CAPSULE, EXTENDED RELEASE | NA | 0.08mg | |||
SILICONE EMULSION | ORAL | CONCENTRATE | NA | NA | |||
SILICONE EMULSION | ORAL | POWDER, FOR SUSPENSION | NA | 62mg/5ml | |||
SILICONE EMULSION | ORAL | SUSPENSION | NA | 5mg | |||
SILICONE EMULSION | TOPICAL | LOTION | NA | 0.5%w/w | |||
SILICONE/POLYESTER FILM STRIP | TRANSDERMAL | FILM, EXTENDED RELEASE | NA | 873mg | |||
SILICONE/POLYESTER FILM STRIP | TRANSDERMAL | SYSTEM | NA | 2608mg | |||
SILODRATE | ORAL | TABLET | 9T3UU8T0QK | 11mg | |||
SILODRATE | ORAL | TABLET, ORALLY DISINTEGRATING | 9T3UU8T0QK | 12mg | |||
SIMETHICONE | ORAL | CAPSULE | 8050815 | NA | 5.7mg | ||
SIMETHICONE | ORAL | CAPSULE, COATED PELLETS | 8050815 | NA | 0.61mg | ||
SIMETHICONE | ORAL | CAPSULE, DELAYED RELEASE | 8050815 | NA | 1mg | ||
SIMETHICONE | ORAL | CAPSULE, EXTENDED RELEASE | 8050815 | NA | 2mg | ||
SIMETHICONE | ORAL | CAPSULE, LIQUID FILLED | 8050815 | NA | 0.03mg | ||
SIMETHICONE | ORAL | GRANULE, EFFERVESCENT | 8050815 | NA | 0.04mg | ||
SIMETHICONE | ORAL | GRANULE, FOR SOLUTION | 8050815 | NA | 72mg | ||
SIMETHICONE | ORAL | GRANULE, FOR SUSPENSION | 8050815 | NA | 40mg | ||
SIMETHICONE | ORAL | PASTILLE | 8050815 | NA | 0.4mg | ||
SIMETHICONE | ORAL | POWDER, FOR SOLUTION | 8050815 | NA | 8mg | ||
SIMETHICONE | ORAL | POWDER, FOR SUSPENSION | 8050815 | NA | 193mg | ||
SIMETHICONE | ORAL | SOLUTION | 8050815 | NA | 26mg | ||
SIMETHICONE | ORAL | SUSPENSION | 8050815 | NA | 360mg | ||
SIMETHICONE | ORAL | TABLET | 8050815 | NA | 1.5mg | ||
SIMETHICONE | ORAL | TABLET, COATED | 8050815 | NA | NA | ||
SIMETHICONE | ORAL | TABLET, DELAYED RELEASE | 8050815 | NA | 2mg | ||
SIMETHICONE | ORAL | TABLET, EXTENDED RELEASE | 8050815 | NA | 7.5mg | ||
SIMETHICONE | ORAL | TABLET, FILM COATED | 8050815 | NA | 0.18mg | ||
SIMETHICONE | ORAL | TABLET, ORALLY DISINTEGRATING | 8050815 | NA | 0.04mg | ||
SIMETHICONE | RECTAL | SOLUTION | 8050815 | NA | NA | ||
SIMETHICONE | TOPICAL | CREAM | 8050815 | NA | 0.2%w/w | ||
SIMETHICONE | TOPICAL | LOTION | 8050815 | NA | 0.01%w/v | ||
SIMETHICONE | TOPICAL | SUSPENSION | 8050815 | NA | 0.11%w/w | ||
SIMETHICONE EMULSION | ORAL | CAPSULE | NA | 14.4mg | |||
SIMETHICONE EMULSION | ORAL | CAPSULE, EXTENDED RELEASE | NA | 4mg | |||
SIMETHICONE EMULSION | ORAL | PASTE | NA | 54mg | |||
SIMETHICONE EMULSION | ORAL | POWDER, FOR SOLUTION | NA | 0.05mg/1ml | |||
SIMETHICONE EMULSION | ORAL | POWDER, FOR SUSPENSION | NA | 35mg | |||
SIMETHICONE EMULSION | ORAL | SOLUTION | NA | 2mg | |||
SIMETHICONE EMULSION | ORAL | SUSPENSION | NA | 360mg | |||
SIMETHICONE EMULSION | ORAL | TABLET | NA | 48mg | |||
SIMETHICONE EMULSION | ORAL | TABLET, COATED | NA | 0.01mg | |||
SIMETHICONE EMULSION | ORAL | TABLET, DELAYED RELEASE | NA | 1mg | |||
SIMETHICONE EMULSION | ORAL | TABLET, EXTENDED RELEASE | NA | 2mg | |||
SIMETHICONE EMULSION | ORAL | TABLET, FILM COATED | NA | 1mg | |||
SIMETHICONE EMULSION | ORAL | TABLET, FILM COATED, EXTENDED RELEASE | NA | 1.41mg | |||
SIMETHICONE EMULSION | TOPICAL | CREAM | NA | 4mg | |||
SIMETHICONE EMULSION | TOPICAL | OINTMENT | NA | NA | |||
SOAP | ORAL | TABLET, EXTENDED RELEASE | 8046717 | NA | 0.6mg | ||
SOAP | TOPICAL | SOAP | 8046717 | NA | 95.05%w/w | ||
SODIUM 1,2-ETHANEDISULFONATE | ORAL | SOLUTION | 5325439 | 2YZU14UIFP | 1mg/5ml | ||
SODIUM 1,2-ETHANEDISULFONATE | ORAL | TABLET | 5325439 | 2YZU14UIFP | NA | ||
SODIUM ACETATE | AURICULAR (OTIC) | SOLUTION | 6131904 | 4550K0SC9B | 0.02%w/v | ||
SODIUM ACETATE | AURICULAR (OTIC) | SOLUTION/ DROPS | 6131904 | 4550K0SC9B | 0.03%w/w | ||
SODIUM ACETATE | AURICULAR (OTIC) | SUSPENSION | 6131904 | 4550K0SC9B | 0.68%w/v | ||
SODIUM ACETATE | AURICULAR (OTIC) | SUSPENSION/ DROPS | 6131904 | 4550K0SC9B | 0.03%w/v | ||
SODIUM ACETATE | INTRA-ARTICULAR | INJECTION | 6131904 | 4550K0SC9B | ADJ PH | ||
SODIUM ACETATE | INTRACAVITARY | INJECTION | 6131904 | 4550K0SC9B | 0.1ml | ||
SODIUM ACETATE | INTRADERMAL | INJECTION | 6131904 | 4550K0SC9B | 1.6mg | ||
SODIUM ACETATE | INTRALESIONAL | INJECTION | 6131904 | 4550K0SC9B | ADJ PH | ||
SODIUM ACETATE | INTRAMUSCULAR | INJECTION | 6131904 | 4550K0SC9B | 19mg | ||
SODIUM ACETATE | INTRAOCULAR | SOLUTION | 6131904 | 4550K0SC9B | 195mg | Y | |
SODIUM ACETATE | INTRASYNOVIAL | INJECTION | 6131904 | 4550K0SC9B | ADJ PH | ||
SODIUM ACETATE | INTRAVENOUS | INJECTION | 6131904 | 4550K0SC9B | 4239mg | ||
SODIUM ACETATE | INTRAVENOUS | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 6131904 | 4550K0SC9B | 141mg | ||
SODIUM ACETATE | INTRAVENOUS | INJECTION, SOLUTION | 6131904 | 4550K0SC9B | 328mg | ||
SODIUM ACETATE | INTRAVENOUS | LIQUID | 6131904 | 4550K0SC9B | 0.2%w/v | ||
SODIUM ACETATE | INTRAVENOUS | SOLUTION | 6131904 | 4550K0SC9B | 20mg | ||
SODIUM ACETATE | INTRAVITREAL | INJECTION, SUSPENSION | 6131904 | 4550K0SC9B | 0.39%w/v | ||
SODIUM ACETATE | OPHTHALMIC | EMULSION | 6131904 | 4550K0SC9B | 0.05%w/w | ||
SODIUM ACETATE | OPHTHALMIC | SOLUTION | 6131904 | 4550K0SC9B | 0.07%w/v | ||
SODIUM ACETATE | OPHTHALMIC | SOLUTION/ DROPS | 6131904 | 4550K0SC9B | 1.24%w/v | ||
SODIUM ACETATE | ORAL | LIQUID | 6131904 | 4550K0SC9B | 13mg | ||
SODIUM ACETATE | ORAL | POWDER, FOR SOLUTION | 6131904 | 4550K0SC9B | 0.1mg | ||
SODIUM ACETATE | ORAL | SOLUTION | 6131904 | 4550K0SC9B | 44mg | ||
SODIUM ACETATE | ORAL | SYRUP | 6131904 | 4550K0SC9B | 21.45mg/5ml | ||
SODIUM ACETATE | PARENTERAL | INJECTION | 6131904 | 4550K0SC9B | 103.7mg | ||
SODIUM ACETATE | PARENTERAL | INJECTION, POWDER, FOR SOLUTION | 6131904 | 4550K0SC9B | 12.5mg | ||
SODIUM ACETATE | SOFT TISSUE | INJECTION | 6131904 | 4550K0SC9B | ADJ PH | ||
SODIUM ACETATE | SUBCUTANEOUS | INJECTION | 6131904 | 4550K0SC9B | 19mg | ||
SODIUM ACETATE | SUBCUTANEOUS | INJECTION, SOLUTION | 6131904 | 4550K0SC9B | 0.16%w/v | ||
SODIUM ACETATE | SUBCUTANEOUS | LIQUID | 6131904 | 4550K0SC9B | 0.2%w/v | ||
SODIUM ACETATE | SUBCUTANEOUS | SOLUTION | 6131904 | 4550K0SC9B | 0.02%w/v | ||
SODIUM ACETATE | SUBMUCOSAL | INJECTION, SOLUTION | 6131904 | 4550K0SC9B | 0.08%w/v | ||
SODIUM ACETATE | TOPICAL | CREAM | 6131904 | 4550K0SC9B | NA | ||
SODIUM ACETATE | TOPICAL | SOLUTION | 6131904 | 4550K0SC9B | NA | ||
SODIUM ACETATE ANHYDROUS | INTRAMUSCULAR | INJECTION | 127093 | NVG71ZZ7P0 | 0.47%w/v | ||
SODIUM ACETATE ANHYDROUS | INTRAVENOUS | INJECTION | 127093 | NVG71ZZ7P0 | 127mg | ||
SODIUM ACETATE ANHYDROUS | INTRAVENOUS | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 127093 | NVG71ZZ7P0 | 0.25%w/v | ||
SODIUM ACETATE ANHYDROUS | INTRAVENOUS | INJECTION, SOLUTION | 127093 | NVG71ZZ7P0 | 0.09%w/v | ||
SODIUM ACETATE ANHYDROUS | INTRAVENOUS | SOLUTION | 127093 | NVG71ZZ7P0 | 177mg | ||
SODIUM ACETATE ANHYDROUS | OPHTHALMIC | EMULSION | 127093 | NVG71ZZ7P0 | 0.05%w/v | ||
SODIUM ACETATE ANHYDROUS | OPHTHALMIC | SOLUTION | 127093 | NVG71ZZ7P0 | 0.03%w/v | ||
SODIUM ACETATE ANHYDROUS | ORAL | SOLUTION | 127093 | NVG71ZZ7P0 | 177mg | ||
SODIUM ACETATE ANHYDROUS | ORAL | SYRUP | 127093 | NVG71ZZ7P0 | 4.1mg/1ml | ||
SODIUM ACETATE ANHYDROUS | SUBCUTANEOUS | INJECTION | 127093 | NVG71ZZ7P0 | 0.16%w/v | ||
SODIUM ACETATE ANHYDROUS | SUBCUTANEOUS | SOLUTION | 127093 | NVG71ZZ7P0 | NA | ||
SODIUM ACETATE ANHYDROUS | TOPICAL | SOLUTION | 127093 | NVG71ZZ7P0 | NA | ||
SODIUM ALGINATE | ORAL | CAPSULE | 9005383 | C269C4G2ZQ | 160mg | Y | |
SODIUM ALGINATE | ORAL | LOZENGE | 9005383 | C269C4G2ZQ | 1274mg | ||
SODIUM ALGINATE | ORAL | SUSPENSION | 9005383 | C269C4G2ZQ | 49mg | ||
SODIUM ALGINATE | ORAL | SYRUP | 9005383 | C269C4G2ZQ | 3mg/1ml | ||
SODIUM ALGINATE | ORAL | TABLET | 9005383 | C269C4G2ZQ | 480mg | ||
SODIUM ALGINATE | ORAL | TABLET, EXTENDED RELEASE | 9005383 | C269C4G2ZQ | 627mg | ||
SODIUM ALGINATE | ORAL | TABLET, FILM COATED, EXTENDED RELEASE | 9005383 | C269C4G2ZQ | 640mg | ||
SODIUM ALGINATE | ORAL | TROCHE | 9005383 | C269C4G2ZQ | 525mg | ||
SODIUM ALGINATE | TOPICAL | LIQUID | 9005383 | C269C4G2ZQ | 0.25%w/w | ||
SODIUM ALKYL SULFATE | DENTAL | PASTE, DENTIFRICE | 8036542 | NA | 0.68%w/w | ||
SODIUM ALUMINOSILICATE | ORAL | TABLET | 1344009 | 058TS43PSM | 94mg | ||
SODIUM ALUMINOSILICATE | ORAL | TABLET, EXTENDED RELEASE | 1344009 | 058TS43PSM | 94mg | ||
SODIUM ASCORBATE | INTRADERMAL | INJECTION, POWDER, FOR SOLUTION | 134032 | S033EH8359 | 0.5mg | ||
SODIUM ASCORBATE | INTRAVENOUS | INJECTION | 134032 | S033EH8359 | 625mg | ||
SODIUM ASCORBATE | INTRAVENOUS | INJECTION, SOLUTION | 134032 | S033EH8359 | 29mg | Y | |
SODIUM ASCORBATE | ORAL | CAPSULE | 134032 | S033EH8359 | 6mg | ||
SODIUM ASCORBATE | ORAL | SUSPENSION, EXTENDED RELEASE | 134032 | S033EH8359 | 16.4mg/5ml | ||
SODIUM ASCORBATE | ORAL | TABLET | 134032 | S033EH8359 | 15mg | ||
SODIUM ASCORBATE | SUBCUTANEOUS | INJECTION, POWDER, FOR SOLUTION | 134032 | S033EH8359 | 0.5mg | ||
SODIUM BENZOATE | BUCCAL | FILM | 532321 | OJ245FE5EU | 1mg | ||
SODIUM BENZOATE | BUCCAL | FILM, SOLUBLE | 532321 | OJ245FE5EU | 3mg | ||
SODIUM BENZOATE | DENTAL | GEL | 532321 | OJ245FE5EU | 0.08%w/w | ||
SODIUM BENZOATE | DENTAL | PASTE | 532321 | OJ245FE5EU | 0.08%w/w | ||
SODIUM BENZOATE | DENTAL | PASTE, DENTIFRICE | 532321 | OJ245FE5EU | 0.5%w/w | ||
SODIUM BENZOATE | INTRAMUSCULAR | INJECTION | 532321 | OJ245FE5EU | 864mg | ||
SODIUM BENZOATE | INTRAMUSCULAR | INJECTION, SOLUTION | 532321 | OJ245FE5EU | 4.8%w/v | ||
SODIUM BENZOATE | INTRAVENOUS | INJECTION | 532321 | OJ245FE5EU | 864mg | ||
SODIUM BENZOATE | INTRAVENOUS | INJECTION, EMULSION | 532321 | OJ245FE5EU | 0.1%w/v | ||
SODIUM BENZOATE | ORAL | CAPSULE | 532321 | OJ245FE5EU | 8.5mg | ||
SODIUM BENZOATE | ORAL | CONCENTRATE | 532321 | OJ245FE5EU | 20mg | Y | |
SODIUM BENZOATE | ORAL | ELIXIR | 532321 | OJ245FE5EU | 5.02mg/5ml | ||
SODIUM BENZOATE | ORAL | GRANULE | 532321 | OJ245FE5EU | NA | ||
SODIUM BENZOATE | ORAL | GRANULE, EFFERVESCENT | 532321 | OJ245FE5EU | 60mg | ||
SODIUM BENZOATE | ORAL | GRANULE, FOR SUSPENSION | 532321 | OJ245FE5EU | 120mg | ||
SODIUM BENZOATE | ORAL | LIQUID | 532321 | OJ245FE5EU | 61mg | ||
SODIUM BENZOATE | ORAL | PASTE | 532321 | OJ245FE5EU | 28mg | ||
SODIUM BENZOATE | ORAL | POWDER, FOR SOLUTION | 532321 | OJ245FE5EU | 98mg | ||
SODIUM BENZOATE | ORAL | POWDER, FOR SUSPENSION | 532321 | OJ245FE5EU | 160mg | ||
SODIUM BENZOATE | ORAL | SOLUTION | 532321 | OJ245FE5EU | 660mg | ||
SODIUM BENZOATE | ORAL | SUSPENSION | 532321 | OJ245FE5EU | 320mg | ||
SODIUM BENZOATE | ORAL | SUSPENSION, EXTENDED RELEASE | 532321 | OJ245FE5EU | 24mg | ||
SODIUM BENZOATE | ORAL | SUSPENSION/ DROPS | 532321 | OJ245FE5EU | 23mg | ||
SODIUM BENZOATE | ORAL | SYRUP | 532321 | OJ245FE5EU | 80mg | ||
SODIUM BENZOATE | ORAL | TABLET | 532321 | OJ245FE5EU | 30mg | ||
SODIUM BENZOATE | ORAL | TABLET, COATED | 532321 | OJ245FE5EU | 0.2mg | ||
SODIUM BENZOATE | ORAL | TABLET, DELAYED RELEASE | 532321 | OJ245FE5EU | 0.34mg | ||
SODIUM BENZOATE | ORAL | TABLET, EXTENDED RELEASE | 532321 | OJ245FE5EU | NA | ||
SODIUM BENZOATE | ORAL | TABLET, FILM COATED | 532321 | OJ245FE5EU | 1mg | ||
SODIUM BENZOATE | RECTAL | ENEMA | 532321 | OJ245FE5EU | 60mg | ||
SODIUM BENZOATE | RECTAL | GEL | 532321 | OJ245FE5EU | 406mg | ||
SODIUM BENZOATE | TOPICAL | CREAM | 532321 | OJ245FE5EU | 0.2%w/w | ||
SODIUM BENZOATE | TOPICAL | GEL | 532321 | OJ245FE5EU | 5mg | ||
SODIUM BENZOATE | TOPICAL | SOLUTION | 532321 | OJ245FE5EU | 0.1%w/v | ||
SODIUM BENZOATE | TOPICAL | SPONGE | 532321 | OJ245FE5EU | NA | ||
SODIUM BENZOATE | TOPICAL | SYSTEM | 532321 | OJ245FE5EU | 2mg | ||
SODIUM BICARBONATE | BUCCAL | GUM, CHEWING | 144558 | 8MDF5V39QO | 240mg | ||
SODIUM BICARBONATE | BUCCAL | TABLET | 144558 | 8MDF5V39QO | 42mg | ||
SODIUM BICARBONATE | INTRAMUSCULAR | INJECTION | 144558 | 8MDF5V39QO | 175mg | Y | |
SODIUM BICARBONATE | INTRAMUSCULAR | INJECTION, POWDER, FOR SOLUTION | 144558 | 8MDF5V39QO | 1000mg | ||
SODIUM BICARBONATE | INTRAMUSCULAR | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 144558 | 8MDF5V39QO | ADJ PH | ||
SODIUM BICARBONATE | INTRAPERITONEAL | INJECTION, POWDER, FOR SOLUTION | 144558 | 8MDF5V39QO | ADJ PH | ||
SODIUM BICARBONATE | INTRATHECAL | INJECTION | 144558 | 8MDF5V39QO | 0.05mg | ||
SODIUM BICARBONATE | INTRAVENOUS | INJECTION | 144558 | 8MDF5V39QO | 812mg | ||
SODIUM BICARBONATE | INTRAVENOUS | INJECTION, POWDER, FOR SOLUTION | 144558 | 8MDF5V39QO | 3219mg | ||
SODIUM BICARBONATE | INTRAVENOUS | INJECTION, POWDER, FOR SUSPENSION | 144558 | 8MDF5V39QO | 160mg | ||
SODIUM BICARBONATE | INTRAVENOUS | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 144558 | 8MDF5V39QO | 3059mg | ||
SODIUM BICARBONATE | INTRAVENOUS | INJECTION, SOLUTION | 144558 | 8MDF5V39QO | 0.37%w/v | ||
SODIUM BICARBONATE | INTRAVITREAL | INJECTION | 144558 | 8MDF5V39QO | 0.18%w/v | ||
SODIUM BICARBONATE | ORAL | CAPSULE | 144558 | 8MDF5V39QO | 320mg | ||
SODIUM BICARBONATE | ORAL | CAPSULE, EXTENDED RELEASE | 144558 | 8MDF5V39QO | 4mg | ||
SODIUM BICARBONATE | ORAL | FILM, SOLUBLE | 144558 | 8MDF5V39QO | 2mg | ||
SODIUM BICARBONATE | ORAL | GRANULE, EFFERVESCENT | 144558 | 8MDF5V39QO | 267mg | ||
SODIUM BICARBONATE | ORAL | GUM, CHEWING | 144558 | 8MDF5V39QO | 360mg | ||
SODIUM BICARBONATE | ORAL | LOZENGE | 144558 | 8MDF5V39QO | 100mg | ||
SODIUM BICARBONATE | ORAL | POWDER, FOR SOLUTION | 144558 | 8MDF5V39QO | 1250mg/100ml | ||
SODIUM BICARBONATE | ORAL | SOLUTION | 144558 | 8MDF5V39QO | ADJ PH | ||
SODIUM BICARBONATE | ORAL | TABLET | 144558 | 8MDF5V39QO | 1300mg | ||
SODIUM BICARBONATE | ORAL | TABLET, CHEWABLE | 144558 | 8MDF5V39QO | 140mg | ||
SODIUM BICARBONATE | ORAL | TABLET, COATED | 144558 | 8MDF5V39QO | 10.6mg | ||
SODIUM BICARBONATE | ORAL | TABLET, DELAYED RELEASE | 144558 | 8MDF5V39QO | 30mg | ||
SODIUM BICARBONATE | ORAL | TABLET, EFFERVESCENT | 144558 | 8MDF5V39QO | 57600mg | ||
SODIUM BICARBONATE | ORAL | TABLET, EXTENDED RELEASE | 144558 | 8MDF5V39QO | 81mg | ||
SODIUM BICARBONATE | ORAL | TABLET, FILM COATED | 144558 | 8MDF5V39QO | 86mg | ||
SODIUM BICARBONATE | ORAL | TABLET, FILM COATED, EXTENDED RELEASE | 144558 | 8MDF5V39QO | 2.56mg | ||
SODIUM BICARBONATE | ORAL | TABLET, ORALLY DISINTEGRATING | 144558 | 8MDF5V39QO | 107mg | ||
SODIUM BICARBONATE | ORAL | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE | 144558 | 8MDF5V39QO | 6mg | ||
SODIUM BICARBONATE | RESPIRATORY (INHALATION) | SOLUTION | 144558 | 8MDF5V39QO | 2%w/w | ||
SODIUM BICARBONATE | SUBCUTANEOUS | INJECTION | 144558 | 8MDF5V39QO | ADJ PH | ||
SODIUM BICARBONATE | SUBLINGUAL | TABLET | 144558 | 8MDF5V39QO | 6mg | ||
SODIUM BICARBONATE | VAGINAL | INSERT | 144558 | 8MDF5V39QO | 129mg | ||
SODIUM BISULFATE | INTRAMUSCULAR | INJECTION | 7681381 | BU8V88OWIQ | 0.32%w/v | ||
SODIUM BISULFATE | INTRAVENOUS | INJECTION | 7681381 | BU8V88OWIQ | 0.32%w/v | ||
SODIUM BISULFATE | OPHTHALMIC | SUSPENSION/ DROPS | 7681381 | BU8V88OWIQ | 0.06%w/v | Y | |
SODIUM BISULFATE | ORAL | CONCENTRATE | 7681381 | BU8V88OWIQ | 0.95mg/1ml | ||
SODIUM BISULFATE | RESPIRATORY (INHALATION) | SOLUTION | 7681381 | BU8V88OWIQ | 0.01%w/w | ||
SODIUM BISULFATE | SUBCUTANEOUS | INJECTION | 7681381 | BU8V88OWIQ | 0.1%w/v | ||
SODIUM BISULFATE ACETONE | INFILTRATION | INJECTION | 7546125 | A9IO7TF4S0 | 2mg | ||
SODIUM BISULFITE | AURICULAR (OTIC) | SOLUTION | 7631905 | TZX5469Z6I | 0.08%w/v | ||
SODIUM BISULFITE | AURICULAR (OTIC) | SUSPENSION | 7631905 | TZX5469Z6I | NA | ||
SODIUM BISULFITE | INTRA-ARTICULAR | INJECTION | 7631905 | TZX5469Z6I | 0.32%w/v | ||
SODIUM BISULFITE | INTRACARDIAC | INJECTION | 7631905 | TZX5469Z6I | 0.1%w/v | ||
SODIUM BISULFITE | INTRALESIONAL | INJECTION | 7631905 | TZX5469Z6I | 0.32%w/v | ||
SODIUM BISULFITE | INTRAMUSCULAR | INJECTION | 7631905 | TZX5469Z6I | 96mg | Y | |
SODIUM BISULFITE | INTRAMUSCULAR | INJECTION, POWDER, FOR SOLUTION | 7631905 | TZX5469Z6I | 51.8mg | ||
SODIUM BISULFITE | INTRAPERITONEAL | INJECTION | 7631905 | TZX5469Z6I | 0.66%w/v | ||
SODIUM BISULFITE | INTRASYNOVIAL | INJECTION | 7631905 | TZX5469Z6I | 0.32%w/v | ||
SODIUM BISULFITE | INTRAVENOUS | INJECTION | 7631905 | TZX5469Z6I | 96mg | Y | |
SODIUM BISULFITE | INTRAVENOUS | INJECTION, POWDER, FOR SOLUTION | 7631905 | TZX5469Z6I | 51.8mg | ||
SODIUM BISULFITE | INTRAVENOUS | INJECTION, SOLUTION | 7631905 | TZX5469Z6I | 0.05%w/v | ||
SODIUM BISULFITE | IONTOPHORESIS | SOLUTION | 7631905 | TZX5469Z6I | 0.06%w/v | ||
SODIUM BISULFITE | IRRIGATION | INJECTION | 7631905 | TZX5469Z6I | 0.66%w/w | ||
SODIUM BISULFITE | OPHTHALMIC | DROPS | 7631905 | TZX5469Z6I | 0.06%w/w | ||
SODIUM BISULFITE | OPHTHALMIC | SOLUTION | 7631905 | TZX5469Z6I | 0.1%w/w | ||
SODIUM BISULFITE | OPHTHALMIC | SOLUTION/ DROPS | 7631905 | TZX5469Z6I | 0.1%w/w | ||
SODIUM BISULFITE | OPHTHALMIC | SUSPENSION/ DROPS | 7631905 | TZX5469Z6I | 0.06%w/w | ||
SODIUM BISULFITE | ORAL | CAPSULE | 7631905 | TZX5469Z6I | 0.36mg | ||
SODIUM BISULFITE | ORAL | CONCENTRATE | 7631905 | TZX5469Z6I | 0.5mg/1ml | ||
SODIUM BISULFITE | ORAL | SOLUTION | 7631905 | TZX5469Z6I | 1mg | ||
SODIUM BISULFITE | ORAL | SUSPENSION | 7631905 | TZX5469Z6I | 5mg | ||
SODIUM BISULFITE | ORAL | SYRUP | 7631905 | TZX5469Z6I | NA | ||
SODIUM BISULFITE | ORAL | TABLET | 7631905 | TZX5469Z6I | 9mg | ||
SODIUM BISULFITE | RESPIRATORY (INHALATION) | INHALANT | 7631905 | TZX5469Z6I | NA | ||
SODIUM BISULFITE | RESPIRATORY (INHALATION) | LIQUID | 7631905 | TZX5469Z6I | 0.3%w/w | ||
SODIUM BISULFITE | RESPIRATORY (INHALATION) | SOLUTION | 7631905 | TZX5469Z6I | 0.3%w/w | ||
SODIUM BISULFITE | SOFT TISSUE | INJECTION | 7631905 | TZX5469Z6I | 0.1%w/v | ||
SODIUM BISULFITE | SUBCUTANEOUS | INJECTION | 7631905 | TZX5469Z6I | 0.22%w/v | ||
SODIUM BISULFITE | SUBLINGUAL | TABLET | 7631905 | TZX5469Z6I | 0.5mg | ||
SODIUM BISULFITE | TOPICAL | CREAM | 7631905 | TZX5469Z6I | 0.3%w/w | ||
SODIUM BISULFITE | TOPICAL | POWDER, FOR SOLUTION | 7631905 | TZX5469Z6I | 0.1%w/v | ||
SODIUM BISULFITE | TOPICAL | SOLUTION | 7631905 | TZX5469Z6I | 0.06%w/v | ||
SODIUM BITARTRATE | ORAL | TABLET, EXTENDED RELEASE | 526943 | 75E63I9H07 | 306mg | ||
SODIUM BORATE | AURICULAR (OTIC) | SOLUTION | 1303964 | 91MBZ8H3QO | 0.3%w/w | ||
SODIUM BORATE | OPHTHALMIC | EMULSION | 1303964 | 91MBZ8H3QO | 0.11%w/v | ||
SODIUM BORATE | OPHTHALMIC | SOLUTION | 1303964 | 91MBZ8H3QO | 2mg | ||
SODIUM BORATE | OPHTHALMIC | SOLUTION/ DROPS | 1303964 | 91MBZ8H3QO | 1.1%w/v | ||
SODIUM BORATE | OPHTHALMIC | SUSPENSION/ DROPS | 1303964 | 91MBZ8H3QO | 0.03%w/w | ||
SODIUM BORATE | TOPICAL | CREAM | 1303964 | 91MBZ8H3QO | NA | ||
SODIUM C10-18 ALKANESULFONATES | TOPICAL | SHAMPOO, SUSPENSION | 68037490 | V1Q1CE5CWQ | 2.5%w/w | ||
SODIUM CARBONATE | BUCCAL | GUM, CHEWING | 497198 | 45P3261C7T | 720mg | ||
SODIUM CARBONATE | BUCCAL | TABLET | 497198 | 45P3261C7T | 20mg | ||
SODIUM CARBONATE | INFILTRATION | INJECTION | 497198 | 45P3261C7T | ADJ PH | ||
SODIUM CARBONATE | INTRA-ARTERIAL | INJECTION, SOLUTION | 497198 | 45P3261C7T | ADJ PH | ||
SODIUM CARBONATE | INTRAMUSCULAR | INJECTION | 497198 | 45P3261C7T | 32.4mg | ||
SODIUM CARBONATE | INTRAMUSCULAR | INJECTION, POWDER, FOR SOLUTION | 497198 | 45P3261C7T | 630mg | ||
SODIUM CARBONATE | INTRAVASCULAR | INJECTION | 497198 | 45P3261C7T | ADJ PH | ||
SODIUM CARBONATE | INTRAVASCULAR | INJECTION, SOLUTION | 497198 | 45P3261C7T | ADJ PH | ||
SODIUM CARBONATE | INTRAVENOUS | INJECTION | 497198 | 45P3261C7T | 241mg | ||
SODIUM CARBONATE | INTRAVENOUS | INJECTION, POWDER, FOR SOLUTION | 497198 | 45P3261C7T | 1000mg | ||
SODIUM CARBONATE | INTRAVENOUS | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 497198 | 45P3261C7T | 1247mg | ||
SODIUM CARBONATE | INTRAVENOUS | INJECTION, SOLUTION | 497198 | 45P3261C7T | ADJ PH | ||
SODIUM CARBONATE | OPHTHALMIC | SOLUTION | 497198 | 45P3261C7T | 0.01%w/v | ||
SODIUM CARBONATE | ORAL | CAPSULE, DELAYED RELEASE | 497198 | 45P3261C7T | 90mg | ||
SODIUM CARBONATE | ORAL | CAPSULE, EXTENDED RELEASE | 497198 | 45P3261C7T | 6mg | ||
SODIUM CARBONATE | ORAL | GRANULE, FOR SUSPENSION | 497198 | 45P3261C7T | 7mg | ||
SODIUM CARBONATE | ORAL | GUM, CHEWING | 497198 | 45P3261C7T | 240mg | ||
SODIUM CARBONATE | ORAL | LOZENGE | 497198 | 45P3261C7T | 500mg | ||
SODIUM CARBONATE | ORAL | TABLET | 497198 | 45P3261C7T | 10.4mg | ||
SODIUM CARBONATE | ORAL | TABLET, DELAYED RELEASE | 497198 | 45P3261C7T | 90mg | ||
SODIUM CARBONATE | ORAL | TABLET, EFFERVESCENT | 497198 | 45P3261C7T | 430mg | ||
SODIUM CARBONATE | ORAL | TABLET, EXTENDED RELEASE | 497198 | 45P3261C7T | 80mg | ||
SODIUM CARBONATE | ORAL | TABLET, FILM COATED | 497198 | 45P3261C7T | 30mg | ||
SODIUM CARBONATE | ORAL | TROCHE | 497198 | 45P3261C7T | 375mg | ||
SODIUM CARBONATE | SUBCUTANEOUS | INJECTION | 497198 | 45P3261C7T | ADJ PH | ||
SODIUM CARBONATE | SUBLINGUAL | TABLET | 497198 | 45P3261C7T | 8mg | ||
SODIUM CARBONATE | TOPICAL | SOAP | 497198 | 45P3261C7T | 0.5%w/w | ||
SODIUM CARBONATE MONOHYDRATE | INTRA-ARTERIAL | INJECTION | 5968116 | 2A1Q1Q3557 | ADJ PH | ||
SODIUM CARBONATE MONOHYDRATE | INTRACARDIAC | INJECTION | 5968116 | 2A1Q1Q3557 | ADJ PH | ||
SODIUM CARBONATE MONOHYDRATE | INTRAVENOUS | INJECTION | 5968116 | 2A1Q1Q3557 | ADJ PH | ||
SODIUM CARBONATE MONOHYDRATE | OPHTHALMIC | SOLUTION | 5968116 | 2A1Q1Q3557 | ADJ PH | ||
SODIUM CARBONATE MONOHYDRATE | ORAL | POWDER, FOR SUSPENSION | 5968116 | 2A1Q1Q3557 | 6mg | ||
SODIUM CARBONATE MONOHYDRATE | ORAL | TABLET | 5968116 | 2A1Q1Q3557 | 30mg | ||
SODIUM CARBONATE MONOHYDRATE | ORAL | TABLET, FILM COATED | 5968116 | 2A1Q1Q3557 | 208mg | ||
SODIUM CELLULOSE | ORAL | CAPSULE | NA | 150mg | |||
SODIUM CETOSTEARYL SULFATE | TOPICAL | CREAM | 59186413 | 7ZBS06BH4B | 1%w/w | ||
SODIUM CHLORATE | INTRAVENOUS | INJECTION | 7775099 | T95DR77GMR | 0.45%w/v | ||
SODIUM CHLORIDE | AURICULAR (OTIC) | SOLUTION | 7647145 | 451W47IQ8X | 18mg | ||
SODIUM CHLORIDE | AURICULAR (OTIC) | SOLUTION/ DROPS | 7647145 | 451W47IQ8X | 18mg | Y | |
SODIUM CHLORIDE | AURICULAR (OTIC) | SUSPENSION | 7647145 | 451W47IQ8X | 0.9%w/v | ||
SODIUM CHLORIDE | AURICULAR (OTIC) | SUSPENSION/ DROPS | 7647145 | 451W47IQ8X | 3mg | ||
SODIUM CHLORIDE | DENTAL | INJECTION | 7647145 | 451W47IQ8X | 0.4%w/v | ||
SODIUM CHLORIDE | DENTAL | POWDER, DENTIFRICE | 7647145 | 451W47IQ8X | 0.03mg/mg | ||
SODIUM CHLORIDE | ENDOTRACHEAL | INJECTION | 7647145 | 451W47IQ8X | 68mg | ||
SODIUM CHLORIDE | ENDOTRACHEAL | POWDER, FOR SUSPENSION | 7647145 | 451W47IQ8X | 46.76mg | ||
SODIUM CHLORIDE | ENDOTRACHEAL | SUSPENSION | 7647145 | 451W47IQ8X | 7.6mg | ||
SODIUM CHLORIDE | EPIDURAL | INJECTION | 7647145 | 451W47IQ8X | 648mg | ||
SODIUM CHLORIDE | EPIDURAL | INJECTION, SOLUTION | 7647145 | 451W47IQ8X | 3535mg | ||
SODIUM CHLORIDE | EPIDURAL | INJECTION, SUSPENSION, LIPOSOMAL | 7647145 | 451W47IQ8X | 11mg | ||
SODIUM CHLORIDE | EPIDURAL | SOLUTION | 7647145 | 451W47IQ8X | 0.9%w/v | ||
SODIUM CHLORIDE | INFILTRATION | INJECTION | 7647145 | 451W47IQ8X | 648mg | ||
SODIUM CHLORIDE | INFILTRATION | INJECTION, SOLUTION | 7647145 | 451W47IQ8X | 3535mg | ||
SODIUM CHLORIDE | INTRA-ARTERIAL | INJECTION | 7647145 | 451W47IQ8X | 278mg | ||
SODIUM CHLORIDE | INTRA-ARTERIAL | INJECTION, POWDER, FOR SOLUTION | 7647145 | 451W47IQ8X | 1.35mg | ||
SODIUM CHLORIDE | INTRA-ARTERIAL | INJECTION, SOLUTION | 7647145 | 451W47IQ8X | 278mg | ||
SODIUM CHLORIDE | INTRA-ARTICULAR | INJECTION | 7647145 | 451W47IQ8X | 26mg | ||
SODIUM CHLORIDE | INTRA-ARTICULAR | INJECTION, POWDER, FOR SUSPENSION | 7647145 | 451W47IQ8X | 45mg | ||
SODIUM CHLORIDE | INTRA-ARTICULAR | INJECTION, SUSPENSION | 7647145 | 451W47IQ8X | 26mg | ||
SODIUM CHLORIDE | INTRABURSAL | INJECTION | 7647145 | 451W47IQ8X | 9mg | ||
SODIUM CHLORIDE | INTRACARDIAC | INJECTION | 7647145 | 451W47IQ8X | 70mg | ||
SODIUM CHLORIDE | INTRACAUDAL | INJECTION | 7647145 | 451W47IQ8X | 210mg | ||
SODIUM CHLORIDE | INTRACAUDAL | INJECTION, SOLUTION | 7647145 | 451W47IQ8X | 210mg | ||
SODIUM CHLORIDE | INTRACAVITARY | INJECTION | 7647145 | 451W47IQ8X | 0.82%w/v | ||
SODIUM CHLORIDE | INTRADERMAL | INJECTION | 7647145 | 451W47IQ8X | 7mg | ||
SODIUM CHLORIDE | INTRALESIONAL | INJECTION | 7647145 | 451W47IQ8X | 0.9%w/v | ||
SODIUM CHLORIDE | INTRALESIONAL | INJECTION, SUSPENSION | 7647145 | 451W47IQ8X | 13mg | ||
SODIUM CHLORIDE | INTRAMUSCULAR | INJECTION | 7647145 | 451W47IQ8X | 1486mg | Y | |
SODIUM CHLORIDE | INTRAMUSCULAR | INJECTION, POWDER, FOR SOLUTION | 7647145 | 451W47IQ8X | 226mg | ||
SODIUM CHLORIDE | INTRAMUSCULAR | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 7647145 | 451W47IQ8X | 360mg | ||
SODIUM CHLORIDE | INTRAMUSCULAR | INJECTION, SOLUTION | 7647145 | 451W47IQ8X | 709mg | ||
SODIUM CHLORIDE | INTRAMUSCULAR | INJECTION, SOLUTION, CONCENTRATE | 7647145 | 451W47IQ8X | 0.86%w/v | ||
SODIUM CHLORIDE | INTRAMUSCULAR | INJECTION, SUSPENSION | 7647145 | 451W47IQ8X | 26mg | ||
SODIUM CHLORIDE | INTRAMUSCULAR | INJECTION, SUSPENSION, EXTENDED RELEASE | 7647145 | 451W47IQ8X | 24mg | ||
SODIUM CHLORIDE | INTRAMUSCULAR | LIQUID | 7647145 | 451W47IQ8X | 17mg | ||
SODIUM CHLORIDE | INTRAMUSCULAR | SOLUTION | 7647145 | 451W47IQ8X | 90mg | ||
SODIUM CHLORIDE | INTRAMUSCULAR | SUSPENSION | 7647145 | 451W47IQ8X | 9mg | ||
SODIUM CHLORIDE | INTRAOCULAR | INJECTION, SOLUTION, CONCENTRATE | 7647145 | 451W47IQ8X | 0.86%w/v | ||
SODIUM CHLORIDE | INTRAOCULAR | SOLUTION | 7647145 | 451W47IQ8X | 320mg | Y | |
SODIUM CHLORIDE | INTRAPERITONEAL | INJECTION, POWDER, FOR SOLUTION | 7647145 | 451W47IQ8X | 226mg | ||
SODIUM CHLORIDE | INTRAPERITONEAL | SOLUTION | 7647145 | 451W47IQ8X | 0.54%w/v | ||
SODIUM CHLORIDE | INTRAPLEURAL | INJECTION, POWDER, FOR SOLUTION | 7647145 | 451W47IQ8X | 226mg | ||
SODIUM CHLORIDE | INTRASYNOVIAL | INJECTION | 7647145 | 451W47IQ8X | 0.9%w/v | ||
SODIUM CHLORIDE | INTRASYNOVIAL | INJECTION, SUSPENSION | 7647145 | 451W47IQ8X | 4mg | Y | |
SODIUM CHLORIDE | INTRATHECAL | INJECTION | 7647145 | 451W47IQ8X | 196mg | ||
SODIUM CHLORIDE | INTRATHECAL | INJECTION, POWDER, FOR SOLUTION | 7647145 | 451W47IQ8X | 1.35mg | ||
SODIUM CHLORIDE | INTRATHECAL | INJECTION, SOLUTION | 7647145 | 451W47IQ8X | 131mg | ||
SODIUM CHLORIDE | INTRATUMOR | INJECTION | 7647145 | 451W47IQ8X | 1.2%w/v | ||
SODIUM CHLORIDE | INTRATYMPANIC | SUSPENSION | 7647145 | 451W47IQ8X | 2mg | Y | |
SODIUM CHLORIDE | INTRAVASCULAR | INJECTION | 7647145 | 451W47IQ8X | 0.86%w/v | ||
SODIUM CHLORIDE | INTRAVASCULAR | SOLUTION | 7647145 | 451W47IQ8X | NA | ||
SODIUM CHLORIDE | INTRAVENOUS | INJECTION | 7647145 | 451W47IQ8X | 28773mg | ||
SODIUM CHLORIDE | INTRAVENOUS | INJECTION, EMULSION | 7647145 | 451W47IQ8X | 0.62%w/v | ||
SODIUM CHLORIDE | INTRAVENOUS | INJECTION, POWDER, FOR SOLUTION | 7647145 | 451W47IQ8X | 2922mg | ||
SODIUM CHLORIDE | INTRAVENOUS | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 7647145 | 451W47IQ8X | 360mg | ||
SODIUM CHLORIDE | INTRAVENOUS | INJECTION, SOLUTION | 7647145 | 451W47IQ8X | 2187mg | ||
SODIUM CHLORIDE | INTRAVENOUS | INJECTION, SOLUTION, CONCENTRATE | 7647145 | 451W47IQ8X | 0.86%w/v | ||
SODIUM CHLORIDE | INTRAVENOUS | INJECTION, SUSPENSION | 7647145 | 451W47IQ8X | 0.9%w/v | ||
SODIUM CHLORIDE | INTRAVENOUS | LIQUID | 7647145 | 451W47IQ8X | 6320mg | ||
SODIUM CHLORIDE | INTRAVENOUS | SOLUTION | 7647145 | 451W47IQ8X | 90mg | ||
SODIUM CHLORIDE | INTRAVESICAL | INJECTION, SOLUTION | 7647145 | 451W47IQ8X | 351mg | ||
SODIUM CHLORIDE | INTRAVITREAL | INJECTION | 7647145 | 451W47IQ8X | 10%w/v | ||
SODIUM CHLORIDE | INTRAVITREAL | INJECTION, SUSPENSION | 7647145 | 451W47IQ8X | 6mg | ||
SODIUM CHLORIDE | IONTOPHORESIS | SOLUTION | 7647145 | 451W47IQ8X | 0.6%w/v | ||
SODIUM CHLORIDE | IONTOPHORESIS | SYSTEM | 7647145 | 451W47IQ8X | 3.1mg | ||
SODIUM CHLORIDE | NASAL | DROPS | 7647145 | 451W47IQ8X | NA | ||
SODIUM CHLORIDE | NASAL | JELLY | 7647145 | 451W47IQ8X | NA | ||
SODIUM CHLORIDE | NASAL | LIQUID | 7647145 | 451W47IQ8X | 7.4mg/1ml | ||
SODIUM CHLORIDE | NASAL | SOLUTION | 7647145 | 451W47IQ8X | 330mg | ||
SODIUM CHLORIDE | NASAL | SPRAY | 7647145 | 451W47IQ8X | 30mg | ||
SODIUM CHLORIDE | NASAL | SPRAY, METERED | 7647145 | 451W47IQ8X | 36mg | ||
SODIUM CHLORIDE | OPHTHALMIC | DROPS | 7647145 | 451W47IQ8X | 0.08%w/w | ||
SODIUM CHLORIDE | OPHTHALMIC | GEL | 7647145 | 451W47IQ8X | 0.06%w/w | ||
SODIUM CHLORIDE | OPHTHALMIC | POWDER, FOR SOLUTION | 7647145 | 451W47IQ8X | 0.9%w/w | ||
SODIUM CHLORIDE | OPHTHALMIC | SOLUTION | 7647145 | 451W47IQ8X | 13mg | ||
SODIUM CHLORIDE | OPHTHALMIC | SOLUTION/ DROPS | 7647145 | 451W47IQ8X | 55mg | ||
SODIUM CHLORIDE | OPHTHALMIC | SUSPENSION | 7647145 | 451W47IQ8X | 10mg | ||
SODIUM CHLORIDE | OPHTHALMIC | SUSPENSION/ DROPS | 7647145 | 451W47IQ8X | 3mg | ||
SODIUM CHLORIDE | ORAL | CAPSULE | 7647145 | 451W47IQ8X | 6mg | ||
SODIUM CHLORIDE | ORAL | CAPSULE, EXTENDED RELEASE | 7647145 | 451W47IQ8X | 41mg | ||
SODIUM CHLORIDE | ORAL | DROPS | 7647145 | 451W47IQ8X | NA | ||
SODIUM CHLORIDE | ORAL | ELIXIR | 7647145 | 451W47IQ8X | 1mg | ||
SODIUM CHLORIDE | ORAL | GRANULE, FOR SUSPENSION | 7647145 | 451W47IQ8X | 162mg | ||
SODIUM CHLORIDE | ORAL | POWDER, FOR SUSPENSION | 7647145 | 451W47IQ8X | 98mg | ||
SODIUM CHLORIDE | ORAL | SOLUTION | 7647145 | 451W47IQ8X | 148mg | ||
SODIUM CHLORIDE | ORAL | SUSPENSION | 7647145 | 451W47IQ8X | 1126mg | ||
SODIUM CHLORIDE | ORAL | SYRUP | 7647145 | 451W47IQ8X | 40mg | Y | |
SODIUM CHLORIDE | ORAL | TABLET | 7647145 | 451W47IQ8X | 231mg | ||
SODIUM CHLORIDE | ORAL | TABLET, CHEWABLE | 7647145 | 451W47IQ8X | 20mg | Y | |
SODIUM CHLORIDE | ORAL | TABLET, COATED | 7647145 | 451W47IQ8X | 54.7mg | ||
SODIUM CHLORIDE | ORAL | TABLET, DELAYED RELEASE | 7647145 | 451W47IQ8X | 97mg | ||
SODIUM CHLORIDE | ORAL | TABLET, EXTENDED RELEASE | 7647145 | 451W47IQ8X | 335.1mg | ||
SODIUM CHLORIDE | ORAL | TABLET, FILM COATED | 7647145 | 451W47IQ8X | 100mg | ||
SODIUM CHLORIDE | ORAL | TABLET, FILM COATED, EXTENDED RELEASE | 7647145 | 451W47IQ8X | 46.8mg | ||
SODIUM CHLORIDE | ORAL | TABLET, ORALLY DISINTEGRATING | 7647145 | 451W47IQ8X | 10mg | ||
SODIUM CHLORIDE | PARENTERAL | INJECTION | 7647145 | 451W47IQ8X | 584mg | ||
SODIUM CHLORIDE | PARENTERAL | INJECTION, SOLUTION | 7647145 | 451W47IQ8X | 210mg | Y | |
SODIUM CHLORIDE | PERIDURAL | INJECTION | 7647145 | 451W47IQ8X | 8.07mg | ||
SODIUM CHLORIDE | PERINEURAL | INJECTION | 7647145 | 451W47IQ8X | 648mg | ||
SODIUM CHLORIDE | RECTAL | ENEMA | 7647145 | 451W47IQ8X | 0.7%w/w | ||
SODIUM CHLORIDE | RECTAL | SOLUTION | 7647145 | 451W47IQ8X | NA | ||
SODIUM CHLORIDE | RECTAL | SUPPOSITORY | 7647145 | 451W47IQ8X | 140mg | Y | |
SODIUM CHLORIDE | RESPIRATORY (INHALATION) | INHALANT | 7647145 | 451W47IQ8X | 3mg | ||
SODIUM CHLORIDE | RESPIRATORY (INHALATION) | POWDER | 7647145 | 451W47IQ8X | NA | ||
SODIUM CHLORIDE | RESPIRATORY (INHALATION) | SOLUTION | 7647145 | 451W47IQ8X | 108mg | ||
SODIUM CHLORIDE | RESPIRATORY (INHALATION) | SUSPENSION | 7647145 | 451W47IQ8X | 43mg | ||
SODIUM CHLORIDE | RETROBULBAR | INJECTION | 7647145 | 451W47IQ8X | 648mg | ||
SODIUM CHLORIDE | SOFT TISSUE | INJECTION | 7647145 | 451W47IQ8X | 0.9%w/v | ||
SODIUM CHLORIDE | SOFT TISSUE | INJECTION, SUSPENSION | 7647145 | 451W47IQ8X | 26mg | ||
SODIUM CHLORIDE | SUBARACHNOID | INJECTION, SOLUTION | 7647145 | 451W47IQ8X | 0.9%w/v | ||
SODIUM CHLORIDE | SUBCUTANEOUS | IMPLANT | 7647145 | 451W47IQ8X | 77mg | ||
SODIUM CHLORIDE | SUBCUTANEOUS | INJECTION | 7647145 | 451W47IQ8X | 1486mg | Y | |
SODIUM CHLORIDE | SUBCUTANEOUS | INJECTION, POWDER, FOR SOLUTION | 7647145 | 451W47IQ8X | 0.68%w/v | ||
SODIUM CHLORIDE | SUBCUTANEOUS | INJECTION, POWDER, FOR SUSPENSION | 7647145 | 451W47IQ8X | NA | ||
SODIUM CHLORIDE | SUBCUTANEOUS | INJECTION, SOLUTION | 7647145 | 451W47IQ8X | 225mg | ||
SODIUM CHLORIDE | SUBCUTANEOUS | INJECTION, SOLUTION, CONCENTRATE | 7647145 | 451W47IQ8X | 0.86%w/v | ||
SODIUM CHLORIDE | SUBCUTANEOUS | INJECTION, SUSPENSION | 7647145 | 451W47IQ8X | 0.8%w/v | ||
SODIUM CHLORIDE | SUBCUTANEOUS | LIQUID | 7647145 | 451W47IQ8X | 0.7%w/v | ||
SODIUM CHLORIDE | SUBCUTANEOUS | SOLUTION | 7647145 | 451W47IQ8X | 90mg | ||
SODIUM CHLORIDE | SUBCUTANEOUS | SUSPENSION | 7647145 | 451W47IQ8X | 0.8%w/v | ||
SODIUM CHLORIDE | SUBMUCOSAL | INJECTION | 7647145 | 451W47IQ8X | 17mg | ||
SODIUM CHLORIDE | SUBMUCOSAL | INJECTION, SOLUTION | 7647145 | 451W47IQ8X | 16%w/v | ||
SODIUM CHLORIDE | TOPICAL | CREAM | 7647145 | 451W47IQ8X | 0.4%w/w | ||
SODIUM CHLORIDE | TOPICAL | GEL | 7647145 | 451W47IQ8X | 0.18%w/w | ||
SODIUM CHLORIDE | TOPICAL | LOTION | 7647145 | 451W47IQ8X | 0.3%w/v | ||
SODIUM CHLORIDE | TOPICAL | POWDER | 7647145 | 451W47IQ8X | NA | ||
SODIUM CHLORIDE | TOPICAL | SHAMPOO | 7647145 | 451W47IQ8X | 150mg | ||
SODIUM CHLORIDE | TOPICAL | SOAP | 7647145 | 451W47IQ8X | 1.26%w/w | ||
SODIUM CHLORIDE | TOPICAL | SOLUTION | 7647145 | 451W47IQ8X | 210mg | Y | |
SODIUM CHLORIDE | TOPICAL | SOLUTION/ DROPS | 7647145 | 451W47IQ8X | 0.86%w/v | ||
SODIUM CHLORIDE | TOPICAL | SUSPENSION | 7647145 | 451W47IQ8X | 0.32%w/v | ||
SODIUM CHLORIDE | TOPICAL | SUSPENSION/ DROPS | 7647145 | 451W47IQ8X | 0.23%w/v | ||
SODIUM CHLORIDE | TOPICAL | SYSTEM | 7647145 | 451W47IQ8X | 3.1mg | ||
SODIUM CHLORIDE | VAGINAL | GEL | 7647145 | 451W47IQ8X | 10%w/w | ||
SODIUM CHLORITE | OPHTHALMIC | SOLUTION | 7758192 | G538EBV4VF | 0.01%w/v | ||
SODIUM CHLORITE | OPHTHALMIC | SOLUTION/ DROPS | 7758192 | G538EBV4VF | 0.01%w/v | ||
SODIUM COCOMONOGLYCERIDE SULFONATE | DENTAL | PASTE, DENTIFRICE | NA | 0.81%w/w | |||
SODIUM COCOYL ISETHIONATE | TOPICAL | SHAMPOO | 61789320 | 518XTE8493 | 1%w/w | ||
SODIUM DESOXYCHOLATE | INTRAVENOUS | INJECTION | 302954 | 436LS6U35Y | 3mg | ||
SODIUM DESOXYCHOLATE | INTRAVENOUS | INJECTION, POWDER, FOR SOLUTION | 302954 | 436LS6U35Y | 41mg | ||
SODIUM DITHIONATE | INTRAMUSCULAR | INJECTION, SOLUTION | 7631949 | RPF7Z41GAW | 48mg | ||
SODIUM DITHIONATE | INTRAVENOUS | INJECTION, SOLUTION | 7631949 | RPF7Z41GAW | 48mg | ||
SODIUM DITHIONITE | INTRAVENOUS | INJECTION | 7775146 | 2K5B8F6ES1 | 1mg | ||
SODIUM FORMALDEHYDE SULFOXYLATE | INTRAMUSCULAR | INJECTION | 149440 | X4ZGP7K714 | 3mg | ||
SODIUM FORMALDEHYDE SULFOXYLATE | INTRAVENOUS | INJECTION | 149440 | X4ZGP7K714 | 3mg | ||
SODIUM FORMALDEHYDE SULFOXYLATE | INTRAVENOUS | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 149440 | X4ZGP7K714 | 0.1%w/v | ||
SODIUM FORMALDEHYDE SULFOXYLATE | SUBCUTANEOUS | INJECTION | 149440 | X4ZGP7K714 | 3mg | ||
SODIUM FORMALDEHYDE SULFOXYLATE | TOPICAL | CREAM | 149440 | X4ZGP7K714 | NA | ||
SODIUM GLUCONATE | INTRAVENOUS | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 527071 | R6Q3791S76 | 3mg | ||
SODIUM GLUCONATE | ORAL | SOLUTION | 527071 | R6Q3791S76 | 2.5mg/1ml | ||
SODIUM GLUCONATE | ORAL | TABLET | 527071 | R6Q3791S76 | 59mg | ||
SODIUM HYDROXIDE | AURICULAR (OTIC) | SOLUTION | 1310732 | 55X04QC32I | 0.8%w/w | ||
SODIUM HYDROXIDE | AURICULAR (OTIC) | SOLUTION/ DROPS | 1310732 | 55X04QC32I | ADJ PH | ||
SODIUM HYDROXIDE | AURICULAR (OTIC) | SUSPENSION | 1310732 | 55X04QC32I | ADJ PH | ||
SODIUM HYDROXIDE | AURICULAR (OTIC) | SUSPENSION/ DROPS | 1310732 | 55X04QC32I | ADJ PH | ||
SODIUM HYDROXIDE | BUCCAL | FILM | 1310732 | 55X04QC32I | 0.09mg | ||
SODIUM HYDROXIDE | BUCCAL | FILM, SOLUBLE | 1310732 | 55X04QC32I | 5mg | ||
SODIUM HYDROXIDE | BUCCAL | MOUTHWASH | 1310732 | 55X04QC32I | 2mg/1ml | ||
SODIUM HYDROXIDE | DENTAL | INJECTION | 1310732 | 55X04QC32I | ADJ PH | ||
SODIUM HYDROXIDE | DENTAL | PASTE | 1310732 | 55X04QC32I | 0.6%w/w | ||
SODIUM HYDROXIDE | DENTAL | SOLUTION | 1310732 | 55X04QC32I | ADJ PH | ||
SODIUM HYDROXIDE | ENDOTRACHEAL | INJECTION | 1310732 | 55X04QC32I | ADJ PH | ||
SODIUM HYDROXIDE | ENDOTRACHEAL | POWDER, FOR SUSPENSION | 1310732 | 55X04QC32I | ADJ PH | ||
SODIUM HYDROXIDE | ENDOTRACHEAL | SUSPENSION | 1310732 | 55X04QC32I | ADJ PH | ||
SODIUM HYDROXIDE | EPIDURAL | INJECTION | 1310732 | 55X04QC32I | ADJ PH | ||
SODIUM HYDROXIDE | EPIDURAL | INJECTION, SOLUTION | 1310732 | 55X04QC32I | ADJ PH | ||
SODIUM HYDROXIDE | EPIDURAL | SOLUTION | 1310732 | 55X04QC32I | ADJ PH | ||
SODIUM HYDROXIDE | EXTRACORPOREAL | INJECTION | 1310732 | 55X04QC32I | ADJ PH | ||
SODIUM HYDROXIDE | INFILTRATION | INJECTION | 1310732 | 55X04QC32I | ADJ PH | ||
SODIUM HYDROXIDE | INFILTRATION | INJECTION, SOLUTION | 1310732 | 55X04QC32I | ADJ PH | ||
SODIUM HYDROXIDE | INTERSTITIAL | INJECTION | 1310732 | 55X04QC32I | ADJ PH | ||
SODIUM HYDROXIDE | INTRA-AMNIOTIC | INJECTION | 1310732 | 55X04QC32I | ADJ PH | ||
SODIUM HYDROXIDE | INTRA-ARTERIAL | INJECTION | 1310732 | 55X04QC32I | 176mg | ||
SODIUM HYDROXIDE | INTRA-ARTERIAL | INJECTION, POWDER, FOR SOLUTION | 1310732 | 55X04QC32I | ADJ PH | ||
SODIUM HYDROXIDE | INTRA-ARTERIAL | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 1310732 | 55X04QC32I | ADJ PH | ||
SODIUM HYDROXIDE | INTRA-ARTERIAL | INJECTION, SOLUTION | 1310732 | 55X04QC32I | ADJ PH | ||
SODIUM HYDROXIDE | INTRA-ARTERIAL | SOLUTION | 1310732 | 55X04QC32I | ADJ PH | ||
SODIUM HYDROXIDE | INTRA-ARTICULAR | INJECTION | 1310732 | 55X04QC32I | ADJ PH | ||
SODIUM HYDROXIDE | INTRA-ARTICULAR | INJECTION, SOLUTION | 1310732 | 55X04QC32I | ADJ PH | ||
SODIUM HYDROXIDE | INTRA-ARTICULAR | INJECTION, SUSPENSION | 1310732 | 55X04QC32I | ADJ PH | ||
SODIUM HYDROXIDE | INTRA-ARTICULAR | SUSPENSION, EXTENDED RELEASE | 1310732 | 55X04QC32I | ADJ PH | ||
SODIUM HYDROXIDE | INTRABURSAL | INJECTION | 1310732 | 55X04QC32I | ADJ PH | ||
SODIUM HYDROXIDE | INTRACARDIAC | INJECTION | 1310732 | 55X04QC32I | ADJ PH | ||
SODIUM HYDROXIDE | INTRACAUDAL | INJECTION | 1310732 | 55X04QC32I | ADJ PH | ||
SODIUM HYDROXIDE | INTRACAUDAL | INJECTION, SOLUTION | 1310732 | 55X04QC32I | ADJ PH | ||
SODIUM HYDROXIDE | INTRACAVERNOUS | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 1310732 | 55X04QC32I | ADJ PH | Y | |
SODIUM HYDROXIDE | INTRACAVITARY | INJECTION | 1310732 | 55X04QC32I | ADJ PH | ||
SODIUM HYDROXIDE | INTRACAVITARY | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 1310732 | 55X04QC32I | ADJ PH | ||
SODIUM HYDROXIDE | INTRADERMAL | INJECTION | 1310732 | 55X04QC32I | ADJ PH | ||
SODIUM HYDROXIDE | INTRADERMAL | INJECTION, POWDER, FOR SOLUTION | 1310732 | 55X04QC32I | ADJ PH | ||
SODIUM HYDROXIDE | INTRADERMAL | SUSPENSION, EXTENDED RELEASE | 1310732 | 55X04QC32I | ADJ PH | ||
SODIUM HYDROXIDE | INTRADISCAL | INJECTION, POWDER, FOR SOLUTION | 1310732 | 55X04QC32I | ADJ PH | ||
SODIUM HYDROXIDE | INTRALESIONAL | INJECTION | 1310732 | 55X04QC32I | ADJ PH | ||
SODIUM HYDROXIDE | INTRALESIONAL | INJECTION, SUSPENSION | 1310732 | 55X04QC32I | ADJ PH | ||
SODIUM HYDROXIDE | INTRALESIONAL | SUSPENSION, EXTENDED RELEASE | 1310732 | 55X04QC32I | ADJ PH | ||
SODIUM HYDROXIDE | INTRAMUSCULAR | INJECTION | 1310732 | 55X04QC32I | 176mg | ||
SODIUM HYDROXIDE | INTRAMUSCULAR | INJECTION, POWDER, FOR SOLUTION | 1310732 | 55X04QC32I | 7.01mg | ||
SODIUM HYDROXIDE | INTRAMUSCULAR | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 1310732 | 55X04QC32I | 0.35%w/v | ||
SODIUM HYDROXIDE | INTRAMUSCULAR | INJECTION, SOLUTION | 1310732 | 55X04QC32I | 78mg | ||
SODIUM HYDROXIDE | INTRAMUSCULAR | INJECTION, SUSPENSION | 1310732 | 55X04QC32I | ADJ PH | ||
SODIUM HYDROXIDE | INTRAMUSCULAR | INJECTION, SUSPENSION, EXTENDED RELEASE | 1310732 | 55X04QC32I | 27mg | Y | |
SODIUM HYDROXIDE | INTRAMUSCULAR | LIQUID | 1310732 | 55X04QC32I | ADJ PH | ||
SODIUM HYDROXIDE | INTRAMUSCULAR | SOLUTION | 1310732 | 55X04QC32I | ADJ PH | ||
SODIUM HYDROXIDE | INTRAMUSCULAR | SUSPENSION, EXTENDED RELEASE | 1310732 | 55X04QC32I | 5.4mg | ||
SODIUM HYDROXIDE | INTRAOCULAR | SOLUTION | 1310732 | 55X04QC32I | ADJ PH | ||
SODIUM HYDROXIDE | INTRAPERITONEAL | INJECTION | 1310732 | 55X04QC32I | ADJ PH | ||
SODIUM HYDROXIDE | INTRAPERITONEAL | SOLUTION | 1310732 | 55X04QC32I | ADJ PH | ||
SODIUM HYDROXIDE | INTRAPLEURAL | INJECTION | 1310732 | 55X04QC32I | ADJ PH | ||
SODIUM HYDROXIDE | INTRASPINAL | INJECTION | 1310732 | 55X04QC32I | ADJ PH | ||
SODIUM HYDROXIDE | INTRASYNOVIAL | INJECTION | 1310732 | 55X04QC32I | ADJ PH | ||
SODIUM HYDROXIDE | INTRASYNOVIAL | INJECTION, SUSPENSION | 1310732 | 55X04QC32I | ADJ PH | ||
SODIUM HYDROXIDE | INTRASYNOVIAL | SUSPENSION, EXTENDED RELEASE | 1310732 | 55X04QC32I | ADJ PH | ||
SODIUM HYDROXIDE | INTRATHECAL | INJECTION | 1310732 | 55X04QC32I | 176mg | ||
SODIUM HYDROXIDE | INTRATHECAL | INJECTION, POWDER, FOR SOLUTION | 1310732 | 55X04QC32I | ADJ PH | ||
SODIUM HYDROXIDE | INTRATHECAL | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 1310732 | 55X04QC32I | ADJ PH | ||
SODIUM HYDROXIDE | INTRATHECAL | INJECTION, SOLUTION | 1310732 | 55X04QC32I | ADJ PH | ||
SODIUM HYDROXIDE | INTRATHECAL | SOLUTION | 1310732 | 55X04QC32I | ADJ PH | ||
SODIUM HYDROXIDE | INTRATUMOR | INJECTION | 1310732 | 55X04QC32I | ADJ PH | ||
SODIUM HYDROXIDE | INTRATUMOR | INJECTION, POWDER, FOR SOLUTION | 1310732 | 55X04QC32I | ADJ PH | ||
SODIUM HYDROXIDE | INTRAVASCULAR | INJECTION | 1310732 | 55X04QC32I | ADJ PH | ||
SODIUM HYDROXIDE | INTRAVASCULAR | INJECTION, SOLUTION | 1310732 | 55X04QC32I | ADJ PH | ||
SODIUM HYDROXIDE | INTRAVASCULAR | SOLUTION | 1310732 | 55X04QC32I | ADJ PH | ||
SODIUM HYDROXIDE | INTRAVENOUS | INJECTABLE, LIPOSOMAL | 1310732 | 55X04QC32I | ADJ PH | ||
SODIUM HYDROXIDE | INTRAVENOUS | INJECTION | 1310732 | 55X04QC32I | 456mg | ||
SODIUM HYDROXIDE | INTRAVENOUS | INJECTION, EMULSION | 1310732 | 55X04QC32I | ADJ PH | ||
SODIUM HYDROXIDE | INTRAVENOUS | INJECTION, POWDER, FOR SOLUTION | 1310732 | 55X04QC32I | 136.55mg | ||
SODIUM HYDROXIDE | INTRAVENOUS | INJECTION, POWDER, FOR SUSPENSION | 1310732 | 55X04QC32I | ADJ PH | ||
SODIUM HYDROXIDE | INTRAVENOUS | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 1310732 | 55X04QC32I | 78.36mg | ||
SODIUM HYDROXIDE | INTRAVENOUS | INJECTION, SOLUTION | 1310732 | 55X04QC32I | 78mg | ||
SODIUM HYDROXIDE | INTRAVENOUS | INJECTION, SUSPENSION | 1310732 | 55X04QC32I | ADJ PH | ||
SODIUM HYDROXIDE | INTRAVENOUS | INJECTION, SUSPENSION, LIPOSOMAL | 1310732 | 55X04QC32I | ADJ PH | ||
SODIUM HYDROXIDE | INTRAVENOUS | LIQUID | 1310732 | 55X04QC32I | ADJ PH | ||
SODIUM HYDROXIDE | INTRAVENOUS | POWDER | 1310732 | 55X04QC32I | ADJ PH | ||
SODIUM HYDROXIDE | INTRAVENOUS | SOLUTION | 1310732 | 55X04QC32I | 2.78%w/v | ||
SODIUM HYDROXIDE | INTRAVENOUS | SOLUTION, CONCENTRATE | 1310732 | 55X04QC32I | ADJ PH | ||
SODIUM HYDROXIDE | INTRAVESICAL | INJECTION, SOLUTION | 1310732 | 55X04QC32I | ADJ PH | ||
SODIUM HYDROXIDE | INTRAVITREAL | INJECTION | 1310732 | 55X04QC32I | ADJ PH | ||
SODIUM HYDROXIDE | INTRAVITREAL | INJECTION, SUSPENSION | 1310732 | 55X04QC32I | ADJ PH | ||
SODIUM HYDROXIDE | IONTOPHORESIS | SOLUTION | 1310732 | 55X04QC32I | ADJ PH | ||
SODIUM HYDROXIDE | IRRIGATION | SOLUTION | 1310732 | 55X04QC32I | ADJ PH | ||
SODIUM HYDROXIDE | NASAL | SOLUTION | 1310732 | 55X04QC32I | 20mg | ||
SODIUM HYDROXIDE | NASAL | SPRAY | 1310732 | 55X04QC32I | ADJ PH | ||
SODIUM HYDROXIDE | NASAL | SPRAY, METERED | 1310732 | 55X04QC32I | ADJ PH | ||
SODIUM HYDROXIDE | OPHTHALMIC | DROPS | 1310732 | 55X04QC32I | NA | ||
SODIUM HYDROXIDE | OPHTHALMIC | EMULSION | 1310732 | 55X04QC32I | 0.02%w/v | ||
SODIUM HYDROXIDE | OPHTHALMIC | GEL | 1310732 | 55X04QC32I | 6mg | ||
SODIUM HYDROXIDE | OPHTHALMIC | SOLUTION | 1310732 | 55X04QC32I | 0.05%w/v | ||
SODIUM HYDROXIDE | OPHTHALMIC | SOLUTION/ DROPS | 1310732 | 55X04QC32I | ADJ PH | ||
SODIUM HYDROXIDE | OPHTHALMIC | SUSPENSION | 1310732 | 55X04QC32I | ADJ PH | ||
SODIUM HYDROXIDE | OPHTHALMIC | SUSPENSION/ DROPS | 1310732 | 55X04QC32I | ADJ PH | ||
SODIUM HYDROXIDE | ORAL | CAPSULE | 1310732 | 55X04QC32I | 60mg | ||
SODIUM HYDROXIDE | ORAL | CAPSULE, COATED | 1310732 | 55X04QC32I | 0.08mg | ||
SODIUM HYDROXIDE | ORAL | CAPSULE, COATED PELLETS | 1310732 | 55X04QC32I | 0.01mg | ||
SODIUM HYDROXIDE | ORAL | CAPSULE, DELAYED RELEASE | 1310732 | 55X04QC32I | 0.25mg | ||
SODIUM HYDROXIDE | ORAL | CAPSULE, LIQUID FILLED | 1310732 | 55X04QC32I | 1.5mg | ||
SODIUM HYDROXIDE | ORAL | CONCENTRATE | 1310732 | 55X04QC32I | 10mg/5ml | ||
SODIUM HYDROXIDE | ORAL | ELIXIR | 1310732 | 55X04QC32I | ADJ PH | ||
SODIUM HYDROXIDE | ORAL | EMULSION | 1310732 | 55X04QC32I | ADJ PH | ||
SODIUM HYDROXIDE | ORAL | FILM, SOLUBLE | 1310732 | 55X04QC32I | 11mg | Y | |
SODIUM HYDROXIDE | ORAL | GRANULE, FOR SUSPENSION | 1310732 | 55X04QC32I | ADJ PH | ||
SODIUM HYDROXIDE | ORAL | LIQUID | 1310732 | 55X04QC32I | 2mg/5ml | ||
SODIUM HYDROXIDE | ORAL | POWDER, FOR SOLUTION | 1310732 | 55X04QC32I | ADJ PH | ||
SODIUM HYDROXIDE | ORAL | POWDER, FOR SUSPENSION | 1310732 | 55X04QC32I | 9mg | Y | |
SODIUM HYDROXIDE | ORAL | SOLUTION | 1310732 | 55X04QC32I | 9120mg | ||
SODIUM HYDROXIDE | ORAL | SUSPENSION | 1310732 | 55X04QC32I | 400mg | ||
SODIUM HYDROXIDE | ORAL | SYRUP | 1310732 | 55X04QC32I | 71mg/5ml | ||
SODIUM HYDROXIDE | ORAL | TABLET | 1310732 | 55X04QC32I | 10mg | ||
SODIUM HYDROXIDE | ORAL | TABLET, COATED | 1310732 | 55X04QC32I | NA | ||
SODIUM HYDROXIDE | ORAL | TABLET, DELAYED RELEASE | 1310732 | 55X04QC32I | 4mg | ||
SODIUM HYDROXIDE | ORAL | TABLET, EXTENDED RELEASE | 1310732 | 55X04QC32I | 13mg | ||
SODIUM HYDROXIDE | ORAL | TABLET, FILM COATED | 1310732 | 55X04QC32I | 8mg | ||
SODIUM HYDROXIDE | ORAL | TABLET, ORALLY DISINTEGRATING | 1310732 | 55X04QC32I | 1mg | ||
SODIUM HYDROXIDE | PARENTERAL | INJECTION | 1310732 | 55X04QC32I | ADJ PH | ||
SODIUM HYDROXIDE | PARENTERAL | INJECTION, POWDER, FOR SOLUTION | 1310732 | 55X04QC32I | ADJ PH | ||
SODIUM HYDROXIDE | PARENTERAL | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 1310732 | 55X04QC32I | ADJ PH | ||
SODIUM HYDROXIDE | PARENTERAL | INJECTION, SOLUTION | 1310732 | 55X04QC32I | ADJ PH | ||
SODIUM HYDROXIDE | PERIDURAL | INJECTION | 1310732 | 55X04QC32I | ADJ PH | ||
SODIUM HYDROXIDE | PERINEURAL | INJECTION | 1310732 | 55X04QC32I | ADJ PH | ||
SODIUM HYDROXIDE | PERIODONTAL | SOLUTION | 1310732 | 55X04QC32I | ADJ PH | ||
SODIUM HYDROXIDE | RECTAL | ENEMA | 1310732 | 55X04QC32I | 0.44%v/v | ||
SODIUM HYDROXIDE | RECTAL | INJECTION, POWDER, FOR SOLUTION | 1310732 | 55X04QC32I | ADJ PH | ||
SODIUM HYDROXIDE | RECTAL | SOLUTION | 1310732 | 55X04QC32I | NA | ||
SODIUM HYDROXIDE | RESPIRATORY (INHALATION) | AEROSOL, METERED | 1310732 | 55X04QC32I | ADJ PH | ||
SODIUM HYDROXIDE | RESPIRATORY (INHALATION) | POWDER | 1310732 | 55X04QC32I | ADJ PH | ||
SODIUM HYDROXIDE | RESPIRATORY (INHALATION) | SOLUTION | 1310732 | 55X04QC32I | 8%w/v | ||
SODIUM HYDROXIDE | RETROBULBAR | INJECTION | 1310732 | 55X04QC32I | ADJ PH | ||
SODIUM HYDROXIDE | SOFT TISSUE | INJECTION | 1310732 | 55X04QC32I | ADJ PH | ||
SODIUM HYDROXIDE | SOFT TISSUE | INJECTION, SUSPENSION | 1310732 | 55X04QC32I | ADJ PH | ||
SODIUM HYDROXIDE | SUBARACHNOID | INJECTION, SOLUTION | 1310732 | 55X04QC32I | ADJ PH | ||
SODIUM HYDROXIDE | SUBCONJUNCTIVAL | INJECTION | 1310732 | 55X04QC32I | ADJ PH | ||
SODIUM HYDROXIDE | SUBCUTANEOUS | INJECTION | 1310732 | 55X04QC32I | 31.45mg | ||
SODIUM HYDROXIDE | SUBCUTANEOUS | INJECTION, POWDER, FOR SOLUTION | 1310732 | 55X04QC32I | ADJ PH | ||
SODIUM HYDROXIDE | SUBCUTANEOUS | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 1310732 | 55X04QC32I | ADJ PH | ||
SODIUM HYDROXIDE | SUBCUTANEOUS | INJECTION, SOLUTION | 1310732 | 55X04QC32I | 1%w/v | ||
SODIUM HYDROXIDE | SUBCUTANEOUS | INJECTION, SUSPENSION | 1310732 | 55X04QC32I | ADJ PH | ||
SODIUM HYDROXIDE | SUBCUTANEOUS | SOLUTION | 1310732 | 55X04QC32I | ADJ PH | ||
SODIUM HYDROXIDE | SUBCUTANEOUS | SUSPENSION | 1310732 | 55X04QC32I | ADJ PH | ||
SODIUM HYDROXIDE | SUBCUTANEOUS | SUSPENSION, EXTENDED RELEASE | 1310732 | 55X04QC32I | NA | ||
SODIUM HYDROXIDE | SUBMUCOSAL | INJECTION | 1310732 | 55X04QC32I | ADJ PH | ||
SODIUM HYDROXIDE | SUBMUCOSAL | INJECTION, SOLUTION | 1310732 | 55X04QC32I | ADJ PH | ||
SODIUM HYDROXIDE | TOPICAL | AEROSOL, FOAM | 1310732 | 55X04QC32I | ADJ PH | ||
SODIUM HYDROXIDE | TOPICAL | CREAM | 1310732 | 55X04QC32I | 69mg | ||
SODIUM HYDROXIDE | TOPICAL | CREAM, AUGMENTED | 1310732 | 55X04QC32I | 2.72%w/w | ||
SODIUM HYDROXIDE | TOPICAL | DISC | 1310732 | 55X04QC32I | ADJ PH | ||
SODIUM HYDROXIDE | TOPICAL | EMULSION | 1310732 | 55X04QC32I | 0.2%w/w | ||
SODIUM HYDROXIDE | TOPICAL | GEL | 1310732 | 55X04QC32I | 3.2%w/w | ||
SODIUM HYDROXIDE | TOPICAL | JELLY | 1310732 | 55X04QC32I | ADJ PH | ||
SODIUM HYDROXIDE | TOPICAL | LIQUID | 1310732 | 55X04QC32I | ADJ PH | ||
SODIUM HYDROXIDE | TOPICAL | LOTION | 1310732 | 55X04QC32I | 15mg | ||
SODIUM HYDROXIDE | TOPICAL | LOTION, AUGMENTED | 1310732 | 55X04QC32I | ADJ PH | ||
SODIUM HYDROXIDE | TOPICAL | OINTMENT | 1310732 | 55X04QC32I | ADJ PH | ||
SODIUM HYDROXIDE | TOPICAL | OINTMENT, AUGMENTED | 1310732 | 55X04QC32I | 0.11%w/w | ||
SODIUM HYDROXIDE | TOPICAL | SHAMPOO | 1310732 | 55X04QC32I | 3mg | ||
SODIUM HYDROXIDE | TOPICAL | SOLUTION | 1310732 | 55X04QC32I | 39mg | ||
SODIUM HYDROXIDE | TOPICAL | SOLUTION/ DROPS | 1310732 | 55X04QC32I | ADJ PH | ||
SODIUM HYDROXIDE | TOPICAL | SPONGE | 1310732 | 55X04QC32I | ADJ PH | ||
SODIUM HYDROXIDE | TOPICAL | SUSPENSION/ DROPS | 1310732 | 55X04QC32I | ADJ PH | ||
SODIUM HYDROXIDE | TOPICAL | SWAB | 1310732 | 55X04QC32I | 0.01%w/w | ||
SODIUM HYDROXIDE | TRANSDERMAL | FILM, EXTENDED RELEASE | 1310732 | 55X04QC32I | 0.85mg | ||
SODIUM HYDROXIDE | TRANSDERMAL | GEL | 1310732 | 55X04QC32I | 350mg | ||
SODIUM HYDROXIDE | TRANSDERMAL | GEL, METERED | 1310732 | 55X04QC32I | 350mg | Y | |
SODIUM HYDROXIDE | URETERAL | SOLUTION | 1310732 | 55X04QC32I | ADJ PH | ||
SODIUM HYDROXIDE | URETHRAL | SOLUTION | 1310732 | 55X04QC32I | ADJ PH | ||
SODIUM HYDROXIDE | VAGINAL | CREAM | 1310732 | 55X04QC32I | 0.19%w/w | ||
SODIUM HYDROXIDE | VAGINAL | GEL | 1310732 | 55X04QC32I | 20mg | ||
SODIUM HYPOCHLORITE | ORAL | SUSPENSION | 7681529 | DY38VHM5OD | 3mg/1ml | ||
SODIUM IODIDE | INTRAVENOUS | INJECTION | 7681825 | F5WR8N145C | 10mg | ||
SODIUM IODIDE | TOPICAL | SPONGE | 7681825 | F5WR8N145C | 0.74%w/w | ||
SODIUM IODIDE | VAGINAL | DOUCHE | 7681825 | F5WR8N145C | 0.75%w/w | ||
SODIUM LACTATE | INFILTRATION | INJECTION, SOLUTION | 72173 | TU7HW0W0QT | 0.17%v/v | ||
SODIUM LACTATE | INTRAPERITONEAL | SOLUTION | 72173 | TU7HW0W0QT | 0.45%w/v | ||
SODIUM LACTATE | INTRAVENOUS | INJECTION | 72173 | TU7HW0W0QT | 54mg | ||
SODIUM LACTATE | INTRAVENOUS | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 72173 | TU7HW0W0QT | 18.7mg | ||
SODIUM LACTATE | ORAL | SUSPENSION | 72173 | TU7HW0W0QT | 20mg/1ml | ||
SODIUM LACTATE | TOPICAL | GEL | 72173 | TU7HW0W0QT | 4mg | ||
SODIUM LACTATE | TOPICAL | SOLUTION | 72173 | TU7HW0W0QT | 0.93%w/w | ||
SODIUM LACTATE, L- | INTRACARDIAC | INJECTION | 867561 | P2Y1C6M9PS | 0.18%w/v | ||
SODIUM LACTATE, L- | INTRAMUSCULAR | INJECTION | 867561 | P2Y1C6M9PS | 0.18%w/v | ||
SODIUM LACTATE, L- | INTRAVENOUS | INJECTION | 867561 | P2Y1C6M9PS | 0.18%w/v | ||
SODIUM LACTATE, L- | SUBCUTANEOUS | INJECTION | 867561 | P2Y1C6M9PS | 0.18%w/v | ||
SODIUM LAURETH-2 SULFATE | TOPICAL | SHAMPOO | 3088311 | ZZQ59TY3KG | 47.6%w/w | ||
SODIUM LAURETH-3 SULFATE | ORAL | CAPSULE | 13150000 | BPV390UAP0 | 3.5mg | ||
SODIUM LAURETH-3 SULFATE | ORAL | TABLET | 13150000 | BPV390UAP0 | 0.91mg | ||
SODIUM LAURETH-3 SULFATE | TOPICAL | CREAM | 13150000 | BPV390UAP0 | NA | ||
SODIUM LAURETH-3 SULFATE | TOPICAL | SHAMPOO | 13150000 | BPV390UAP0 | 3192mg | ||
SODIUM LAURETH-3 SULFATE | TOPICAL | SPRAY | 13150000 | BPV390UAP0 | 0.1%w/w | ||
SODIUM LAURETH-5 SULFATE | TOPICAL | SHAMPOO | 9004824 | 410Q7WN1BX | 38%w/w | ||
SODIUM LAUROYL SARCOSINATE | TOPICAL | LOTION | 137166 | 632GS99618 | 70mg | ||
SODIUM LAUROYL SARCOSINATE | TOPICAL | SHAMPOO | 137166 | 632GS99618 | 12.5%w/w | ||
SODIUM LAUROYL SARCOSINATE | TOPICAL | SUSPENSION | 137166 | 632GS99618 | 0.75%w/w | ||
SODIUM LAURYL SULFATE | BUCCAL | TABLET | 151213 | 368GB5141J | 5.18mg | ||
SODIUM LAURYL SULFATE | DENTAL | GEL | 151213 | 368GB5141J | 1.47%w/w | ||
SODIUM LAURYL SULFATE | DENTAL | PASTE | 151213 | 368GB5141J | 1.5%w/w | ||
SODIUM LAURYL SULFATE | DENTAL | PASTE, DENTIFRICE | 151213 | 368GB5141J | 1.4%w/w | ||
SODIUM LAURYL SULFATE | ORAL | CAPSULE | 151213 | 368GB5141J | 600mg | ||
SODIUM LAURYL SULFATE | ORAL | CAPSULE, COATED PELLETS | 151213 | 368GB5141J | 0.06mg | ||
SODIUM LAURYL SULFATE | ORAL | CAPSULE, COATED, EXTENDED RELEASE | 151213 | 368GB5141J | NA | ||
SODIUM LAURYL SULFATE | ORAL | CAPSULE, DELAYED RELEASE | 151213 | 368GB5141J | 46mg | ||
SODIUM LAURYL SULFATE | ORAL | CAPSULE, DELAYED RELEASE PELLETS | 151213 | 368GB5141J | 99mg | ||
SODIUM LAURYL SULFATE | ORAL | CAPSULE, EXTENDED RELEASE | 151213 | 368GB5141J | 166mg | ||
SODIUM LAURYL SULFATE | ORAL | DROPS | 151213 | 368GB5141J | NA | ||
SODIUM LAURYL SULFATE | ORAL | GRANULE | 151213 | 368GB5141J | 12mg | ||
SODIUM LAURYL SULFATE | ORAL | PELLET | 151213 | 368GB5141J | 2mg | ||
SODIUM LAURYL SULFATE | ORAL | POWDER, FOR SUSPENSION | 151213 | 368GB5141J | 64mg | ||
SODIUM LAURYL SULFATE | ORAL | SUSPENSION | 151213 | 368GB5141J | 705mg | ||
SODIUM LAURYL SULFATE | ORAL | SUSPENSION, EXTENDED RELEASE | 151213 | 368GB5141J | 0.08mg/1ml | ||
SODIUM LAURYL SULFATE | ORAL | TABLET | 151213 | 368GB5141J | 233mg | ||
SODIUM LAURYL SULFATE | ORAL | TABLET, CHEWABLE | 151213 | 368GB5141J | 6mg | ||
SODIUM LAURYL SULFATE | ORAL | TABLET, CHEWABLE, EXTENDED RELEASE | 151213 | 368GB5141J | 1mg | ||
SODIUM LAURYL SULFATE | ORAL | TABLET, COATED | 151213 | 368GB5141J | 123mg | ||
SODIUM LAURYL SULFATE | ORAL | TABLET, DELAYED RELEASE | 151213 | 368GB5141J | 199mg | ||
SODIUM LAURYL SULFATE | ORAL | TABLET, EFFERVESCENT | 151213 | 368GB5141J | 1.5mg | ||
SODIUM LAURYL SULFATE | ORAL | TABLET, EXTENDED RELEASE | 151213 | 368GB5141J | 320mg | ||
SODIUM LAURYL SULFATE | ORAL | TABLET, FILM COATED | 151213 | 368GB5141J | 240mg | ||
SODIUM LAURYL SULFATE | ORAL | TABLET, FILM COATED, EXTENDED RELEASE | 151213 | 368GB5141J | 10.5mg | ||
SODIUM LAURYL SULFATE | ORAL | TABLET, FOR SUSPENSION | 151213 | 368GB5141J | 264mg | ||
SODIUM LAURYL SULFATE | ORAL | TABLET, ORALLY DISINTEGRATING | 151213 | 368GB5141J | 16mg | ||
SODIUM LAURYL SULFATE | ORAL | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE | 151213 | 368GB5141J | 3mg | ||
SODIUM LAURYL SULFATE | RESPIRATORY (INHALATION) | CAPSULE | 151213 | 368GB5141J | NA | ||
SODIUM LAURYL SULFATE | RESPIRATORY (INHALATION) | POWDER | 151213 | 368GB5141J | NA | ||
SODIUM LAURYL SULFATE | SUBLINGUAL | TABLET | 151213 | 368GB5141J | 1.1mg | ||
SODIUM LAURYL SULFATE | TOPICAL | CREAM | 151213 | 368GB5141J | 214mg | ||
SODIUM LAURYL SULFATE | TOPICAL | GEL | 151213 | 368GB5141J | 0.05%w/w | ||
SODIUM LAURYL SULFATE | TOPICAL | LOTION | 151213 | 368GB5141J | 111mg | Y | |
SODIUM LAURYL SULFATE | TOPICAL | OINTMENT | 151213 | 368GB5141J | 14mg | ||
SODIUM LAURYL SULFATE | TOPICAL | SHAMPOO | 151213 | 368GB5141J | 65%w/w | ||
SODIUM LAURYL SULFATE | TOPICAL | SHAMPOO, SUSPENSION | 151213 | 368GB5141J | 40%w/v | ||
SODIUM LAURYL SULFATE | TOPICAL | SPONGE | 151213 | 368GB5141J | 5%w/w | ||
SODIUM LAURYL SULFATE | TOPICAL | SPRAY | 151213 | 368GB5141J | 7mg | ||
SODIUM LAURYL SULFATE | VAGINAL | CREAM | 151213 | 368GB5141J | 12mg | ||
SODIUM LAURYL SULFATE | VAGINAL | GEL | 151213 | 368GB5141J | 0.2%w/w | ||
SODIUM LAURYL SULFATE | VAGINAL | INSERT | 151213 | 368GB5141J | 15mg | ||
SODIUM LAURYL SULFATE | VAGINAL | POWDER | 151213 | 368GB5141J | 3mg | ||
SODIUM LAURYL SULFOACETATE | DENTAL | PASTE, DENTIFRICE | 1847581 | D0Y70F2B9J | 0.75%w/w | ||
SODIUM LAURYL SULFOACETATE | TOPICAL | SHAMPOO | 1847581 | D0Y70F2B9J | 3%w/w | ||
SODIUM METABISULFITE | EPIDURAL | INJECTION | 7681574 | 4VON5FNS3C | 0.05%w/v | ||
SODIUM METABISULFITE | INFILTRATION | INJECTION | 7681574 | 4VON5FNS3C | 0.5%w/v | ||
SODIUM METABISULFITE | INFILTRATION | INJECTION, SOLUTION | 7681574 | 4VON5FNS3C | 0.05%w/v | ||
SODIUM METABISULFITE | INTRA-ARTICULAR | INJECTION | 7681574 | 4VON5FNS3C | 0.2%w/v | ||
SODIUM METABISULFITE | INTRABURSAL | INJECTION | 7681574 | 4VON5FNS3C | 0.2%w/v | ||
SODIUM METABISULFITE | INTRACARDIAC | INJECTION | 7681574 | 4VON5FNS3C | 0.09%w/v | ||
SODIUM METABISULFITE | INTRALESIONAL | INJECTION | 7681574 | 4VON5FNS3C | 0.1%w/v | ||
SODIUM METABISULFITE | INTRAMUSCULAR | INJECTION | 7681574 | 4VON5FNS3C | 27.5%w/v | ||
SODIUM METABISULFITE | INTRAMUSCULAR | INJECTION, SOLUTION | 7681574 | 4VON5FNS3C | 96mg | Y | |
SODIUM METABISULFITE | INTRAMUSCULAR | INJECTION, SOLUTION, CONCENTRATE | 7681574 | 4VON5FNS3C | 0.15%w/v | ||
SODIUM METABISULFITE | INTRAOCULAR | INJECTION, SOLUTION, CONCENTRATE | 7681574 | 4VON5FNS3C | 0.15%w/v | ||
SODIUM METABISULFITE | INTRAPERITONEAL | INJECTION | 7681574 | 4VON5FNS3C | 0.33%w/v | ||
SODIUM METABISULFITE | INTRAVENOUS | INJECTION | 7681574 | 4VON5FNS3C | 27.5%w/v | ||
SODIUM METABISULFITE | INTRAVENOUS | INJECTION, EMULSION | 7681574 | 4VON5FNS3C | 0.03%w/v | ||
SODIUM METABISULFITE | INTRAVENOUS | INJECTION, SOLUTION | 7681574 | 4VON5FNS3C | 79mg | Y | |
SODIUM METABISULFITE | INTRAVENOUS | INJECTION, SOLUTION, CONCENTRATE | 7681574 | 4VON5FNS3C | 0.15%w/v | ||
SODIUM METABISULFITE | IONTOPHORESIS | SOLUTION | 7681574 | 4VON5FNS3C | 0.05%w/v | ||
SODIUM METABISULFITE | IONTOPHORESIS | SYSTEM | 7681574 | 4VON5FNS3C | 0.5mg | ||
SODIUM METABISULFITE | OPHTHALMIC | SOLUTION | 7681574 | 4VON5FNS3C | 0.2%w/w | ||
SODIUM METABISULFITE | OPHTHALMIC | SUSPENSION/ DROPS | 7681574 | 4VON5FNS3C | 0.1%w/w | ||
SODIUM METABISULFITE | ORAL | CAPSULE | 7681574 | 4VON5FNS3C | 0.36mg | ||
SODIUM METABISULFITE | ORAL | CONCENTRATE | 7681574 | 4VON5FNS3C | 2mg/1ml | ||
SODIUM METABISULFITE | ORAL | LIQUID | 7681574 | 4VON5FNS3C | 1mg/5ml | ||
SODIUM METABISULFITE | ORAL | SOLUTION | 7681574 | 4VON5FNS3C | 640mg | ||
SODIUM METABISULFITE | ORAL | SUSPENSION | 7681574 | 4VON5FNS3C | 40mg | ||
SODIUM METABISULFITE | ORAL | SUSPENSION, EXTENDED RELEASE | 7681574 | 4VON5FNS3C | 100mg | ||
SODIUM METABISULFITE | ORAL | SYRUP | 7681574 | 4VON5FNS3C | 80mg | Y | |
SODIUM METABISULFITE | ORAL | TABLET | 7681574 | 4VON5FNS3C | 8mg | ||
SODIUM METABISULFITE | ORAL | TABLET, CHEWABLE | 7681574 | 4VON5FNS3C | 0.2mg | ||
SODIUM METABISULFITE | PERIDURAL | INJECTION | 7681574 | 4VON5FNS3C | NA | ||
SODIUM METABISULFITE | PERINEURAL | INJECTION | 7681574 | 4VON5FNS3C | 0.05%w/v | ||
SODIUM METABISULFITE | RECTAL | TABLET | 7681574 | 4VON5FNS3C | 2mg | ||
SODIUM METABISULFITE | RESPIRATORY (INHALATION) | SOLUTION | 7681574 | 4VON5FNS3C | 0.3%w/w | ||
SODIUM METABISULFITE | SUBCUTANEOUS | INJECTION | 7681574 | 4VON5FNS3C | 43mg | Y | |
SODIUM METABISULFITE | SUBCUTANEOUS | INJECTION, SOLUTION | 7681574 | 4VON5FNS3C | 79mg | ||
SODIUM METABISULFITE | SUBCUTANEOUS | INJECTION, SOLUTION, CONCENTRATE | 7681574 | 4VON5FNS3C | 0.15%w/v | ||
SODIUM METABISULFITE | SUBLINGUAL | TABLET | 7681574 | 4VON5FNS3C | 2mg | ||
SODIUM METABISULFITE | SUBMUCOSAL | INJECTION | 7681574 | 4VON5FNS3C | 5mg | ||
SODIUM METABISULFITE | SUBMUCOSAL | INJECTION, SOLUTION | 7681574 | 4VON5FNS3C | 5%w/v | ||
SODIUM METABISULFITE | TOPICAL | CREAM, AUGMENTED | 7681574 | 4VON5FNS3C | 0.2%w/w | ||
SODIUM METABISULFITE | TOPICAL | LOTION | 7681574 | 4VON5FNS3C | 0.2%w/v | ||
SODIUM METABISULFITE | TOPICAL | SOAP | 7681574 | 4VON5FNS3C | 0.36%w/w | ||
SODIUM METABISULFITE | TOPICAL | SUSPENSION | 7681574 | 4VON5FNS3C | 0.32%w/w | ||
SODIUM METABISULFITE | TOPICAL | SYSTEM | 7681574 | 4VON5FNS3C | 0.5mg | ||
SODIUM METAPHOSPHATE, INSOLUBLE | TOPICAL | SOAP | 50813166 | GQ3AN47ZIY | 1.44%w/w | ||
SODIUM METHYL COCOYL TAURATE | TOPICAL | SHAMPOO | 12765398 | JVL98CG53G | 65%w/w | ||
SODIUM N-(CARBONYL-METHOXYPOLYETHYLENE GLYCOL 2000)-1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOETHANOLAMINE | INTRAVENOUS | INJECTABLE, LIPOSOMAL | 247925286 | 3L6NN8ZZKU | 129mg | ||
SODIUM N-(CARBONYL-METHOXYPOLYETHYLENE GLYCOL 2000)-1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOETHANOLAMINE | INTRAVENOUS | INJECTION | 247925286 | 3L6NN8ZZKU | 1mg | ||
SODIUM N-(CARBONYL-METHOXYPOLYETHYLENE GLYCOL 2000)-1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOETHANOLAMINE | INTRAVENOUS | INJECTION, SUSPENSION, LIPOSOMAL | 247925286 | 3L6NN8ZZKU | 0.32%w/v | ||
SODIUM NITRATE | OPHTHALMIC | SOLUTION | 7631994 | 8M4L3H2ZVZ | 1.18%w/w | ||
SODIUM OLEATE | INTRAVENOUS | INJECTION, EMULSION | 143191 | 399SL044HN | 225mg | ||
SODIUM PHOSPHATE | BUCCAL | MOUTHWASH | 7632055 | SE337SVY37 | NA | ||
SODIUM PHOSPHATE | INTRA-ARTICULAR | INJECTION | 7632055 | SE337SVY37 | ADJ PH | ||
SODIUM PHOSPHATE | INTRABURSAL | INJECTION | 7632055 | SE337SVY37 | ADJ PH | ||
SODIUM PHOSPHATE | INTRADERMAL | INJECTION | 7632055 | SE337SVY37 | 0.2%w/v | ||
SODIUM PHOSPHATE | INTRAMUSCULAR | INJECTION | 7632055 | SE337SVY37 | 10.6mg | ||
SODIUM PHOSPHATE | INTRAMUSCULAR | INJECTION, POWDER, FOR SOLUTION | 7632055 | SE337SVY37 | 24.75mg | ||
SODIUM PHOSPHATE | INTRAMUSCULAR | INJECTION, SOLUTION | 7632055 | SE337SVY37 | 0.14%w/v | ||
SODIUM PHOSPHATE | INTRAVENOUS | INJECTION | 7632055 | SE337SVY37 | 10.6mg | ||
SODIUM PHOSPHATE | INTRAVENOUS | INJECTION, POWDER, FOR SOLUTION | 7632055 | SE337SVY37 | 24.75mg | ||
SODIUM PHOSPHATE | INTRAVENOUS | INJECTION, SOLUTION | 7632055 | SE337SVY37 | 0.14%w/v | ||
SODIUM PHOSPHATE | NASAL | SOLUTION | 7632055 | SE337SVY37 | 1.89mg/1ml | ||
SODIUM PHOSPHATE | OPHTHALMIC | SOLUTION | 7632055 | SE337SVY37 | 0.81%w/w | ||
SODIUM PHOSPHATE | OPHTHALMIC | SUSPENSION | 7632055 | SE337SVY37 | 0.2%w/w | ||
SODIUM PHOSPHATE | ORAL | CAPSULE | 7632055 | SE337SVY37 | 36mg | ||
SODIUM PHOSPHATE | ORAL | CONCENTRATE | 7632055 | SE337SVY37 | NA | ||
SODIUM PHOSPHATE | ORAL | INJECTION | 7632055 | SE337SVY37 | 10.35mg | ||
SODIUM PHOSPHATE | ORAL | SOLUTION | 7632055 | SE337SVY37 | 27mg/5ml | ||
SODIUM PHOSPHATE | ORAL | SUSPENSION | 7632055 | SE337SVY37 | 40mg | ||
SODIUM PHOSPHATE | ORAL | SYRUP | 7632055 | SE337SVY37 | 1.5mg/1ml | ||
SODIUM PHOSPHATE | ORAL | TABLET | 7632055 | SE337SVY37 | 16mg | ||
SODIUM PHOSPHATE | SUBCUTANEOUS | INJECTION | 7632055 | SE337SVY37 | 0.38%w/v | ||
SODIUM PHOSPHATE | TOPICAL | CREAM | 7632055 | SE337SVY37 | NA | ||
SODIUM PHOSPHATE | TOPICAL | OINTMENT | 7632055 | SE337SVY37 | 0.15%w/w | ||
SODIUM PHOSPHATE | TOPICAL | SOAP | 7632055 | SE337SVY37 | 0.21%w/w | ||
SODIUM PHOSPHATE, DIBASIC | INTRADERMAL | INJECTION | 10140655 | GR686LBA74 | 0.2%w/v | ||
SODIUM PHOSPHATE, DIBASIC | INTRAMUSCULAR | INJECTION | 10140655 | GR686LBA74 | 40mg | ||
SODIUM PHOSPHATE, DIBASIC | INTRAMUSCULAR | INJECTION, POWDER, FOR SOLUTION | 10140655 | GR686LBA74 | 40mg | ||
SODIUM PHOSPHATE, DIBASIC | INTRAVENOUS | INJECTION | 10140655 | GR686LBA74 | 200mg | ||
SODIUM PHOSPHATE, DIBASIC | INTRAVENOUS | INJECTION, POWDER, FOR SOLUTION | 10140655 | GR686LBA74 | 40mg | ||
SODIUM PHOSPHATE, DIBASIC | OPHTHALMIC | SUSPENSION | 10140655 | GR686LBA74 | 0.43%w/w | ||
SODIUM PHOSPHATE, DIBASIC | ORAL | CONCENTRATE | 10140655 | GR686LBA74 | 17mg/5ml | ||
SODIUM PHOSPHATE, DIBASIC | ORAL | FILM, SOLUBLE | 10140655 | GR686LBA74 | 9mg | ||
SODIUM PHOSPHATE, DIBASIC | ORAL | LOZENGE | 10140655 | GR686LBA74 | 31mg | ||
SODIUM PHOSPHATE, DIBASIC | ORAL | SOLUTION | 10140655 | GR686LBA74 | 40mg/1ml | ||
SODIUM PHOSPHATE, DIBASIC | ORAL | SYRUP | 10140655 | GR686LBA74 | 70mg | Y | |
SODIUM PHOSPHATE, DIBASIC | ORAL | TABLET, EXTENDED RELEASE | 10140655 | GR686LBA74 | 143mg | ||
SODIUM PHOSPHATE, DIBASIC | SUBCUTANEOUS | INJECTION | 10140655 | GR686LBA74 | 14mg | ||
SODIUM PHOSPHATE, DIBASIC | SUBCUTANEOUS | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 10140655 | GR686LBA74 | 2.98mg | ||
SODIUM PHOSPHATE, DIBASIC | TOPICAL | CREAM | 10140655 | GR686LBA74 | 0.1%w/w | ||
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS | BUCCAL | FILM | 7558794 | 22ADO53M6F | 0.35mg | ||
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS | INTRA-ARTICULAR | INJECTION | 7558794 | 22ADO53M6F | 28mg | ||
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS | INTRA-ARTICULAR | INJECTION, SUSPENSION | 7558794 | 22ADO53M6F | 36mg | ||
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS | INTRALESIONAL | INJECTION | 7558794 | 22ADO53M6F | 28mg | ||
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS | INTRALESIONAL | INJECTION, SUSPENSION | 7558794 | 22ADO53M6F | 3mg | ||
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS | INTRAMUSCULAR | INJECTION | 7558794 | 22ADO53M6F | 1751mg | ||
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS | INTRAMUSCULAR | INJECTION, POWDER, FOR SOLUTION | 7558794 | 22ADO53M6F | 139.2mg | ||
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS | INTRAMUSCULAR | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 7558794 | 22ADO53M6F | 1751mg | Y | |
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS | INTRAMUSCULAR | INJECTION, SUSPENSION | 7558794 | 22ADO53M6F | 36mg | ||
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS | INTRAMUSCULAR | INJECTION, SUSPENSION, EXTENDED RELEASE | 7558794 | 22ADO53M6F | 8mg | ||
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS | INTRAOCULAR | INSERT | 7558794 | 22ADO53M6F | 0.02mg | ||
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS | INTRASYNOVIAL | INJECTION, SUSPENSION | 7558794 | 22ADO53M6F | 3mg | ||
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS | INTRATHECAL | INJECTION, SOLUTION | 7558794 | 22ADO53M6F | 1mg | ||
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS | INTRAVENOUS | INJECTION | 7558794 | 22ADO53M6F | 381mg | ||
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS | INTRAVENOUS | INJECTION, EMULSION | 7558794 | 22ADO53M6F | 0.28%w/v | ||
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS | INTRAVENOUS | INJECTION, POWDER, FOR SOLUTION | 7558794 | 22ADO53M6F | 139.2mg | ||
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS | INTRAVENOUS | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 7558794 | 22ADO53M6F | 1751mg | Y | |
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS | INTRAVENOUS | INJECTION, SOLUTION | 7558794 | 22ADO53M6F | 2460mg | ||
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS | INTRAVENOUS | LIQUID | 7558794 | 22ADO53M6F | 381mg | ||
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS | INTRAVENOUS | SOLUTION | 7558794 | 22ADO53M6F | 381mg | ||
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS | INTRAVESICAL | INJECTION, SOLUTION | 7558794 | 22ADO53M6F | 38.25mg | ||
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS | NASAL | SOLUTION | 7558794 | 22ADO53M6F | 5mg | ||
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS | NASAL | SPRAY | 7558794 | 22ADO53M6F | 0.21mg/0.1ml | ||
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS | NASAL | SPRAY, METERED | 7558794 | 22ADO53M6F | 7mg | ||
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS | OPHTHALMIC | SOLUTION | 7558794 | 22ADO53M6F | 1.21%w/v | ||
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS | OPHTHALMIC | SOLUTION/ DROPS | 7558794 | 22ADO53M6F | 1.4%w/v | ||
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS | OPHTHALMIC | SUSPENSION | 7558794 | 22ADO53M6F | NA | ||
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS | ORAL | CAPSULE | 7558794 | 22ADO53M6F | 40mg | ||
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS | ORAL | CAPSULE, DELAYED RELEASE | 7558794 | 22ADO53M6F | 43mg | ||
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS | ORAL | CAPSULE, EXTENDED RELEASE | 7558794 | 22ADO53M6F | 207mg | ||
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS | ORAL | FILM, SOLUBLE | 7558794 | 22ADO53M6F | 0.05mg | ||
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS | ORAL | LOZENGE | 7558794 | 22ADO53M6F | 31mg | Y | |
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS | ORAL | SOLUTION | 7558794 | 22ADO53M6F | 140mg | ||
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS | ORAL | SUSPENSION | 7558794 | 22ADO53M6F | 66mg | ||
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS | ORAL | SYRUP | 7558794 | 22ADO53M6F | 70mg | Y | |
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS | ORAL | TABLET | 7558794 | 22ADO53M6F | 96mg | ||
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS | ORAL | TABLET, EXTENDED RELEASE | 7558794 | 22ADO53M6F | 210mg | ||
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS | ORAL | TABLET, FILM COATED | 7558794 | 22ADO53M6F | 0.01mg | ||
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS | ORAL | TABLET, FOR SUSPENSION | 7558794 | 22ADO53M6F | 60mg | ||
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS | ORAL | TROCHE | 7558794 | 22ADO53M6F | 28mg | ||
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS | SOFT TISSUE | INJECTION, SUSPENSION | 7558794 | 22ADO53M6F | 3mg | ||
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS | SUBCUTANEOUS | INJECTION | 7558794 | 22ADO53M6F | 20mg | ||
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS | SUBCUTANEOUS | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 7558794 | 22ADO53M6F | 0.03mg | ||
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS | SUBCUTANEOUS | INJECTION, SOLUTION | 7558794 | 22ADO53M6F | 0.11%w/v | ||
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS | SUBLINGUAL | FILM | 7558794 | 22ADO53M6F | 6mg | ||
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS | TOPICAL | AEROSOL, FOAM | 7558794 | 22ADO53M6F | 0.09%w/w | ||
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS | TOPICAL | CREAM | 7558794 | 22ADO53M6F | 0.36%w/w | ||
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS | TOPICAL | OINTMENT | 7558794 | 22ADO53M6F | 1mg | ||
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS | TOPICAL | SOLUTION/ DROPS | 7558794 | 22ADO53M6F | 0.14%w/v | ||
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS | TRANSMUCOSAL | LOZENGE | 7558794 | 22ADO53M6F | 112mg | ||
SODIUM PHOSPHATE, DIBASIC, DIHYDRATE | INTRAVENOUS | INJECTION | 10028247 | 94255I6E2T | 55mg | ||
SODIUM PHOSPHATE, DIBASIC, DIHYDRATE | INTRAVENOUS | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 10028247 | 94255I6E2T | 3mg | ||
SODIUM PHOSPHATE, DIBASIC, DIHYDRATE | INTRAVENOUS | INJECTION, SOLUTION | 10028247 | 94255I6E2T | 55mg | ||
SODIUM PHOSPHATE, DIBASIC, DIHYDRATE | INTRAVENOUS | SOLUTION | 10028247 | 94255I6E2T | 52mg | Y | |
SODIUM PHOSPHATE, DIBASIC, DIHYDRATE | NASAL | SPRAY | 10028247 | 94255I6E2T | 12mg | ||
SODIUM PHOSPHATE, DIBASIC, DIHYDRATE | NASAL | SPRAY, METERED | 10028247 | 94255I6E2T | 3mg/1ml | ||
SODIUM PHOSPHATE, DIBASIC, DIHYDRATE | OPHTHALMIC | SOLUTION/ DROPS | 10028247 | 94255I6E2T | 1.2%w/v | ||
SODIUM PHOSPHATE, DIBASIC, DIHYDRATE | ORAL | CAPSULE, DELAYED RELEASE | 10028247 | 94255I6E2T | 18mg | ||
SODIUM PHOSPHATE, DIBASIC, DIHYDRATE | ORAL | SOLUTION | 10028247 | 94255I6E2T | 2.5mg/1ml | ||
SODIUM PHOSPHATE, DIBASIC, DIHYDRATE | ORAL | SUSPENSION | 10028247 | 94255I6E2T | 1030mg/120ml | ||
SODIUM PHOSPHATE, DIBASIC, DIHYDRATE | SUBCUTANEOUS | INJECTION | 10028247 | 94255I6E2T | 20mg | ||
SODIUM PHOSPHATE, DIBASIC, DIHYDRATE | SUBCUTANEOUS | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 10028247 | 94255I6E2T | 3mg | ||
SODIUM PHOSPHATE, DIBASIC, DIHYDRATE | SUBCUTANEOUS | INJECTION, SOLUTION | 10028247 | 94255I6E2T | 0.14%w/v | ||
SODIUM PHOSPHATE, DIBASIC, DIHYDRATE | TOPICAL | CREAM | 10028247 | 94255I6E2T | 0.25%w/w | ||
SODIUM PHOSPHATE, DIBASIC, DIHYDRATE | TOPICAL | GEL | 10028247 | 94255I6E2T | NA | ||
SODIUM PHOSPHATE, DIBASIC, DIHYDRATE | TOPICAL | OINTMENT | 10028247 | 94255I6E2T | 4mg | ||
SODIUM PHOSPHATE, DIBASIC, DODECAHYDRATE | INTRAVENOUS | INJECTION, SOLUTION | 10039324 | E1W4N241FO | 0.39%w/v | ||
SODIUM PHOSPHATE, DIBASIC, DODECAHYDRATE | NASAL | SPRAY | 10039324 | E1W4N241FO | 7mg | ||
SODIUM PHOSPHATE, DIBASIC, DODECAHYDRATE | NASAL | SPRAY, METERED | 10039324 | E1W4N241FO | 7mg | ||
SODIUM PHOSPHATE, DIBASIC, DODECAHYDRATE | OPHTHALMIC | SOLUTION | 10039324 | E1W4N241FO | 5mg | ||
SODIUM PHOSPHATE, DIBASIC, DODECAHYDRATE | OPHTHALMIC | SOLUTION/ DROPS | 10039324 | E1W4N241FO | 5mg | Y | |
SODIUM PHOSPHATE, DIBASIC, DODECAHYDRATE | SUBCUTANEOUS | INJECTION, SUSPENSION | 10039324 | E1W4N241FO | 0.06%w/v | ||
SODIUM PHOSPHATE, DIBASIC, DODECAHYDRATE | SUBCUTANEOUS | SUSPENSION | 10039324 | E1W4N241FO | 0.06%w/v | ||
SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE | AURICULAR (OTIC) | DROPS | 7782856 | 70WT22SF4B | 0.3%w/w | ||
SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE | AURICULAR (OTIC) | SOLUTION | 7782856 | 70WT22SF4B | 0.5%w/w | ||
SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE | DENTAL | PASTE, DENTIFRICE | 7782856 | 70WT22SF4B | 0.56%w/w | ||
SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE | INTRA-ARTICULAR | INJECTION | 7782856 | 70WT22SF4B | 3mg | ||
SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE | INTRA-ARTICULAR | INJECTION, SUSPENSION | 7782856 | 70WT22SF4B | 3mg | ||
SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE | INTRABURSAL | INJECTION | 7782856 | 70WT22SF4B | ADJ PH | ||
SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE | INTRALESIONAL | INJECTION, SUSPENSION | 7782856 | 70WT22SF4B | 3mg | ||
SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE | INTRAMUSCULAR | INJECTION | 7782856 | 70WT22SF4B | 200mg | ||
SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE | INTRAMUSCULAR | INJECTION, POWDER, FOR SOLUTION | 7782856 | 70WT22SF4B | 80mg | ||
SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE | INTRAMUSCULAR | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 7782856 | 70WT22SF4B | 279.27mg | ||
SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE | INTRAMUSCULAR | INJECTION, SOLUTION | 7782856 | 70WT22SF4B | 0.34%w/v | ||
SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE | INTRAMUSCULAR | INJECTION, SUSPENSION | 7782856 | 70WT22SF4B | 3mg | ||
SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE | INTRASYNOVIAL | INJECTION, SUSPENSION | 7782856 | 70WT22SF4B | 3mg | ||
SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE | INTRAVENOUS | INJECTION | 7782856 | 70WT22SF4B | 200mg | ||
SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE | INTRAVENOUS | INJECTION, POWDER, FOR SOLUTION | 7782856 | 70WT22SF4B | 80mg | ||
SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE | INTRAVENOUS | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 7782856 | 70WT22SF4B | 279.27mg | ||
SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE | INTRAVENOUS | INJECTION, SOLUTION | 7782856 | 70WT22SF4B | 43mg | ||
SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE | INTRAVITREAL | INJECTION | 7782856 | 70WT22SF4B | 1.33%w/v | ||
SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE | INTRAVITREAL | INJECTION, SUSPENSION | 7782856 | 70WT22SF4B | 3mg | ||
SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE | NASAL | SPRAY | 7782856 | 70WT22SF4B | 5mg | ||
SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE | NASAL | SPRAY, METERED | 7782856 | 70WT22SF4B | 4.86mg/1ml | ||
SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE | OPHTHALMIC | SOLUTION | 7782856 | 70WT22SF4B | 2.15%w/v | ||
SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE | OPHTHALMIC | SOLUTION/ DROPS | 7782856 | 70WT22SF4B | 4mg | ||
SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE | OPHTHALMIC | SUSPENSION | 7782856 | 70WT22SF4B | 0.48%w/w | ||
SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE | OPHTHALMIC | SUSPENSION/ DROPS | 7782856 | 70WT22SF4B | 0.48%w/w | ||
SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE | ORAL | CAPSULE | 7782856 | 70WT22SF4B | 500mg | ||
SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE | ORAL | SOLUTION | 7782856 | 70WT22SF4B | 120mg | ||
SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE | ORAL | SUSPENSION | 7782856 | 70WT22SF4B | 200mg | ||
SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE | ORAL | SYRUP | 7782856 | 70WT22SF4B | 131mg | ||
SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE | ORAL | TABLET | 7782856 | 70WT22SF4B | 80mg | ||
SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE | ORAL | TABLET, COATED | 7782856 | 70WT22SF4B | 0.22mg | ||
SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE | ORAL | TABLET, DELAYED RELEASE | 7782856 | 70WT22SF4B | 16.24mg | ||
SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE | ORAL | TABLET, EXTENDED RELEASE | 7782856 | 70WT22SF4B | 70mg | ||
SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE | ORAL | TABLET, FILM COATED, EXTENDED RELEASE | 7782856 | 70WT22SF4B | 105mg | ||
SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE | SOFT TISSUE | INJECTION | 7782856 | 70WT22SF4B | 3mg | ||
SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE | SUBCUTANEOUS | INJECTION | 7782856 | 70WT22SF4B | 0.38%w/v | ||
SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE | SUBCUTANEOUS | INJECTION, POWDER, FOR SOLUTION | 7782856 | 70WT22SF4B | 3.2mg | ||
SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE | SUBCUTANEOUS | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 7782856 | 70WT22SF4B | 3.43mg | ||
SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE | SUBCUTANEOUS | INJECTION, SUSPENSION | 7782856 | 70WT22SF4B | 0.38%w/v | ||
SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE | TOPICAL | CREAM | 7782856 | 70WT22SF4B | 29mg | Y | |
SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE | TOPICAL | LOTION | 7782856 | 70WT22SF4B | 1.59%w/w | ||
SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE | TOPICAL | OINTMENT | 7782856 | 70WT22SF4B | 0.15%w/w | ||
SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE | TOPICAL | SOLUTION | 7782856 | 70WT22SF4B | 49.78%w/w | ||
SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE | TOPICAL | SPONGE | 7782856 | 70WT22SF4B | 0.9%w/w | ||
SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE | VAGINAL | DOUCHE | 7782856 | 70WT22SF4B | 0.15%w/w | ||
SODIUM PHOSPHATE, MONOBASIC | INTRAMUSCULAR | INJECTION | 3980JIH2SW | 161mg | |||
SODIUM PHOSPHATE, MONOBASIC | INTRAVENOUS | INJECTION | 3980JIH2SW | 161mg | |||
SODIUM PHOSPHATE, MONOBASIC | INTRAVENOUS | INJECTION, POWDER, FOR SOLUTION | 3980JIH2SW | 13.2mg | |||
SODIUM PHOSPHATE, MONOBASIC | IONTOPHORESIS | SYSTEM | 3980JIH2SW | 14.2mg | |||
SODIUM PHOSPHATE, MONOBASIC | ORAL | SOLUTION | 3980JIH2SW | 25mg/5ml | |||
SODIUM PHOSPHATE, MONOBASIC | ORAL | TABLET | 3980JIH2SW | 2mg | |||
SODIUM PHOSPHATE, MONOBASIC | SUBCUTANEOUS | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 3980JIH2SW | 0.22mg | |||
SODIUM PHOSPHATE, MONOBASIC | SUBCUTANEOUS | INJECTION, SUSPENSION | 3980JIH2SW | 0.07%w/v | |||
SODIUM PHOSPHATE, MONOBASIC | TOPICAL | SYSTEM | 3980JIH2SW | 14.2mg | |||
SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS | AURICULAR (OTIC) | DROPS | 7558807 | KH7I04HPUU | 1.1%w/w | ||
SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS | AURICULAR (OTIC) | SOLUTION | 7558807 | KH7I04HPUU | 0.13%w/w | ||
SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS | BUCCAL | FILM | 7558807 | KH7I04HPUU | 1.09mg | ||
SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS | BUCCAL | FILM, SOLUBLE | 7558807 | KH7I04HPUU | 0.03mg | ||
SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS | INTRA-ARTICULAR | INJECTION, SUSPENSION | 7558807 | KH7I04HPUU | 13mg | ||
SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS | INTRALESIONAL | INJECTION, SUSPENSION | 7558807 | KH7I04HPUU | 10mg | ||
SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS | INTRAMUSCULAR | INJECTION | 7558807 | KH7I04HPUU | 13mg | ||
SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS | INTRAMUSCULAR | INJECTION, POWDER, FOR SOLUTION | 7558807 | KH7I04HPUU | 18.81mg | ||
SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS | INTRAMUSCULAR | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 7558807 | KH7I04HPUU | 161mg | Y | |
SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS | INTRAMUSCULAR | INJECTION, SOLUTION | 7558807 | KH7I04HPUU | 0.62%w/v | ||
SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS | INTRAMUSCULAR | INJECTION, SUSPENSION | 7558807 | KH7I04HPUU | 13mg | ||
SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS | INTRAMUSCULAR | INJECTION, SUSPENSION, EXTENDED RELEASE | 7558807 | KH7I04HPUU | 8mg | Y | |
SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS | INTRAOCULAR | INSERT | 7558807 | KH7I04HPUU | 0.01mg | ||
SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS | INTRASYNOVIAL | INJECTION, SUSPENSION | 7558807 | KH7I04HPUU | 10mg | ||
SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS | INTRAVASCULAR | INJECTION | 7558807 | KH7I04HPUU | 0.01%w/v | ||
SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS | INTRAVENOUS | INJECTION | 7558807 | KH7I04HPUU | 12.8mg | ||
SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS | INTRAVENOUS | INJECTION, POWDER, FOR SOLUTION | 7558807 | KH7I04HPUU | 18.81mg | ||
SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS | INTRAVENOUS | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 7558807 | KH7I04HPUU | 161mg | Y | |
SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS | INTRAVENOUS | INJECTION, SOLUTION | 7558807 | KH7I04HPUU | 0.62%w/v | ||
SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS | INTRAVENOUS | SOLUTION | 7558807 | KH7I04HPUU | 40mg | ||
SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS | INTRAVESICAL | SOLUTION | 7558807 | KH7I04HPUU | 0.12mg | ||
SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS | OPHTHALMIC | SOLUTION | 7558807 | KH7I04HPUU | 0.78%w/v | ||
SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS | OPHTHALMIC | SOLUTION/ DROPS | 7558807 | KH7I04HPUU | 0.46%w/v | ||
SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS | OPHTHALMIC | SUSPENSION | 7558807 | KH7I04HPUU | 0.65%w/w | ||
SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS | OPHTHALMIC | SUSPENSION/ DROPS | 7558807 | KH7I04HPUU | 0.44%w/w | ||
SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS | ORAL | SOLUTION | 7558807 | KH7I04HPUU | 120mg | ||
SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS | ORAL | SUSPENSION | 7558807 | KH7I04HPUU | 65mg | ||
SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS | ORAL | SYRUP | 7558807 | KH7I04HPUU | 0.7mg/1ml | ||
SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS | ORAL | TABLET | 7558807 | KH7I04HPUU | 4.18mg | ||
SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS | ORAL | TABLET, DELAYED RELEASE | 7558807 | KH7I04HPUU | 23.4mg | ||
SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS | ORAL | TABLET, EXTENDED RELEASE | 7558807 | KH7I04HPUU | 62mg | ||
SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS | SOFT TISSUE | INJECTION, SUSPENSION | 7558807 | KH7I04HPUU | 13mg | ||
SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS | SUBCUTANEOUS | INJECTION | 7558807 | KH7I04HPUU | 33.1mg | ||
SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS | SUBCUTANEOUS | INJECTION, POWDER, FOR SOLUTION | 7558807 | KH7I04HPUU | 0.2mg | ||
SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS | SUBCUTANEOUS | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 7558807 | KH7I04HPUU | 1.1mg | ||
SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS | TOPICAL | CREAM | 7558807 | KH7I04HPUU | 1%w/w | ||
SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS | TOPICAL | GEL | 7558807 | KH7I04HPUU | 6mg | ||
SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS | TOPICAL | LOTION | 7558807 | KH7I04HPUU | 0.2%w/w | ||
SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS | TOPICAL | SHAMPOO, SUSPENSION | 7558807 | KH7I04HPUU | 1%w/v | ||
SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS | TOPICAL | SOLUTION | 7558807 | KH7I04HPUU | 0.47%w/v | ||
SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS | VAGINAL | CREAM | 7558807 | KH7I04HPUU | ADJ PH | ||
SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE | INTRAMUSCULAR | INJECTION | 13472350 | 5QWK665956 | 12.8mg | ||
SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE | INTRATHECAL | INJECTION, SOLUTION | 13472350 | 5QWK665956 | 0.01%w/v | ||
SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE | INTRAVENOUS | INJECTION | 13472350 | 5QWK665956 | 12.8mg | ||
SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE | INTRAVENOUS | INJECTION, POWDER, FOR SOLUTION | 13472350 | 5QWK665956 | 1.6mg | ||
SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE | INTRAVENOUS | INJECTION, SOLUTION | 13472350 | 5QWK665956 | 115mg | Y | |
SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE | OPHTHALMIC | SOLUTION | 13472350 | 5QWK665956 | 2mg | ||
SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE | OPHTHALMIC | SOLUTION/ DROPS | 13472350 | 5QWK665956 | 1.15%w/v | ||
SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE | ORAL | SOLUTION | 13472350 | 5QWK665956 | 63mg | ||
SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE | ORAL | SUSPENSION | 13472350 | 5QWK665956 | 140mg | ||
SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE | SUBCUTANEOUS | INJECTION | 13472350 | 5QWK665956 | 0.3%w/v | ||
SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE | SUBCUTANEOUS | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 13472350 | 5QWK665956 | 1.3mg | ||
SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE | SUBCUTANEOUS | INJECTION, SOLUTION | 13472350 | 5QWK665956 | 0.3%w/v | ||
SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE | TOPICAL | GEL | 13472350 | 5QWK665956 | 0.02%w/w | ||
SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | INTRA-ARTICULAR | INJECTION | 10049215 | 593YOG76RN | 14mg | ||
SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | INTRA-ARTICULAR | INJECTION, SUSPENSION | 10049215 | 593YOG76RN | 13mg | ||
SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | INTRALESIONAL | INJECTION | 10049215 | 593YOG76RN | 14mg | ||
SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | INTRALESIONAL | INJECTION, SUSPENSION | 10049215 | 593YOG76RN | 13mg | ||
SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | INTRAMUSCULAR | INJECTION | 10049215 | 593YOG76RN | 120mg | ||
SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | INTRAMUSCULAR | INJECTION, POWDER, FOR SOLUTION | 10049215 | 593YOG76RN | 1.84mg | ||
SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | INTRAMUSCULAR | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 10049215 | 593YOG76RN | 15.55mg | ||
SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | INTRAMUSCULAR | INJECTION, SUSPENSION | 10049215 | 593YOG76RN | 13mg | ||
SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | INTRAMUSCULAR | INJECTION, SUSPENSION, EXTENDED RELEASE | 10049215 | 593YOG76RN | 30mg | Y | |
SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | INTRASYNOVIAL | INJECTION, SUSPENSION | 10049215 | 593YOG76RN | 13mg | ||
SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | INTRAVASCULAR | INJECTION | 10049215 | 593YOG76RN | 0.15mg | ||
SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | INTRAVENOUS | INJECTION | 10049215 | 593YOG76RN | 120mg | ||
SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | INTRAVENOUS | INJECTION, POWDER, FOR SOLUTION | 10049215 | 593YOG76RN | 13.61mg | ||
SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | INTRAVENOUS | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 10049215 | 593YOG76RN | 15.55mg | ||
SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | INTRAVENOUS | INJECTION, SOLUTION | 10049215 | 593YOG76RN | 27mg | ||
SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | INTRAVESICAL | SOLUTION | 10049215 | 593YOG76RN | 0.12mg | ||
SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | INTRAVITREAL | INJECTION | 10049215 | 593YOG76RN | 0.86%w/v | ||
SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | INTRAVITREAL | INJECTION, SUSPENSION | 10049215 | 593YOG76RN | 0.04%w/v | ||
SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | OPHTHALMIC | SOLUTION | 10049215 | 593YOG76RN | 4mg | ||
SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | OPHTHALMIC | SOLUTION/ DROPS | 10049215 | 593YOG76RN | 8mg | ||
SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | OPHTHALMIC | SUSPENSION | 10049215 | 593YOG76RN | 0.04%w/w | ||
SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | ORAL | CAPSULE | 10049215 | 593YOG76RN | 600mg | ||
SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | ORAL | INJECTION | 10049215 | 593YOG76RN | 10.06mg | ||
SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | ORAL | SOLUTION | 10049215 | 593YOG76RN | 1500mg | ||
SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | ORAL | SUSPENSION | 10049215 | 593YOG76RN | 104mg | ||
SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | ORAL | SYRUP | 10049215 | 593YOG76RN | 20.6mg/5ml | ||
SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | ORAL | TABLET | 10049215 | 593YOG76RN | 31.72mg | ||
SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | ORAL | TABLET, DELAYED RELEASE | 10049215 | 593YOG76RN | 35mg | ||
SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | ORAL | TABLET, FILM COATED | 10049215 | 593YOG76RN | 0.11mg | ||
SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | SOFT TISSUE | INJECTION, SUSPENSION | 10049215 | 593YOG76RN | 13mg | ||
SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | SUBCUTANEOUS | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 10049215 | 593YOG76RN | 2mg | ||
SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | SUBCUTANEOUS | SUSPENSION | 10049215 | 593YOG76RN | 0.07%w/v | ||
SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | TOPICAL | CREAM | 10049215 | 593YOG76RN | 10mg | ||
SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | TOPICAL | LOTION | 10049215 | 593YOG76RN | 8mg | ||
SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | TOPICAL | LOTION, AUGMENTED | 10049215 | 593YOG76RN | 10mg | ||
SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | TOPICAL | SOLUTION | 10049215 | 593YOG76RN | 0.46%w/v | ||
SODIUM PHOSPHATE, TRIBASIC | BUCCAL | FILM, SOLUBLE | A752Q30A6X | 0.03mg | |||
SODIUM PHOSPHATE, TRIBASIC | ORAL | GRANULE | A752Q30A6X | 1mg | |||
SODIUM PHOSPHATE, TRIBASIC | ORAL | POWDER, FOR SUSPENSION | A752Q30A6X | 650mg | |||
SODIUM PHOSPHATE, TRIBASIC, ANHYDROUS | ORAL | POWDER, FOR SUSPENSION | 7601549 | SX01TZO3QZ | 209mg | ||
SODIUM PHOSPHATE, TRIBASIC, ANHYDROUS | ORAL | SUSPENSION | 7601549 | SX01TZO3QZ | 528mg | ||
SODIUM PHOSPHATE, TRIBASIC, DODECAHYDRATE | ORAL | CAPSULE, DELAYED RELEASE PELLETS | 10101890 | B70850QPHR | 11mg | ||
SODIUM PHOSPHATE, TRIBASIC, DODECAHYDRATE | ORAL | GRANULE | 10101890 | B70850QPHR | 5mg | ||
SODIUM PHOSPHATE, TRIBASIC, MONOHYDRATE | INTRAMUSCULAR | INJECTION | 27176085 | J9O85FKF29 | 4.3mg | ||
SODIUM PHOSPHATE, TRIBASIC, MONOHYDRATE | INTRAVENOUS | INJECTION | 27176085 | J9O85FKF29 | 4.3mg | ||
SODIUM PHOSPHATE, TRIBASIC, MONOHYDRATE | ORAL | POWDER, FOR SUSPENSION | 27176085 | J9O85FKF29 | 88mg | ||
SODIUM PHOSPHATE, TRIBASIC, MONOHYDRATE | ORAL | TABLET | 27176085 | J9O85FKF29 | 88mg | ||
SODIUM PHOSPHATE, TRIBASIC, MONOHYDRATE | ORAL | TABLET, DELAYED RELEASE | 27176085 | J9O85FKF29 | 24.5mg | ||
SODIUM PHOSPHATE, TRIBASIC, MONOHYDRATE | SUBCUTANEOUS | INJECTION | 27176085 | J9O85FKF29 | 4.3mg | ||
SODIUM PHOSPHITE | INTRAMUSCULAR | INJECTION, POWDER, FOR SOLUTION | 13708855 | X65D416703 | 20mg | ||
SODIUM PHOSPHITE | INTRAVENOUS | INJECTION, POWDER, FOR SOLUTION | 13708855 | X65D416703 | 20mg | ||
SODIUM POLYACRYLATE | TOPICAL | SYSTEM | 9003047 | NA | 840mg | ||
SODIUM POLYMETAPHOSPHATE | BUCCAL | SOLUTION | 68915311 | P1BM4ZH95L | NA | ||
SODIUM POLYMETAPHOSPHATE | ORAL | SUSPENSION | 68915311 | P1BM4ZH95L | 1mg/1ml | ||
SODIUM POLYSTYRENE SULFONATE | OPHTHALMIC | SUSPENSION | 25704181 | 1699G8679Z | 0.25%v/v | ||
SODIUM POLYSTYRENE SULFONATE | OPHTHALMIC | SUSPENSION/ DROPS | 25704181 | 1699G8679Z | 0.25%w/v | ||
SODIUM POLYSTYRENE SULFONATE | ORAL | CAPSULE, EXTENDED RELEASE | 25704181 | 1699G8679Z | 170.4mg | ||
SODIUM POLYSTYRENE SULFONATE | ORAL | POWDER, FOR SUSPENSION | 25704181 | 1699G8679Z | 728mg | ||
SODIUM POLYSTYRENE SULFONATE | ORAL | SUSPENSION | 25704181 | 1699G8679Z | 518mg | ||
SODIUM POLYSTYRENE SULFONATE | ORAL | SUSPENSION, EXTENDED RELEASE | 25704181 | 1699G8679Z | 261mg | ||
SODIUM POLYSTYRENE SULFONATE | ORAL | TABLET, CHEWABLE, EXTENDED RELEASE | 25704181 | 1699G8679Z | 125mg | ||
SODIUM POLYSTYRENE SULFONATE | ORAL | TABLET, ORALLY DISINTEGRATING | 25704181 | 1699G8679Z | 73mg | ||
SODIUM PROPIONATE | ORAL | CAPSULE | 137406 | DK6Y9P42IN | NA | ||
SODIUM PROPIONATE | ORAL | CAPSULE, EXTENDED RELEASE | 137406 | DK6Y9P42IN | NA | ||
SODIUM PROPIONATE | ORAL | POWDER, FOR SOLUTION | 137406 | DK6Y9P42IN | NA | ||
SODIUM PROPIONATE | ORAL | POWDER, FOR SUSPENSION | 137406 | DK6Y9P42IN | 12.5mg/5ml | ||
SODIUM PROPIONATE | ORAL | SOLUTION | 137406 | DK6Y9P42IN | 80mg | ||
SODIUM PROPIONATE | ORAL | SUSPENSION | 137406 | DK6Y9P42IN | NA | ||
SODIUM PROPIONATE | ORAL | SYRUP | 137406 | DK6Y9P42IN | 40mg | ||
SODIUM PYROPHOSPHATE | BUCCAL | SOLUTION | 7722885 | O352864B8Z | NA | ||
SODIUM PYROPHOSPHATE | DENTAL | PASTE, DENTIFRICE | 7722885 | O352864B8Z | 1%w/w | ||
SODIUM PYROPHOSPHATE | INTRAVENOUS | INJECTION | 7722885 | O352864B8Z | 12mg | ||
SODIUM PYRROLIDONE CARBOXYLATE | TOPICAL | LOTION | 54571674 | 469OTG57A2 | 42mg | ||
SODIUM SALICYLATE | INTRAMUSCULAR | INJECTION | 54217 | WIQ1H85SYP | 250mg | ||
SODIUM SILICATE | TOPICAL | SOAP | 1344098 | IJF18F77L3 | 0.36%w/w | ||
SODIUM STARCH GLYCOLATE TYPE A | BUCCAL | TABLET | 9063381 | H8AV0SQX4D | 10mg | ||
SODIUM STARCH GLYCOLATE TYPE A | ORAL | CAPSULE | 9063381 | H8AV0SQX4D | 540mg | ||
SODIUM STARCH GLYCOLATE TYPE A | ORAL | CAPSULE, COATED PELLETS | 9063381 | H8AV0SQX4D | 16.71mg | ||
SODIUM STARCH GLYCOLATE TYPE A | ORAL | CAPSULE, DELAYED RELEASE | 9063381 | H8AV0SQX4D | 110mg | ||
SODIUM STARCH GLYCOLATE TYPE A | ORAL | CAPSULE, EXTENDED RELEASE | 9063381 | H8AV0SQX4D | 90mg | ||
SODIUM STARCH GLYCOLATE TYPE A | ORAL | POWDER, FOR SUSPENSION | 9063381 | H8AV0SQX4D | 42mg | ||
SODIUM STARCH GLYCOLATE TYPE A | ORAL | TABLET | 9063381 | H8AV0SQX4D | 876mg | ||
SODIUM STARCH GLYCOLATE TYPE A | ORAL | TABLET, CHEWABLE | 9063381 | H8AV0SQX4D | 280mg | ||
SODIUM STARCH GLYCOLATE TYPE A | ORAL | TABLET, COATED | 9063381 | H8AV0SQX4D | 72mg | ||
SODIUM STARCH GLYCOLATE TYPE A | ORAL | TABLET, DELAYED RELEASE | 9063381 | H8AV0SQX4D | 363mg | ||
SODIUM STARCH GLYCOLATE TYPE A | ORAL | TABLET, EXTENDED RELEASE | H8AV0SQX4D | 161mg | |||
SODIUM STARCH GLYCOLATE TYPE A | ORAL | TABLET, FILM COATED | 9063381 | H8AV0SQX4D | 272mg | ||
SODIUM STARCH GLYCOLATE TYPE A | ORAL | TABLET, FOR SUSPENSION | 9063381 | H8AV0SQX4D | 165mg | ||
SODIUM STARCH GLYCOLATE TYPE A | ORAL | TABLET, ORALLY DISINTEGRATING | 9063381 | H8AV0SQX4D | 29mg | ||
SODIUM STARCH GLYCOLATE TYPE A | ORAL | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE | 9063381 | H8AV0SQX4D | 119mg | ||
SODIUM STARCH GLYCOLATE TYPE A | SUBLINGUAL | TABLET | 9063381 | H8AV0SQX4D | 10mg | ||
SODIUM STARCH GLYCOLATE TYPE B | ORAL | CAPSULE | SP4S77AHO6 | 53mg | |||
SODIUM STARCH GLYCOLATE TYPE B | ORAL | TABLET | 9063381 | SP4S77AHO6 | 72mg | ||
SODIUM STARCH GLYCOLATE TYPE B | ORAL | TABLET, DELAYED RELEASE | 9063381 | SP4S77AHO6 | 8mg | ||
SODIUM STARCH GLYCOLATE TYPE B | ORAL | TABLET, FILM COATED | 9063381 | SP4S77AHO6 | 12mg | ||
SODIUM STEARATE | ORAL | TABLET | 822162 | QU7E2XA9TG | 9.48mg | ||
SODIUM STEARATE | ORAL | TABLET, DELAYED RELEASE | 822162 | QU7E2XA9TG | 10mg | ||
SODIUM STEARATE | ORAL | TABLET, ORALLY DISINTEGRATING | 822162 | QU7E2XA9TG | 0.85mg | ||
SODIUM STEARYL FUMARATE | ORAL | CAPSULE | 4070808 | 7CV7WJK4UI | 180mg | ||
SODIUM STEARYL FUMARATE | ORAL | CAPSULE, DELAYED RELEASE | 4070808 | 7CV7WJK4UI | 8.4mg | ||
SODIUM STEARYL FUMARATE | ORAL | CAPSULE, EXTENDED RELEASE | 4070808 | 7CV7WJK4UI | 21mg | ||
SODIUM STEARYL FUMARATE | ORAL | GRANULE | 4070808 | 7CV7WJK4UI | 77mg | ||
SODIUM STEARYL FUMARATE | ORAL | GRANULE, FOR SOLUTION | 4070808 | 7CV7WJK4UI | 18.2mg/120ml | ||
SODIUM STEARYL FUMARATE | ORAL | LOZENGE | 4070808 | 7CV7WJK4UI | 125mg | ||
SODIUM STEARYL FUMARATE | ORAL | PELLET | 4070808 | 7CV7WJK4UI | 43mg | ||
SODIUM STEARYL FUMARATE | ORAL | POWDER, FOR SUSPENSION | 4070808 | 7CV7WJK4UI | 3.74mg/5ml | ||
SODIUM STEARYL FUMARATE | ORAL | TABLET | 4070808 | 7CV7WJK4UI | 153mg | ||
SODIUM STEARYL FUMARATE | ORAL | TABLET, CHEWABLE | 4070808 | 7CV7WJK4UI | 28mg | ||
SODIUM STEARYL FUMARATE | ORAL | TABLET, COATED | 4070808 | 7CV7WJK4UI | 1.18mg | ||
SODIUM STEARYL FUMARATE | ORAL | TABLET, DELAYED RELEASE | 4070808 | 7CV7WJK4UI | 216mg | ||
SODIUM STEARYL FUMARATE | ORAL | TABLET, EXTENDED RELEASE | 4070808 | 7CV7WJK4UI | 42mg | ||
SODIUM STEARYL FUMARATE | ORAL | TABLET, FILM COATED | 4070808 | 7CV7WJK4UI | 98mg | ||
SODIUM STEARYL FUMARATE | ORAL | TABLET, FILM COATED, EXTENDED RELEASE | 4070808 | 7CV7WJK4UI | 4mg | ||
SODIUM STEARYL FUMARATE | ORAL | TABLET, FOR SUSPENSION | 4070808 | 7CV7WJK4UI | 435mg | ||
SODIUM STEARYL FUMARATE | ORAL | TABLET, ORALLY DISINTEGRATING | 4070808 | 7CV7WJK4UI | 153mg | ||
SODIUM STEARYL FUMARATE | SUBLINGUAL | TABLET | 4070808 | 7CV7WJK4UI | 29mg | ||
SODIUM SUCCINATE HEXAHYDRATE | INTRAVENOUS | INJECTION, POWDER, FOR SUSPENSION | 6106214 | U16QOD6C4E | 27mg | ||
SODIUM SULFATE | OPHTHALMIC | SOLUTION | 7727733 | 0YPR65R21J | 1.2%w/v | ||
SODIUM SULFATE | OPHTHALMIC | SOLUTION/ DROPS | 7727733 | 0YPR65R21J | 13mg | ||
SODIUM SULFATE | OPHTHALMIC | SUSPENSION | 7727733 | 0YPR65R21J | 1mg | ||
SODIUM SULFATE | ORAL | TABLET | 7727733 | 0YPR65R21J | 182mg | ||
SODIUM SULFATE | ORAL | TABLET, COATED | 7727733 | 0YPR65R21J | NA | ||
SODIUM SULFATE | ORAL | TABLET, DELAYED RELEASE | 7727733 | 0YPR65R21J | 16.24mg | ||
SODIUM SULFATE | TOPICAL | SHAMPOO | 7727733 | 0YPR65R21J | 5%w/w | ||
SODIUM SULFATE | TOPICAL | SOAP | 7727733 | 0YPR65R21J | 0.05%w/w | ||
SODIUM SULFATE ANHYDROUS | INTRAVENOUS | INJECTION, SOLUTION | 7757826 | 36KCS0R750 | 1.14%w/v | ||
SODIUM SULFATE ANHYDROUS | OPHTHALMIC | SOLUTION | 7757826 | 36KCS0R750 | 7mg | ||
SODIUM SULFATE ANHYDROUS | OPHTHALMIC | SOLUTION/ DROPS | 7757826 | 36KCS0R750 | 0.17%w/w | ||
SODIUM SULFATE ANHYDROUS | OPHTHALMIC | SUSPENSION | 7757826 | 36KCS0R750 | 1.2%w/v | ||
SODIUM SULFATE ANHYDROUS | ORAL | TABLET | 7757826 | 36KCS0R750 | 96mg | ||
SODIUM SULFATE ANHYDROUS | ORAL | TABLET, COATED | 7757826 | 36KCS0R750 | NA | ||
SODIUM SULFATE ANHYDROUS | RESPIRATORY (INHALATION) | SOLUTION | 7757826 | 36KCS0R750 | 0.03%w/w | ||
SODIUM SULFITE | AURICULAR (OTIC) | SOLUTION | 7757837 | VTK01UQK3G | 0.02%w/v | ||
SODIUM SULFITE | INTRA-ARTICULAR | INJECTION | 7757837 | VTK01UQK3G | 2mg | Y | |
SODIUM SULFITE | INTRA-ARTICULAR | INJECTION, SOLUTION | 7757837 | VTK01UQK3G | 2mg | ||
SODIUM SULFITE | INTRALESIONAL | INJECTION | 7757837 | VTK01UQK3G | 2mg | ||
SODIUM SULFITE | INTRAMUSCULAR | INJECTION | 7757837 | VTK01UQK3G | 96mg | ||
SODIUM SULFITE | INTRAMUSCULAR | INJECTION, SOLUTION | 7757837 | VTK01UQK3G | 2mg | ||
SODIUM SULFITE | INTRAVENOUS | INJECTION | 7757837 | VTK01UQK3G | 96mg | Y | |
SODIUM SULFITE | INTRAVENOUS | INJECTION, SOLUTION | 7757837 | VTK01UQK3G | 2mg | ||
SODIUM SULFITE | OPHTHALMIC | SOLUTION | 7757837 | VTK01UQK3G | 4mg | ||
SODIUM SULFITE | OPHTHALMIC | SOLUTION/ DROPS | 7757837 | VTK01UQK3G | 0.2%w/v | ||
SODIUM SULFITE | ORAL | CAPSULE | 7757837 | VTK01UQK3G | 0.5mg | ||
SODIUM SULFITE | ORAL | CONCENTRATE | 7757837 | VTK01UQK3G | 0.3mg/1ml | ||
SODIUM SULFITE | ORAL | SUSPENSION | 7757837 | VTK01UQK3G | 1.15mg/1ml | ||
SODIUM SULFITE | ORAL | TABLET | 7757837 | VTK01UQK3G | 5mg | ||
SODIUM SULFITE | SOFT TISSUE | INJECTION | 7757837 | VTK01UQK3G | 2mg | ||
SODIUM SULFITE | SUBCUTANEOUS | INJECTION | 7757837 | VTK01UQK3G | 0.15%w/v | ||
SODIUM SULFITE | TOPICAL | CREAM | 7757837 | VTK01UQK3G | 8mg | ||
SODIUM SULFITE | TOPICAL | SHAMPOO | 7757837 | VTK01UQK3G | 0.05%w/w | ||
SODIUM TALLOWATE, BEEF | TOPICAL | SOAP | 8052480 | 07RIK6QMEW | 80%w/w | ||
SODIUM TARTRATE | INTRAMUSCULAR | INJECTION | 868188 | QTO9JB4MDD | 288mg | ||
SODIUM TARTRATE | INTRAVENOUS | INJECTION | 868188 | QTO9JB4MDD | 288mg | ||
SODIUM TARTRATE | INTRAVENOUS | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 868188 | QTO9JB4MDD | 0.4%w/v | ||
SODIUM TARTRATE DIHYDRATE | INTRAMUSCULAR | INJECTION | 6106247 | DIA7C37AOW | 288mg | ||
SODIUM TARTRATE DIHYDRATE | INTRAVENOUS | INJECTION | 6106247 | DIA7C37AOW | 288mg | ||
SODIUM TARTRATE DIHYDRATE | INTRAVENOUS | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 6106247 | DIA7C37AOW | 0.4%w/v | ||
SODIUM TARTRATE DIHYDRATE | SUBCUTANEOUS | INJECTION | 6106247 | DIA7C37AOW | 3mg | ||
SODIUM THIOSULFATE | INTRAVENOUS | INJECTION | 10102177 | HX1032V43M | 18mg | ||
SODIUM THIOSULFATE | OPHTHALMIC | SOLUTION | 10102177 | HX1032V43M | 0.5%w/v | ||
SODIUM THIOSULFATE | OPHTHALMIC | SOLUTION/ DROPS | 10102177 | HX1032V43M | 0.31%w/v | ||
SODIUM THIOSULFATE | OPHTHALMIC | SUSPENSION | 10102177 | HX1032V43M | 0.32%w/w | ||
SODIUM THIOSULFATE | OPHTHALMIC | SUSPENSION/ DROPS | 10102177 | HX1032V43M | 3.15%w/w | ||
SODIUM THIOSULFATE | ORAL | CAPSULE | 10102177 | HX1032V43M | 20mg | ||
SODIUM THIOSULFATE | ORAL | SOLUTION | 10102177 | HX1032V43M | 22mg/1ml | ||
SODIUM THIOSULFATE | ORAL | SOLUTION/ DROPS | 10102177 | HX1032V43M | 0.5mg/1ml | ||
SODIUM THIOSULFATE | ORAL | TABLET | 10102177 | HX1032V43M | 3mg | ||
SODIUM THIOSULFATE | TOPICAL | CREAM | 10102177 | HX1032V43M | 6mg | ||
SODIUM THIOSULFATE | TOPICAL | CREAM, AUGMENTED | 10102177 | HX1032V43M | 0.1%w/w | ||
SODIUM THIOSULFATE ANHYDROUS | INTRAVENOUS | SOLUTION | 7772987 | L0IYT1O31N | 1.9mg | ||
SODIUM THIOSULFATE ANHYDROUS | ORAL | SOLUTION | 7772987 | L0IYT1O31N | 2mg | ||
SODIUM THIOSULFATE ANHYDROUS | ORAL | TABLET | 7772987 | L0IYT1O31N | 0.06mg | ||
SODIUM TRIPOLYPHOSPHATE | ORAL | TABLET | 5HK03SA80J | 16mg | |||
SOLVENT ORANGE 2 | ORAL | TABLET, COATED | 2646175 | E939MCU4ID | 0.07mg | ||
SOLVENT ORANGE 2 | RECTAL | SUPPOSITORY | 2646175 | E939MCU4ID | NA | ||
SORBIC ACID | OPHTHALMIC | EMULSION | 110441 | X045WJ989B | 1mg | Y | |
SORBIC ACID | OPHTHALMIC | SOLUTION | 110441 | X045WJ989B | 0.2%w/v | ||
SORBIC ACID | OPHTHALMIC | SOLUTION/ DROPS | 110441 | X045WJ989B | 0.2%w/v | ||
SORBIC ACID | ORAL | CAPSULE | 110441 | X045WJ989B | 0.94mg | ||
SORBIC ACID | ORAL | CAPSULE, EXTENDED RELEASE | 110441 | X045WJ989B | 0.94mg | ||
SORBIC ACID | ORAL | CONCENTRATE | 110441 | X045WJ989B | 1mg | ||
SORBIC ACID | ORAL | LIQUID | 110441 | X045WJ989B | 80mg | ||
SORBIC ACID | ORAL | SOLUTION | 110441 | X045WJ989B | 80mg | ||
SORBIC ACID | ORAL | SUSPENSION | 110441 | X045WJ989B | 40mg | ||
SORBIC ACID | ORAL | SYRUP | 110441 | X045WJ989B | 80mg | ||
SORBIC ACID | ORAL | TABLET | 110441 | X045WJ989B | 10mg | ||
SORBIC ACID | ORAL | TABLET, CHEWABLE | 110441 | X045WJ989B | NA | ||
SORBIC ACID | ORAL | TABLET, COATED | 110441 | X045WJ989B | 1mg | ||
SORBIC ACID | ORAL | TABLET, DELAYED RELEASE | 110441 | X045WJ989B | 0.03mg | ||
SORBIC ACID | ORAL | TABLET, FILM COATED | 110441 | X045WJ989B | 5mg | ||
SORBIC ACID | ORAL | TABLET, FILM COATED, EXTENDED RELEASE | 110441 | X045WJ989B | 1mg | ||
SORBIC ACID | SUBLINGUAL | TABLET | 110441 | X045WJ989B | 0.16mg | ||
SORBIC ACID | TOPICAL | AEROSOL, FOAM | 110441 | X045WJ989B | 6mg | ||
SORBIC ACID | TOPICAL | CREAM | 110441 | X045WJ989B | 2mg | ||
SORBIC ACID | TOPICAL | GEL | 110441 | X045WJ989B | 2mg | ||
SORBIC ACID | TOPICAL | LOTION | 110441 | X045WJ989B | 4mg | Y | |
SORBIC ACID | TOPICAL | OINTMENT | 110441 | X045WJ989B | 0.1%w/w | ||
SORBITAN | ORAL | CAPSULE | 12441097 | 6O92ICV9RU | 19.08mg | ||
SORBITAN | ORAL | CAPSULE, LIQUID FILLED | 12441097 | 6O92ICV9RU | NA | ||
SORBITAN | ORAL | ELIXIR | 12441097 | 6O92ICV9RU | 0.6ml/15ml | ||
SORBITAN MONOLAURATE | INTRAMUSCULAR | INJECTION, SUSPENSION, EXTENDED RELEASE | 1338392 | 6W9PS8B71J | 15mg | ||
SORBITAN MONOLAURATE | NASAL | SPRAY, METERED | 1338392 | 6W9PS8B71J | 1mg | ||
SORBITAN MONOLAURATE | ORAL | CAPSULE | 1338392 | 6W9PS8B71J | 0.08mg | ||
SORBITAN MONOLAURATE | ORAL | EMULSION | 1338392 | 6W9PS8B71J | NA | ||
SORBITAN MONOLAURATE | ORAL | POWDER, FOR SUSPENSION | 1338392 | 6W9PS8B71J | 800mg | ||
SORBITAN MONOLAURATE | ORAL | SUSPENSION | 1338392 | 6W9PS8B71J | 2.5mg/5ml | ||
SORBITAN MONOLAURATE | ORAL | TABLET | 1338392 | 6W9PS8B71J | 800mg | ||
SORBITAN MONOLAURATE | ORAL | TABLET, FILM COATED | 1338392 | 6W9PS8B71J | 800mg | ||
SORBITAN MONOLAURATE | TOPICAL | AEROSOL | 1338392 | 6W9PS8B71J | 4.74%w/w | ||
SORBITAN MONOLAURATE | TOPICAL | AEROSOL, FOAM | 1338392 | 6W9PS8B71J | 341mg | ||
SORBITAN MONOLAURATE | TOPICAL | CREAM | 1338392 | 6W9PS8B71J | 0.5%w/w | ||
SORBITAN MONOLAURATE | TOPICAL | GEL | 1338392 | 6W9PS8B71J | 1%w/w | ||
SORBITAN MONOOLEATE | ORAL | CAPSULE | 1338438 | 06XEA2VD56 | 200mg | ||
SORBITAN MONOOLEATE | ORAL | CAPSULE, EXTENDED RELEASE | 1338438 | 06XEA2VD56 | 1.7mg | ||
SORBITAN MONOOLEATE | ORAL | CAPSULE, LIQUID FILLED | 1338438 | 06XEA2VD56 | 60mg | ||
SORBITAN MONOOLEATE | ORAL | SOLUTION | 1338438 | 06XEA2VD56 | 1080mg | Y | |
SORBITAN MONOOLEATE | ORAL | TABLET | 1338438 | 06XEA2VD56 | 19mg | ||
SORBITAN MONOOLEATE | ORAL | TABLET, COATED | 1338438 | 06XEA2VD56 | 0.13mg | ||
SORBITAN MONOOLEATE | ORAL | TABLET, DELAYED RELEASE | 1338438 | 06XEA2VD56 | 4mg | ||
SORBITAN MONOOLEATE | ORAL | TABLET, FILM COATED | 1338438 | 06XEA2VD56 | 12mg | ||
SORBITAN MONOOLEATE | ORAL | TABLET, FILM COATED, EXTENDED RELEASE | 1338438 | 06XEA2VD56 | 2mg | ||
SORBITAN MONOOLEATE | RECTAL | SUPPOSITORY | 1338438 | 06XEA2VD56 | 390mg | Y | |
SORBITAN MONOOLEATE | TOPICAL | CREAM | 1338438 | 06XEA2VD56 | 50mg | ||
SORBITAN MONOOLEATE | TOPICAL | CREAM, AUGMENTED | 1338438 | 06XEA2VD56 | 0.2%w/w | ||
SORBITAN MONOOLEATE | TOPICAL | EMULSION | 1338438 | 06XEA2VD56 | 2.5%w/w | ||
SORBITAN MONOOLEATE | TOPICAL | GEL | 1338438 | 06XEA2VD56 | 20mg | ||
SORBITAN MONOOLEATE | TOPICAL | LOTION | 1338438 | 06XEA2VD56 | 7mg | ||
SORBITAN MONOOLEATE | TOPICAL | OINTMENT | 1338438 | 06XEA2VD56 | NA | ||
SORBITAN MONOOLEATE | TOPICAL | SPRAY | 1338438 | 06XEA2VD56 | 8mg | ||
SORBITAN MONOOLEATE | TRANSDERMAL | FILM, EXTENDED RELEASE | 1338438 | 06XEA2VD56 | NA | ||
SORBITAN MONOOLEATE | TRANSDERMAL | SYSTEM | 1338438 | 06XEA2VD56 | 2.33mg | ||
SORBITAN MONOPALMITATE | TOPICAL | CREAM | 26266579 | 77K6Z421KU | 2%w/w | ||
SORBITAN MONOPALMITATE | TOPICAL | LIQUID | 26266579 | 77K6Z421KU | 2%w/w | ||
SORBITAN MONOPALMITATE | TOPICAL | LOTION | 26266579 | 77K6Z421KU | 20mg | Y | |
SORBITAN MONOPALMITATE | TOPICAL | SYSTEM | 26266579 | 77K6Z421KU | 10.5mg | ||
SORBITAN MONOSTEARATE | ORAL | SUSPENSION | 1338416 | NVZ4I0H58X | 62.5mg/5ml | ||
SORBITAN MONOSTEARATE | ORAL | TABLET | 1338416 | NVZ4I0H58X | 4mg | ||
SORBITAN MONOSTEARATE | TOPICAL | AEROSOL, FOAM | 1338416 | NVZ4I0H58X | 0.55%w/w | ||
SORBITAN MONOSTEARATE | TOPICAL | CREAM | 1338416 | NVZ4I0H58X | 86mg | ||
SORBITAN MONOSTEARATE | TOPICAL | LOTION | 1338416 | NVZ4I0H58X | 89mg | Y | |
SORBITAN MONOSTEARATE | TOPICAL | OINTMENT | 1338416 | NVZ4I0H58X | NA | ||
SORBITAN MONOSTEARATE | TOPICAL | SOLUTION | 1338416 | NVZ4I0H58X | NA | ||
SORBITAN MONOSTEARATE | TOPICAL | SPRAY | 1338416 | NVZ4I0H58X | 4.58%w/w | ||
SORBITAN MONOSTEARATE | TOPICAL | SUSPENSION | 1338416 | NVZ4I0H58X | 2.15%w/w | ||
SORBITAN MONOSTEARATE | VAGINAL | CREAM | 1338416 | NVZ4I0H58X | 100mg | ||
SORBITAN MONOSTEARATE | VAGINAL | SUPPOSITORY | 1338416 | NVZ4I0H58X | NA | ||
SORBITAN SESQUIOLEATE | RECTAL | OINTMENT | 8007430 | 0W8RRI5W5A | 15mg | Y | |
SORBITAN SESQUIOLEATE | TOPICAL | OINTMENT | 8007430 | 0W8RRI5W5A | 75mg | ||
SORBITAN TRIOLEATE | ORAL | CAPSULE | 26266580 | QE6F49RPJ1 | NA | ||
SORBITAN TRIOLEATE | ORAL | POWDER, FOR SUSPENSION | 26266580 | QE6F49RPJ1 | 12mg | ||
SORBITAN TRIOLEATE | ORAL | TABLET | 26266580 | QE6F49RPJ1 | NA | ||
SORBITAN TRIOLEATE | RESPIRATORY (INHALATION) | AEROSOL, METERED | 26266580 | QE6F49RPJ1 | NA | ||
SORBITAN TRIOLEATE | RESPIRATORY (INHALATION) | AEROSOL, SPRAY | 26266580 | QE6F49RPJ1 | 0.86%w/w | ||
SORBITAN TRISTEARATE | TOPICAL | CREAM | 26658195 | 6LUM696811 | 5mg | ||
SORBITAN TRISTEARATE | TOPICAL | LOTION | 26658195 | 6LUM696811 | 585mg | ||
SORBITOL | BUCCAL | GUM, CHEWING | 50704 | 506T60A25R | 5110mg | ||
SORBITOL | DENTAL | PASTE | 50704 | 506T60A25R | 14.6%w/w | ||
SORBITOL | DENTAL | PASTE, DENTIFRICE | 50704 | 506T60A25R | 14%w/w | ||
SORBITOL | INTRA-ARTICULAR | INJECTION | 50704 | 506T60A25R | 45%w/v | ||
SORBITOL | INTRALESIONAL | INJECTION | 50704 | 506T60A25R | 45%w/v | ||
SORBITOL | INTRAMUSCULAR | INJECTION | 50704 | 506T60A25R | NA | ||
SORBITOL | INTRASYNOVIAL | INJECTION | 50704 | 506T60A25R | 45%w/v | ||
SORBITOL | INTRAVENOUS | INJECTION | 50704 | 506T60A25R | 1200mg | ||
SORBITOL | INTRAVENOUS | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 50704 | 506T60A25R | 1.04%w/v | ||
SORBITOL | INTRAVENOUS | INJECTION, SOLUTION | 50704 | 506T60A25R | 3000mg | ||
SORBITOL | NASAL | SOLUTION | 50704 | 506T60A25R | 25mg/1ml | ||
SORBITOL | NASAL | SPRAY | 50704 | 506T60A25R | 49mg | ||
SORBITOL | NASAL | SPRAY, METERED | 50704 | 506T60A25R | 49mg | ||
SORBITOL | OPHTHALMIC | SOLUTION | 50704 | 506T60A25R | 6mg | ||
SORBITOL | OPHTHALMIC | SOLUTION/ DROPS | 50704 | 506T60A25R | 0.25%w/v | ||
SORBITOL | ORAL | CAPSULE | 50704 | 506T60A25R | 744mg | ||
SORBITOL | ORAL | CAPSULE, LIQUID FILLED | 50704 | 506T60A25R | 25mg | ||
SORBITOL | ORAL | CONCENTRATE | 50704 | 506T60A25R | 600mg/1ml | ||
SORBITOL | ORAL | ELIXIR | 50704 | 506T60A25R | 833.3mg | ||
SORBITOL | ORAL | GUM, CHEWING | 50704 | 506T60A25R | 6168mg | ||
SORBITOL | ORAL | LIQUID | 50704 | 506T60A25R | 53460mg | ||
SORBITOL | ORAL | POWDER | 50704 | 506T60A25R | 36000mg | Y | |
SORBITOL | ORAL | POWDER, FOR SUSPENSION | 50704 | 506T60A25R | 12000mg | ||
SORBITOL | ORAL | SOLUTION | 50704 | 506T60A25R | 29268mg | ||
SORBITOL | ORAL | SOLUTION, CONCENTRATE | 50704 | 506T60A25R | 300mg/1ml | ||
SORBITOL | ORAL | SUSPENSION | 50704 | 506T60A25R | 45000mg | ||
SORBITOL | ORAL | SYRUP | 50704 | 506T60A25R | 4370mg/5ml | ||
SORBITOL | ORAL | TABLET | 50704 | 506T60A25R | 337.28mg | ||
SORBITOL | ORAL | TABLET, CHEWABLE | 50704 | 506T60A25R | 3555mg | ||
SORBITOL | ORAL | TABLET, COATED | 50704 | 506T60A25R | 12.96mg | ||
SORBITOL | ORAL | TABLET, DELAYED RELEASE | 50704 | 506T60A25R | 0.01mg | ||
SORBITOL | ORAL | TABLET, EXTENDED RELEASE | 50704 | 506T60A25R | 428mg | ||
SORBITOL | ORAL | TABLET, FILM COATED | 50704 | 506T60A25R | 5mg | ||
SORBITOL | ORAL | TABLET, ORALLY DISINTEGRATING | 50704 | 506T60A25R | 7mg | ||
SORBITOL | RECTAL | SUSPENSION | 50704 | 506T60A25R | 46.18%w/v | ||
SORBITOL | SUBCUTANEOUS | INJECTION | 50704 | 506T60A25R | 4.7%w/v | ||
SORBITOL | SUBCUTANEOUS | INJECTION, SOLUTION | 50704 | 506T60A25R | 4.7%w/v | ||
SORBITOL | SUBLINGUAL | TABLET | 50704 | 506T60A25R | 50.5mg | ||
SORBITOL | TOPICAL | AEROSOL, FOAM | 50704 | 506T60A25R | 4.95%w/w | ||
SORBITOL | TOPICAL | CREAM | 50704 | 506T60A25R | 36.8%w/w | ||
SORBITOL | TOPICAL | CREAM, AUGMENTED | 50704 | 506T60A25R | 15%w/w | ||
SORBITOL | TOPICAL | EMULSION | 50704 | 506T60A25R | 7%w/w | ||
SORBITOL | TOPICAL | LIQUID | 50704 | 506T60A25R | 1%w/w | ||
SORBITOL | TOPICAL | LOTION | 50704 | 506T60A25R | 10.7%w/w | ||
SORBITOL | TOPICAL | OINTMENT | 50704 | 506T60A25R | 10%w/w | ||
SORBITOL | TOPICAL | SYSTEM | 50704 | 506T60A25R | 6300mg | ||
SORBITOL | VAGINAL | CREAM | 50704 | 506T60A25R | 36.8%w/w | ||
SORBITOL SOLUTION | NASAL | SPRAY | 8KW3E207O2 | 70mg | |||
SORBITOL SOLUTION | NASAL | SPRAY, METERED | 8KW3E207O2 | 71mg | |||
SORBITOL SOLUTION | OPHTHALMIC | SOLUTION | 8KW3E207O2 | 20mg | |||
SORBITOL SOLUTION | OPHTHALMIC | SOLUTION/ DROPS | 8KW3E207O2 | 9mg | |||
SORBITOL SOLUTION | ORAL | CAPSULE | 8KW3E207O2 | 372mg | |||
SORBITOL SOLUTION | ORAL | CAPSULE, LIQUID FILLED | 8KW3E207O2 | 222mg | |||
SORBITOL SOLUTION | ORAL | CONCENTRATE | 8KW3E207O2 | 1200mg | |||
SORBITOL SOLUTION | ORAL | SOLUTION | 8KW3E207O2 | 32160mg | |||
SORBITOL SOLUTION | ORAL | SUSPENSION | 8KW3E207O2 | 50000mg | |||
SORBITOL SOLUTION | ORAL | SUSPENSION/ DROPS | 8KW3E207O2 | 1500mg | |||
SORBITOL SOLUTION | ORAL | SYRUP | 8KW3E207O2 | 1200mg | |||
SORBITOL SOLUTION | TOPICAL | CREAM | 8KW3E207O2 | 4128mg | |||
SORBITOL SOLUTION | TOPICAL | LOTION | 8KW3E207O2 | 764mg | |||
SORBITOL SOLUTION | TOPICAL | SYSTEM | 8KW3E207O2 | 5600mg | |||
SORBITOL SOLUTION | VAGINAL | CREAM | 8KW3E207O2 | 1840mg | Y | ||
SORBITOL SPECIAL POLYOL SOLUTION | ORAL | CAPSULE | NA | 501mg | |||
SORBITOL SPECIAL POLYOL SOLUTION | ORAL | CAPSULE, LIQUID FILLED | NA | NA | |||
SORBITOL-GLYCERIN BLEND | ORAL | CAPSULE | NA | 2767mg | |||
SOYBEAN | ORAL | CAPSULE | L7HT8F1ZOD | NA | |||
SOYBEAN | TOPICAL | EMULSION | L7HT8F1ZOD | 3%w/w | |||
SOYBEAN LECITHIN | ORAL | CAPSULE | 8030760 | 1DI56QDM62 | 20mg | ||
SOYBEAN LECITHIN | ORAL | POWDER, FOR SUSPENSION | 8030760 | 1DI56QDM62 | 39mg | ||
SOYBEAN LECITHIN | ORAL | TABLET | 8030760 | 1DI56QDM62 | 8mg | ||
SOYBEAN LECITHIN | ORAL | TABLET, EXTENDED RELEASE | 8030760 | 1DI56QDM62 | 20mg | ||
SOYBEAN LECITHIN | ORAL | TABLET, FILM COATED | 8030760 | 1DI56QDM62 | 0.33mg | ||
SOYBEAN LECITHIN | RESPIRATORY (INHALATION) | AEROSOL, METERED | 8030760 | 1DI56QDM62 | 0.1%w/w | ||
SOYBEAN LECITHIN | VAGINAL | CREAM | 8030760 | 1DI56QDM62 | 1%w/w | ||
SOYBEAN OIL | INTRAVENOUS | INJECTION | 8001227 | 241ATL177A | 10%w/v | ||
SOYBEAN OIL | INTRAVENOUS | INJECTION, EMULSION | 8001227 | 241ATL177A | 20%w/v | ||
SOYBEAN OIL | INTRAVENOUS | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 8001227 | 241ATL177A | 10%w/v | ||
SOYBEAN OIL | INTRAVENOUS | INJECTION, SOLUTION, CONCENTRATE | 8001227 | 241ATL177A | 223mg | ||
SOYBEAN OIL | ORAL | CAPSULE | 8001227 | 241ATL177A | 1249mg | ||
SOYBEAN OIL | ORAL | CAPSULE, LIQUID FILLED | 8001227 | 241ATL177A | 260mg | ||
SOYBEAN OIL | ORAL | TABLET, CHEWABLE | 8001227 | 241ATL177A | 0.14mg | ||
SOYBEAN OIL | TOPICAL | AEROSOL, FOAM | 8001227 | 241ATL177A | 50%w/w | ||
SOYBEAN OIL | TOPICAL | SOLUTION | 8001227 | 241ATL177A | 5.82%w/w | ||
SOYBEAN PHOSPHATIDYLCHOLINE | TOPICAL | GEL | 97281475 | 1T6N4D9YV6 | 6mg | ||
SOYBEAN PHOSPHATIDYLCHOLINE | VAGINAL | CREAM | 97281475 | 1T6N4D9YV6 | 50mg | ||
SPEARMINT | ORAL | SOLUTION | J7I2T6IV1N | 0.04ml/5ml | |||
SPEARMINT | ORAL | TABLET | J7I2T6IV1N | 0.09mg | |||
SPEARMINT | ORAL | TABLET, CHEWABLE | J7I2T6IV1N | 2.1mg | |||
SPEARMINT | ORAL | TABLET, ORALLY DISINTEGRATING | J7I2T6IV1N | 0.06mg | |||
SPEARMINT OIL | DENTAL | PASTE, DENTIFRICE | 8008795 | C3M81465G5 | 27.6%w/w | ||
SPEARMINT OIL | ORAL | CAPSULE | 8008795 | C3M81465G5 | NA | ||
SPEARMINT OIL | ORAL | SOLUTION | 8008795 | C3M81465G5 | NA | ||
SPEARMINT OIL | ORAL | SUSPENSION | 8008795 | C3M81465G5 | 0.59mg/20ml | ||
SPEARMINT OIL | ORAL | SYRUP | 8008795 | C3M81465G5 | NA | ||
SPEARMINT OIL | SUBLINGUAL | TABLET | 8008795 | C3M81465G5 | 0.4mg | ||
SPEARMINT OIL | TOPICAL | OINTMENT | 8008795 | C3M81465G5 | NA | ||
SPERMACETI | TOPICAL | CREAM | 8002231 | P86KHA8V3K | 11%w/w | ||
SQUALANE | ORAL | POWDER | 111013 | GW89575KF9 | 0.02mg | ||
SQUALANE | TOPICAL | AEROSOL, FOAM | 111013 | GW89575KF9 | 2.23%w/w | ||
SQUALANE | TOPICAL | CREAM | 111013 | GW89575KF9 | 6%w/w | ||
SQUALANE | TOPICAL | CREAM, AUGMENTED | 111013 | GW89575KF9 | 120mg | ||
SQUALANE | TOPICAL | SOLUTION | 111013 | GW89575KF9 | 1%w/w | ||
STANNIC CHLORIDE | TOPICAL | SOAP | 7646788 | 67H76LFL3V | 0.2%w/w | ||
STANNOUS CHLORIDE | INTRADERMAL | INJECTION, POWDER, FOR SOLUTION | 10025691 | 1BQV3749L5 | 0.08mg | ||
STANNOUS CHLORIDE | INTRAVENOUS | INJECTION | 10025691 | 1BQV3749L5 | 3.4mg | ||
STANNOUS CHLORIDE | INTRAVENOUS | INJECTION, POWDER, FOR SOLUTION | 10025691 | 1BQV3749L5 | 0.25mg | ||
STANNOUS CHLORIDE | INTRAVENOUS | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 10025691 | 1BQV3749L5 | 0.42mg | ||
STANNOUS CHLORIDE | SUBCUTANEOUS | INJECTION, POWDER, FOR SOLUTION | 10025691 | 1BQV3749L5 | 0.08mg | ||
STANNOUS CHLORIDE ANHYDROUS | INTRAVENOUS | INJECTION | 7772998 | R30H55TN67 | 0.05mg | ||
STANNOUS CHLORIDE ANHYDROUS | TOPICAL | SOAP | 7772998 | R30H55TN67 | NA | ||
STANNOUS FLUORIDE | INTRAVENOUS | INJECTION | 7783473 | 3FTR44B32Q | 0.73mg | ||
STANNOUS TARTRATE | INTRAVENOUS | INJECTION | 815850 | 6JS9U5611X | 0.08mg | ||
STARCH | BUCCAL | TABLET | 9005258 | NA | 45mg | ||
STARCH | ORAL | CAPSULE | 9005258 | NA | 430mg | ||
STARCH | ORAL | CAPSULE, COATED PELLETS | 9005258 | NA | 36.4mg | ||
STARCH | ORAL | CAPSULE, DELAYED RELEASE | 9005258 | NA | 392mg | ||
STARCH | ORAL | CAPSULE, EXTENDED RELEASE | 9005258 | NA | 84.8mg | ||
STARCH | ORAL | GRANULE, FOR SUSPENSION | 9005258 | NA | NA | ||
STARCH | ORAL | POWDER | 9005258 | NA | 0.17mg | ||
STARCH | ORAL | SUSPENSION | 9005258 | NA | 20mg/5ml | ||
STARCH | ORAL | SUSPENSION, EXTENDED RELEASE | 9005258 | NA | 400mg | ||
STARCH | ORAL | TABLET | 9005258 | NA | 2440mg | ||
STARCH | ORAL | TABLET, CHEWABLE | 9005258 | NA | 309mg | ||
STARCH | ORAL | TABLET, COATED | 9005258 | NA | 210mg | ||
STARCH | ORAL | TABLET, DELAYED RELEASE | 9005258 | NA | 179.88mg | ||
STARCH | ORAL | TABLET, EXTENDED RELEASE | 9005258 | NA | 130.45mg | ||
STARCH | ORAL | TABLET, FILM COATED | 9005258 | NA | 480mg | ||
STARCH | ORAL | TABLET, SUGAR COATED | 9005258 | NA | NA | ||
STARCH | ORAL | WAFER | 9005258 | NA | 4.8mg | ||
STARCH | RECTAL | SUPPOSITORY | 9005258 | NA | NA | ||
STARCH | RECTAL | TABLET | 9005258 | NA | 55mg | ||
STARCH | SUBLINGUAL | TABLET | 9005258 | NA | 225mg | ||
STARCH | TOPICAL | CREAM | 9005258 | NA | NA | ||
STARCH | TOPICAL | POWDER | 9005258 | NA | 0.1mg/mg | ||
STARCH 1500, PREGELATINIZED | BUCCAL | TABLET | O8232NY3SJ | 16.6mg | |||
STARCH 1500, PREGELATINIZED | ORAL | CAPSULE | O8232NY3SJ | 5785mg | |||
STARCH 1500, PREGELATINIZED | ORAL | CAPSULE, COATED, EXTENDED RELEASE | O8232NY3SJ | 19mg | |||
STARCH 1500, PREGELATINIZED | ORAL | CAPSULE, DELAYED RELEASE | O8232NY3SJ | 216mg | |||
STARCH 1500, PREGELATINIZED | ORAL | CAPSULE, EXTENDED RELEASE | O8232NY3SJ | 194mg | |||
STARCH 1500, PREGELATINIZED | ORAL | CONCENTRATE | O8232NY3SJ | NA | |||
STARCH 1500, PREGELATINIZED | ORAL | DROPS | O8232NY3SJ | NA | |||
STARCH 1500, PREGELATINIZED | ORAL | PASTILLE | O8232NY3SJ | NA | |||
STARCH 1500, PREGELATINIZED | ORAL | POWDER, FOR SUSPENSION | O8232NY3SJ | 34mg | |||
STARCH 1500, PREGELATINIZED | ORAL | SUSPENSION | O8232NY3SJ | 900mg | |||
STARCH 1500, PREGELATINIZED | ORAL | SUSPENSION, EXTENDED RELEASE | O8232NY3SJ | 113mg | |||
STARCH 1500, PREGELATINIZED | ORAL | SUSPENSION/ DROPS | O8232NY3SJ | 90mg | |||
STARCH 1500, PREGELATINIZED | ORAL | TABLET | O8232NY3SJ | 1116mg | |||
STARCH 1500, PREGELATINIZED | ORAL | TABLET, CHEWABLE | O8232NY3SJ | 180mg | |||
STARCH 1500, PREGELATINIZED | ORAL | TABLET, COATED | O8232NY3SJ | 256mg | |||
STARCH 1500, PREGELATINIZED | ORAL | TABLET, DELAYED RELEASE | O8232NY3SJ | 713mg | Y | ||
STARCH 1500, PREGELATINIZED | ORAL | TABLET, EXTENDED RELEASE | O8232NY3SJ | 184mg | |||
STARCH 1500, PREGELATINIZED | ORAL | TABLET, FILM COATED | O8232NY3SJ | 2000mg | |||
STARCH 1500, PREGELATINIZED | ORAL | TABLET, FILM COATED, EXTENDED RELEASE | O8232NY3SJ | 149mg | |||
STARCH 1500, PREGELATINIZED | ORAL | TABLET, ORALLY DISINTEGRATING | O8232NY3SJ | 100mg | |||
STARCH 1500, PREGELATINIZED | ORAL | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE | O8232NY3SJ | 21mg | |||
STARCH 1500, PREGELATINIZED | SUBLINGUAL | TABLET | O8232NY3SJ | 409mg | |||
STARCH 1500, PREGELATINIZED | VAGINAL | INSERT | O8232NY3SJ | 147mg | |||
STARCH 7150 | ORAL | CAPSULE | NA | 0.44mg | |||
STARCH 7150 | ORAL | TABLET | NA | 50mg | |||
STARCH 825 | ORAL | CAPSULE | NA | 217mg | |||
STARCH 826 | ORAL | CAPSULE | NA | 237mg | |||
STARCH 826 | ORAL | TABLET | NA | 320mg | |||
STARCH 826 | ORAL | TABLET, FILM COATED | NA | 10mg | |||
STARCH 826 | SUBLINGUAL | TABLET | NA | 12mg | |||
STARCH, MODIFIED | ORAL | CAPSULE | NA | 23mg | |||
STARCH, MODIFIED | ORAL | POWDER, FOR SUSPENSION | NA | 10mg/5ml | |||
STARCH, MODIFIED | ORAL | TABLET | NA | 548mg | |||
STARCH, MODIFIED | ORAL | TABLET, ORALLY DISINTEGRATING | NA | 0.4mg | |||
STARCH, POTATO | ORAL | TABLET | 9005258 | 8I089SAH3T | 458mg | ||
STARCH, POTATO | ORAL | TABLET, COATED | 9005258 | 8I089SAH3T | 1.37mg | ||
STARCH, POTATO | ORAL | TABLET, EXTENDED RELEASE | 9005258 | 8I089SAH3T | NA | ||
STARCH, PREGELATINIZED | ORAL | CAPSULE | NA | 1600mg | |||
STARCH, PREGELATINIZED | ORAL | CAPSULE, EXTENDED RELEASE | NA | 141.75mg | |||
STARCH, PREGELATINIZED | ORAL | LOZENGE | NA | 80mg | Y | ||
STARCH, PREGELATINIZED | ORAL | SUSPENSION | NA | 2400mg | |||
STARCH, PREGELATINIZED | ORAL | SUSPENSION, EXTENDED RELEASE | NA | 242mg | |||
STARCH, PREGELATINIZED | ORAL | SUSPENSION/ DROPS | NA | 90mg | |||
STARCH, PREGELATINIZED | ORAL | TABLET | NA | 704mg | |||
STARCH, PREGELATINIZED | ORAL | TABLET, CHEWABLE | NA | 360mg | |||
STARCH, PREGELATINIZED | ORAL | TABLET, COATED | NA | 460mg | |||
STARCH, PREGELATINIZED | ORAL | TABLET, DELAYED RELEASE | NA | 2462mg | |||
STARCH, PREGELATINIZED | ORAL | TABLET, EXTENDED RELEASE | NA | 1086mg | |||
STARCH, PREGELATINIZED | ORAL | TABLET, FILM COATED | NA | 337mg | |||
STARCH, PREGELATINIZED | ORAL | TABLET, ORALLY DISINTEGRATING | NA | 240mg | |||
STARCH, PREGELATINIZED | SUBLINGUAL | TABLET | NA | 120mg | |||
STARCH, RICE | ORAL | TABLET, EXTENDED RELEASE | 9005258 | 4DGK8B7I3S | 301mg | ||
STARCH, TAPIOCA | ORAL | CAPSULE | 9005258 | 24SC3U704I | 100mg | ||
STARCH, TAPIOCA | ORAL | TABLET | 9005258 | 24SC3U704I | 5mg | ||
STARCH, WHEAT | ORAL | CAPSULE, EXTENDED RELEASE | 9005258 | 79QS2MG2LP | 0.75mg | ||
STARCH, WHEAT | ORAL | TABLET | 9005258 | 79QS2MG2LP | 65.59mg | ||
STARCH, WHEAT | ORAL | TABLET, COATED | 9005258 | 79QS2MG2LP | NA | ||
STARCH, WHEAT | ORAL | TABLET, FILM COATED | 9005258 | 79QS2MG2LP | 49mg | ||
STEARALKONIUM CHLORIDE | TOPICAL | LOTION | 122190 | 0OUO26BB88 | 3.15%w/w | ||
STEARAMIDOETHYL DIETHYLAMINE | TOPICAL | OINTMENT | 16889148 | 25FFJ4209Z | NA | ||
STEARAMIDOETHYL DIETHYLAMINE | VAGINAL | CREAM | 16889148 | 25FFJ4209Z | 2.5%w/w | ||
STEARATES | ORAL | TABLET | NA | 4.5mg | |||
STEARETH-10 | RECTAL | AEROSOL, FOAM | 9005009 | FD0913P475 | 34mg | ||
STEARETH-10 | TOPICAL | AEROSOL, FOAM | 9005009 | FD0913P475 | NA | ||
STEARETH-100 | TOPICAL | CREAM | 9005009 | 4OH5W9UM87 | 50mg | ||
STEARETH-100 | TOPICAL | OINTMENT | 9005009 | 4OH5W9UM87 | 86mg | ||
STEARETH-2 | TOPICAL | AEROSOL, FOAM | 16057435 | V56DFE46J5 | 1.09%w/w | ||
STEARETH-2 | TOPICAL | CREAM | 16057435 | V56DFE46J5 | 643mg | ||
STEARETH-2 | TOPICAL | LOTION | 16057435 | V56DFE46J5 | 0.4%w/w | ||
STEARETH-2 | TOPICAL | OINTMENT | 16057435 | V56DFE46J5 | 357mg | ||
STEARETH-20 | TOPICAL | CREAM | 9005009 | L0Q8IK9E08 | 4.15%w/w | ||
STEARETH-21 | TOPICAL | CREAM | 9005009 | 53J3F32P58 | 3%w/w | ||
STEARETH-21 | TOPICAL | LOTION | 9005009 | 53J3F32P58 | 3%w/w | ||
STEARETH-40 | BUCCAL | MOUTHWASH | 9005009 | 6I2K5U1MWS | 0.75mg/1ml | ||
STEARETH-40 | ORAL | TABLET | 9005009 | 6I2K5U1MWS | NA | ||
STEARETH-40 | TOPICAL | AEROSOL, FOAM | 9005009 | 6I2K5U1MWS | 1.09%w/w | ||
STEARETH-40 | TOPICAL | CREAM | 9005009 | 6I2K5U1MWS | 12%w/w | ||
STEARIC ACID | BUCCAL | TABLET | 57114 | 4ELV7Z65AP | 6mg | ||
STEARIC ACID | ORAL | CAPSULE | 57114 | 4ELV7Z65AP | 90mg | ||
STEARIC ACID | ORAL | CAPSULE, EXTENDED RELEASE | 57114 | 4ELV7Z65AP | 64mg | ||
STEARIC ACID | ORAL | EMULSION | 57114 | 4ELV7Z65AP | NA | ||
STEARIC ACID | ORAL | POWDER, FOR SUSPENSION | 57114 | 4ELV7Z65AP | 1203mg/5ml | ||
STEARIC ACID | ORAL | TABLET | 57114 | 4ELV7Z65AP | 336mg | ||
STEARIC ACID | ORAL | TABLET, CHEWABLE | 57114 | 4ELV7Z65AP | 180mg | ||
STEARIC ACID | ORAL | TABLET, COATED | 57114 | 4ELV7Z65AP | 42.4mg | ||
STEARIC ACID | ORAL | TABLET, DELAYED RELEASE | 57114 | 4ELV7Z65AP | 80mg | ||
STEARIC ACID | ORAL | TABLET, EXTENDED RELEASE | 57114 | 4ELV7Z65AP | 200mg | ||
STEARIC ACID | ORAL | TABLET, FILM COATED | 57114 | 4ELV7Z65AP | 176mg | ||
STEARIC ACID | ORAL | TABLET, FILM COATED, EXTENDED RELEASE | 57114 | 4ELV7Z65AP | 120mg | ||
STEARIC ACID | ORAL | TABLET, ORALLY DISINTEGRATING | 57114 | 4ELV7Z65AP | 10mg | ||
STEARIC ACID | SUBCUTANEOUS | IMPLANT | 57114 | 4ELV7Z65AP | 1.04mg | ||
STEARIC ACID | SUBCUTANEOUS | PELLET | 57114 | 4ELV7Z65AP | 0.97mg | ||
STEARIC ACID | SUBLINGUAL | TABLET | 57114 | 4ELV7Z65AP | 9mg | ||
STEARIC ACID | TOPICAL | AEROSOL, FOAM | 57114 | 4ELV7Z65AP | 8%w/w | ||
STEARIC ACID | TOPICAL | CREAM | 57114 | 4ELV7Z65AP | 190mg | ||
STEARIC ACID | TOPICAL | CREAM, AUGMENTED | 57114 | 4ELV7Z65AP | 3%w/w | ||
STEARIC ACID | TOPICAL | EMULSION | 57114 | 4ELV7Z65AP | NA | ||
STEARIC ACID | TOPICAL | LOTION | 57114 | 4ELV7Z65AP | 80mg | ||
STEARIC ACID | TOPICAL | OINTMENT | 57114 | 4ELV7Z65AP | 15%w/w | ||
STEARIC ACID | TOPICAL | SHAMPOO | 57114 | 4ELV7Z65AP | 9.7%w/w | ||
STEARIC ACID | TOPICAL | SOAP | 57114 | 4ELV7Z65AP | 6%w/w | ||
STEARIC ACID | TOPICAL | SOLUTION | 57114 | 4ELV7Z65AP | NA | ||
STEARIC ACID | TOPICAL | SUSPENSION | 57114 | 4ELV7Z65AP | 1.75%w/w | ||
STEARIC ACID | VAGINAL | AEROSOL, FOAM | 57114 | 4ELV7Z65AP | 4%w/w | ||
STEARIC ACID | VAGINAL | CREAM | 57114 | 4ELV7Z65AP | 1088mg | Y | |
STEARIC DIETHANOLAMIDE | ORAL | TABLET | 93823 | 4V4H07OJB9 | NA | ||
STEARIC DIETHANOLAMIDE | TOPICAL | CREAM | 93823 | 4V4H07OJB9 | NA | ||
STEARIC HYDRAZIDE | TOPICAL | SOAP | 4130545 | 3FV1C68XOP | 0.35%w/w | ||
STEAR-O-WET C | ORAL | TABLET | NA | 12mg | |||
STEAR-O-WET C | ORAL | TABLET, EXTENDED RELEASE | NA | 10mg | |||
STEAR-O-WET M | ORAL | CAPSULE | NA | 92mg | |||
STEAR-O-WET M | ORAL | CAPSULE, EXTENDED RELEASE | NA | 14mg | |||
STEAR-O-WET M | ORAL | TABLET | NA | 860mg | |||
STEAR-O-WET M | ORAL | TABLET, COATED | NA | 10mg | |||
STEAR-O-WET M | ORAL | TABLET, DELAYED RELEASE | NA | 34mg | |||
STEAR-O-WET M | ORAL | TABLET, EXTENDED RELEASE | NA | 22mg | Y | ||
STEAR-O-WET M | ORAL | TABLET, FILM COATED | NA | 72mg | |||
STEAROYL POLYOXYL-32 GLYCERIDES | ORAL | CAPSULE | 9011216 | G6EP177239 | 960mg | ||
STEAROYL POLYOXYL-32 GLYCERIDES | ORAL | CAPSULE, EXTENDED RELEASE | 9011216 | G6EP177239 | 8mg | ||
STEAROYL POLYOXYL-32 GLYCERIDES | ORAL | TABLET | 9011216 | G6EP177239 | 3mg | ||
STEAROYL POLYOXYLGLYCERIDES | ORAL | CAPSULE | 9011216 | NA | 2350mg | ||
STEAROYL POLYOXYLGLYCERIDES | ORAL | TABLET | 9011216 | NA | 23.34mg | ||
STEAROYL POLYOXYLGLYCERIDES | TOPICAL | CREAM | 9011216 | NA | 5%w/w | ||
STEARYL ALCOHOL | ORAL | CAPSULE, EXTENDED RELEASE | 112925 | 2KR89I4H1Y | 72mg | ||
STEARYL ALCOHOL | ORAL | POWDER | 112925 | 2KR89I4H1Y | 0.11mg | ||
STEARYL ALCOHOL | ORAL | TABLET | 112925 | 2KR89I4H1Y | 20mg | ||
STEARYL ALCOHOL | ORAL | TABLET, EXTENDED RELEASE | 112925 | 2KR89I4H1Y | 244mg | ||
STEARYL ALCOHOL | ORAL | TABLET, FILM COATED, EXTENDED RELEASE | 112925 | 2KR89I4H1Y | 120mg | ||
STEARYL ALCOHOL | TOPICAL | AEROSOL | 112925 | 2KR89I4H1Y | 0.53%w/w | ||
STEARYL ALCOHOL | TOPICAL | AEROSOL, FOAM | 112925 | 2KR89I4H1Y | 37mg | ||
STEARYL ALCOHOL | TOPICAL | CREAM | 112925 | 2KR89I4H1Y | 1118mg | ||
STEARYL ALCOHOL | TOPICAL | CREAM, AUGMENTED | 112925 | 2KR89I4H1Y | 4%w/w | ||
STEARYL ALCOHOL | TOPICAL | LOTION | 112925 | 2KR89I4H1Y | 1140mg | ||
STEARYL ALCOHOL | TOPICAL | OINTMENT | 112925 | 2KR89I4H1Y | 569mg | ||
STEARYL ALCOHOL | TOPICAL | SUSPENSION | 112925 | 2KR89I4H1Y | 2.01%w/w | ||
STEARYL ALCOHOL | VAGINAL | CREAM | 112925 | 2KR89I4H1Y | 425mg | Y | |
STEARYL ALCOHOL | VAGINAL | SUPPOSITORY | 112925 | 2KR89I4H1Y | 8.5mg | ||
STRAWBERRY | ORAL | POWDER, FOR SUSPENSION | 4J2TY8Y81V | 20mg/5ml | |||
STRAWBERRY | ORAL | SOLUTION | 4J2TY8Y81V | 6mg | |||
STRAWBERRY | ORAL | SUSPENSION | 4J2TY8Y81V | 21mg | |||
STRAWBERRY | ORAL | SYRUP | 4J2TY8Y81V | 2.5mg/5ml | |||
STRAWBERRY | ORAL | TABLET, ORALLY DISINTEGRATING | 4J2TY8Y81V | 1mg | |||
STYRENE/ISOPRENE/STYRENE BLOCK COPOLYMER | TOPICAL | SYSTEM | K7S96QM8DV | 520mg | |||
SUCCINIC ACID | INTRAMUSCULAR | INJECTION | 110156 | AB6MNQ6J6L | ADJ PH | ||
SUCCINIC ACID | INTRAVENOUS | INJECTION | 110156 | AB6MNQ6J6L | 38mg | ||
SUCCINIC ACID | INTRAVENOUS | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 110156 | AB6MNQ6J6L | 3mg | ||
SUCCINIC ACID | ORAL | CAPSULE | 110156 | AB6MNQ6J6L | 390mg | ||
SUCCINIC ACID | ORAL | CONCENTRATE | 110156 | AB6MNQ6J6L | 60mg | ||
SUCCINIC ACID | ORAL | POWDER, FOR SUSPENSION | 110156 | AB6MNQ6J6L | 5mg | ||
SUCCINIC ACID | ORAL | SOLUTION | 110156 | AB6MNQ6J6L | 0.01mg/1ml | ||
SUCCINIC ACID | ORAL | TABLET | 110156 | AB6MNQ6J6L | 125.3mg | ||
SUCCINIC ACID | ORAL | TABLET, CHEWABLE | 110156 | AB6MNQ6J6L | 2.86mg | ||
SUCCINIC ACID | ORAL | TABLET, EXTENDED RELEASE | 110156 | AB6MNQ6J6L | 648mg | ||
SUCCINIC ACID | TOPICAL | GEL | 110156 | AB6MNQ6J6L | ADJ PH | ||
SUCRALOSE | BUCCAL | GUM, CHEWING | 56038132 | 96K6UQ3ZD4 | 70mg | ||
SUCRALOSE | NASAL | SPRAY | 56038132 | 96K6UQ3ZD4 | 2mg | ||
SUCRALOSE | NASAL | SPRAY, METERED | 56038132 | 96K6UQ3ZD4 | 2mg | ||
SUCRALOSE | ORAL | FILM, SOLUBLE | 56038132 | 96K6UQ3ZD4 | 33mg | Y | |
SUCRALOSE | ORAL | GRANULE | 56038132 | 96K6UQ3ZD4 | 5.4mg | ||
SUCRALOSE | ORAL | GRANULE, FOR SUSPENSION | 56038132 | 96K6UQ3ZD4 | 23mg | ||
SUCRALOSE | ORAL | LIQUID | 56038132 | 96K6UQ3ZD4 | 80mg | ||
SUCRALOSE | ORAL | LOZENGE | 56038132 | 96K6UQ3ZD4 | 115mg | ||
SUCRALOSE | ORAL | POWDER, FOR SOLUTION | 56038132 | 96K6UQ3ZD4 | 414mg | ||
SUCRALOSE | ORAL | POWDER, FOR SUSPENSION | 56038132 | 96K6UQ3ZD4 | 400mg | ||
SUCRALOSE | ORAL | SOLUTION | 56038132 | 96K6UQ3ZD4 | 800mg | ||
SUCRALOSE | ORAL | SUSPENSION | 56038132 | 96K6UQ3ZD4 | 264mg | ||
SUCRALOSE | ORAL | SUSPENSION, EXTENDED RELEASE | 56038132 | 96K6UQ3ZD4 | 16mg | ||
SUCRALOSE | ORAL | SYRUP | 56038132 | 96K6UQ3ZD4 | 72mg | Y | |
SUCRALOSE | ORAL | TABLET | 56038132 | 96K6UQ3ZD4 | 45mg | ||
SUCRALOSE | ORAL | TABLET, CHEWABLE | 56038132 | 96K6UQ3ZD4 | 28mg | ||
SUCRALOSE | ORAL | TABLET, EFFERVESCENT | 56038132 | 96K6UQ3ZD4 | 1080mg | ||
SUCRALOSE | ORAL | TABLET, EXTENDED RELEASE | 56038132 | 96K6UQ3ZD4 | 1mg | Y | |
SUCRALOSE | ORAL | TABLET, FILM COATED | 56038132 | 96K6UQ3ZD4 | 0.18mg | ||
SUCRALOSE | ORAL | TABLET, FOR SUSPENSION | 56038132 | 96K6UQ3ZD4 | 65mg | ||
SUCRALOSE | ORAL | TABLET, ORALLY DISINTEGRATING | 56038132 | 96K6UQ3ZD4 | 60mg | ||
SUCRALOSE | ORAL | TROCHE | 56038132 | 96K6UQ3ZD4 | 60mg | ||
SUCRALOSE | SUBLINGUAL | TABLET | 56038132 | 96K6UQ3ZD4 | 12mg | ||
SUCROSE | BUCCAL | LOZENGE | 57501 | C151H8M554 | NA | ||
SUCROSE | BUCCAL | TABLET | 57501 | C151H8M554 | 109mg | ||
SUCROSE | BUCCAL | TROCHE | 57501 | C151H8M554 | NA | ||
SUCROSE | INTRAVENOUS | INJECTABLE, LIPOSOMAL | 57501 | C151H8M554 | 7560mg | ||
SUCROSE | INTRAVENOUS | INJECTION | 57501 | C151H8M554 | 19.5%w/v | ||
SUCROSE | INTRAVENOUS | INJECTION, EMULSION | 57501 | C151H8M554 | 970mg | ||
SUCROSE | INTRAVENOUS | INJECTION, POWDER, FOR SUSPENSION | 57501 | C151H8M554 | 900mg | ||
SUCROSE | INTRAVENOUS | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 57501 | C151H8M554 | 2000mg | ||
SUCROSE | INTRAVENOUS | INJECTION, SOLUTION | 57501 | C151H8M554 | NA | ||
SUCROSE | INTRAVENOUS | INJECTION, SUSPENSION, LIPOSOMAL | 57501 | C151H8M554 | 9.4%w/v | ||
SUCROSE | ORAL | CAPSULE | 57501 | C151H8M554 | 3568mg | ||
SUCROSE | ORAL | CAPSULE, COATED PELLETS | 57501 | C151H8M554 | 59.8mg | ||
SUCROSE | ORAL | CAPSULE, COATED, EXTENDED RELEASE | 57501 | C151H8M554 | 86mg | ||
SUCROSE | ORAL | CAPSULE, DELAYED RELEASE | 57501 | C151H8M554 | 955mg | ||
SUCROSE | ORAL | CAPSULE, EXTENDED RELEASE | 57501 | C151H8M554 | 619mg | ||
SUCROSE | ORAL | CONCENTRATE | 57501 | C151H8M554 | 4800mg | ||
SUCROSE | ORAL | DROPS | 57501 | C151H8M554 | NA | ||
SUCROSE | ORAL | ELIXIR | 57501 | C151H8M554 | 18000mg | ||
SUCROSE | ORAL | GRANULE | 57501 | C151H8M554 | NA | ||
SUCROSE | ORAL | GRANULE, FOR SOLUTION | 57501 | C151H8M554 | 42596mg | ||
SUCROSE | ORAL | GRANULE, FOR SUSPENSION | 57501 | C151H8M554 | 31885mg | ||
SUCROSE | ORAL | GRANULE, FOR SUSPENSION, EXTENDED RELEASE | 57501 | C151H8M554 | NA | ||
SUCROSE | ORAL | LIQUID | 57501 | C151H8M554 | 37500mg | ||
SUCROSE | ORAL | LOZENGE | 57501 | C151H8M554 | 1255mg | Y | |
SUCROSE | ORAL | PASTILLE | 57501 | C151H8M554 | 426mg | ||
SUCROSE | ORAL | POWDER | 57501 | C151H8M554 | 27768mg | ||
SUCROSE | ORAL | POWDER, FOR SOLUTION | 57501 | C151H8M554 | 38666mg | ||
SUCROSE | ORAL | POWDER, FOR SUSPENSION | 57501 | C151H8M554 | 40017mg | ||
SUCROSE | ORAL | SOLUTION | 57501 | C151H8M554 | 70000mg | Y | |
SUCROSE | ORAL | SUSPENSION | 57501 | C151H8M554 | 48209mg | ||
SUCROSE | ORAL | SUSPENSION, EXTENDED RELEASE | 57501 | C151H8M554 | 5400mg | ||
SUCROSE | ORAL | SUSPENSION/ DROPS | 57501 | C151H8M554 | 3750mg | ||
SUCROSE | ORAL | SYRUP | 57501 | C151H8M554 | 46400mg | ||
SUCROSE | ORAL | TABLET | 57501 | C151H8M554 | 4249mg | ||
SUCROSE | ORAL | TABLET, CHEWABLE | 57501 | C151H8M554 | 7258mg | Y | |
SUCROSE | ORAL | TABLET, COATED | 57501 | C151H8M554 | 516.42mg | ||
SUCROSE | ORAL | TABLET, DELAYED RELEASE | 57501 | C151H8M554 | 295.33mg | ||
SUCROSE | ORAL | TABLET, EXTENDED RELEASE | 57501 | C151H8M554 | 284.54mg | ||
SUCROSE | ORAL | TABLET, FILM COATED | 57501 | C151H8M554 | 145mg | Y | |
SUCROSE | ORAL | TABLET, FILM COATED, EXTENDED RELEASE | 57501 | C151H8M554 | 119.12mg | ||
SUCROSE | ORAL | TROCHE | 57501 | C151H8M554 | NA | ||
SUCROSE | ORAL | WAFER | 57501 | C151H8M554 | 155.2mg | ||
SUCROSE | RECTAL | SOLUTION | 57501 | C151H8M554 | 35.42%w/v | ||
SUCROSE | RECTAL | SUPPOSITORY | 57501 | C151H8M554 | NA | ||
SUCROSE | SUBCUTANEOUS | INJECTION | 57501 | C151H8M554 | 47.75mg | ||
SUCROSE | SUBCUTANEOUS | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 57501 | C151H8M554 | 308mg | ||
SUCROSE | SUBCUTANEOUS | INJECTION, SUSPENSION, EXTENDED RELEASE | 57501 | C151H8M554 | 1mg | ||
SUCROSE | SUBLINGUAL | TABLET | 57501 | C151H8M554 | 109mg | ||
SUCROSE DISTEARATE (HLB 5) | TOPICAL | CREAM | 27195160 | 33X4X4B90S | 25mg | ||
SUCROSE PALMITATE | ORAL | TABLET | 26446388 | 3OSQ643ZK5 | 1.25mg | ||
SUCROSE STEARATE | ORAL | CAPSULE, EXTENDED RELEASE | 25168734 | 274KW0O50M | 57mg | ||
SUCROSE STEARATE | ORAL | TABLET, EXTENDED RELEASE | 25168734 | 274KW0O50M | 57mg | ||
SUCROSE STEARATE | ORAL | TABLET, FILM COATED | 25168734 | 274KW0O50M | 65mg | ||
SUCROSE STEARATE | TOPICAL | CREAM | 25168734 | 274KW0O50M | 5%w/w | ||
SUGAR LIQUID TYPE NO. 0 | ORAL | SYRUP | NA | 1.39ml | |||
SUGAR SPHERES | ORAL | CAPSULE | NA | 1470mg | |||
SUGAR SPHERES | ORAL | CAPSULE, COATED | NA | 660mg | |||
SUGAR SPHERES | ORAL | CAPSULE, COATED PELLETS | NA | 122.19mg | |||
SUGAR SPHERES | ORAL | CAPSULE, DELAYED RELEASE | NA | 2521mg | |||
SUGAR SPHERES | ORAL | CAPSULE, DELAYED RELEASE PELLETS | NA | 1080mg | |||
SUGAR SPHERES | ORAL | CAPSULE, EXTENDED RELEASE | NA | 1761mg | |||
SUGAR SPHERES | ORAL | GRANULE | NA | 1880mg | |||
SUGAR SPHERES | ORAL | GRANULE, FOR SUSPENSION | NA | 240mg | |||
SUGAR SPHERES | ORAL | TABLET | NA | 253mg | |||
SUGAR SPHERES | ORAL | TABLET, COATED | NA | 10mg | |||
SUGAR SPHERES | ORAL | TABLET, DELAYED RELEASE | NA | 28mg | |||
SUGAR SPHERES | ORAL | TABLET, EXTENDED RELEASE | NA | 253mg | |||
SUGAR SPHERES | ORAL | TABLET, ORALLY DISINTEGRATING | NA | 448mg | |||
SUGAR SPHERES | ORAL | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE | NA | 420mg | |||
SUGAR/STARCH INSERT GRANULES | ORAL | SUSPENSION | NA | 2252.4mg/5ml | |||
SULFUR | INTRAVENOUS | INJECTION | 10544500 | 70FD1KFU70 | NA | ||
SULFURIC ACID | AURICULAR (OTIC) | SUSPENSION | 7664939 | O40UQP6WCF | 0.02%w/v | ||
SULFURIC ACID | ENDOTRACHEAL | INJECTION | 7664939 | O40UQP6WCF | ADJ PH | ||
SULFURIC ACID | EPIDURAL | INJECTION | 7664939 | O40UQP6WCF | ADJ PH | ||
SULFURIC ACID | EPIDURAL | INJECTION, SOLUTION | 7664939 | O40UQP6WCF | ADJ PH | ||
SULFURIC ACID | INTRAMUSCULAR | INJECTION | 7664939 | O40UQP6WCF | 566mg | ||
SULFURIC ACID | INTRAMUSCULAR | INJECTION, SOLUTION | 7664939 | O40UQP6WCF | 315mg | ||
SULFURIC ACID | INTRAPERITONEAL | INJECTION | 7664939 | O40UQP6WCF | ADJ PH | ||
SULFURIC ACID | INTRATHECAL | INJECTION | 7664939 | O40UQP6WCF | ADJ PH | ||
SULFURIC ACID | INTRATHECAL | INJECTION, SOLUTION | 7664939 | O40UQP6WCF | ADJ PH | ||
SULFURIC ACID | INTRAVENOUS | INJECTION | 7664939 | O40UQP6WCF | 566mg | ||
SULFURIC ACID | INTRAVENOUS | INJECTION, POWDER, FOR SOLUTION | 7664939 | O40UQP6WCF | ADJ PH | ||
SULFURIC ACID | INTRAVENOUS | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 7664939 | O40UQP6WCF | ADJ PH | ||
SULFURIC ACID | INTRAVENOUS | INJECTION, SOLUTION | 7664939 | O40UQP6WCF | 315mg | ||
SULFURIC ACID | INTRAVENOUS | SOLUTION | 7664939 | O40UQP6WCF | ADJ PH | ||
SULFURIC ACID | IRRIGATION | INJECTION | 7664939 | O40UQP6WCF | ADJ PH | ||
SULFURIC ACID | IRRIGATION | SOLUTION | 7664939 | O40UQP6WCF | ADJ PH | ||
SULFURIC ACID | NASAL | SPRAY | 7664939 | O40UQP6WCF | 8mg | ||
SULFURIC ACID | OPHTHALMIC | SOLUTION | 7664939 | O40UQP6WCF | 0.02%w/w | ||
SULFURIC ACID | OPHTHALMIC | SOLUTION/ DROPS | 7664939 | O40UQP6WCF | ADJ PH | ||
SULFURIC ACID | OPHTHALMIC | SUSPENSION | 7664939 | O40UQP6WCF | ADJ PH | ||
SULFURIC ACID | ORAL | SOLUTION | 7664939 | O40UQP6WCF | ADJ PH | ||
SULFURIC ACID | PARENTERAL | INJECTION, POWDER, FOR SOLUTION | 7664939 | O40UQP6WCF | ADJ PH | ||
SULFURIC ACID | RESPIRATORY (INHALATION) | CAPSULE | 7664939 | O40UQP6WCF | 78mg | ||
SULFURIC ACID | RESPIRATORY (INHALATION) | SOLUTION | 7664939 | O40UQP6WCF | 150mg | ||
SULFURIC ACID | SUBCUTANEOUS | INJECTION | 7664939 | O40UQP6WCF | ADJ PH | ||
SULFURIC ACID | SUBCUTANEOUS | INJECTION, SOLUTION | 7664939 | O40UQP6WCF | 2mg | ||
SULFURIC ACID | TOPICAL | CREAM | 7664939 | O40UQP6WCF | ADJ PH | ||
SULFUROUS ACID | INTRAMUSCULAR | INJECTION | 7782992 | J1P7893F4J | ADJ PH | ||
SYNCHRON ORAL CARRIER | ORAL | TABLET, EXTENDED RELEASE | NA | 475mg | |||
SYNCHRON ORAL CARRIER VEHICLE TYPE EM | ORAL | TABLET, EXTENDED RELEASE | NA | 220mg | |||
SYNTHETIC BEESWAX | TOPICAL | CREAM | 08MNR5YE2R | 3.5%w/w | |||
SYNTHETIC IRON OXIDES | ORAL | CAPSULE, COATED, EXTENDED RELEASE | NA | NA | |||
SYNTHETIC IRON OXIDES | ORAL | TABLET, FILM COATED | NA | NA | |||
SYNTHETIC IRON OXIDES | ORAL | TABLET, ORALLY DISINTEGRATING | NA | 0.1mg |
FDA/Center for Drug Evaluation and Research
Office of Generic Drugs
Office of Bioequivalence
Mailbox for IID corrections: IIDUpdate@fda.hhs.gov
Update Frequency: Quarterly
Data Through: December 19, 2024
Database Last Updated: January 22, 2025